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Introduction 
 
 
 
La compartimentation des cellules eucaryotiques est réalisée grâce à l’acquisition d’organelles 
séparées du reste de la cellule par des membranes. Toutefois, la majorité des fonctions 
physiologiques de la cellule restent tributaire des protéines. La production de protéines n’étant 
réalisée que dans le cytoplasme, la cellule doit être en mesure de cibler ses différentes 
protéines vers leur lieu de destination fonctionnel. Ce ciblage est accompli grâce à la présence 
dans les protéines de séquence signal spécifiant leur localisation cellulaire. 
Parmi les organites de la cellule eucaryotique, le réticulum endoplasmique tient une place 
particulière. La translocation des protéines vers cette organelle est un processus 
cotraductionnel qui nécessite un facteur soluble : la particule de reconnaissance du signal 
(SRP). Depuis la caractérisation de SRP par Walter et Blobel en 1980, la particule a été 
trouvée dans tous les organismes étudiés à ce jour. 
 
 
Le cycle de SRP est initié dans le cytoplasme, par une liaison de faible affinité de la particule 
avec les ribosomes. Si la chaîne naissante comprend une séquence signal, SRP reste 
étroitement lié au complexe ribosome-chaîne naissante par une interaction de la sous unité 
protéique SRP54. Cette interaction de SRP avec le ribosome conduit à un délai ou un arrêt de 
l’élongation de la chaîne naissante. Cet arrêt améliore l’efficacité de translocation des 
protéines vers le réticulum endoplasmique, en augmentant la fenêtre temporelle pendant 
laquelle la chaîne naissante est dans une conformation compatible avec sa translocation. Le 
complexe SRP-ribosome-chaîne naissante est alors adressé à la membrane du réticulum 
endoplasmique via l’interaction de SRP avec son récepteur spécifique. Une fois à la 
membrane du réticulum, SRP lié à son récepteur se détache du ribosome et la traduction de la 
chaîne naissante reprend. Le ribosome qui est maintenant engagé au niveau du translocon, 
traduit sa chaîne naissante à travers la membrane du réticulum. Enfin, une étape d’hydrolyse 
de GTP dissocie SRP de son récepteur et la particule retourne dans le cytoplasme pour y 
initier un nouveau cycle d’adressage. 
 
 
La particule des mammifères est composée d’un ARN de 300 nucléotides et de six protéines : 
SRP9, SRP14, SRP19, SRP54, SRP68, SRP72. Elle se divise en deux domaines 
fonctionnellement distincts. Le domaine S qui est responsable de la reconnaissance de la 
séquence signal, ainsi que de l’interaction avec le récepteur SRP, et qui comprend la partie 
centrale de l’ARN SRP et les protéines SRP19, SRP54, SRP68 et SRP72. Le deuxième 
domaine, le domaine Alu, contient les extrémités 3’ et 5’ de l’ARN SRP, ainsi que 
l’hétérodimère SRP9/14. Il est responsable de la fonction d’arrêt d’élongation de la chaîne 
naissante. 
A l’exception de la particule chloroplastique, tous les SRPs sont des complexes 
ribonucléoprotéiques composés d’un ARN et d’au moins une protéine. 
La sous unité protéique SRP54 est la plus importante de toutes, elle est d’ailleurs conservée 
dans toutes les particules. Cette protéine est responsable de la reconnaissance de la séquence 
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signal, ainsi que de l’adressage, par le biais de son interaction avec le récepteur SRP au sein 
de la membrane du réticulum endoplasmique. 
Les protéines SRP9 et SRP14 sont les seuls composants protéiques du domaine Alu. Elles se 
lient à l’ARN SRP sous la forme exclusive d’un hétérodimère 9/14 qui reconnaît une 
séquence simple brin hautement conservée. L’hétérodimère est impliqué dans la fonction 
d’arrêt d’élongation, comme le montre la délétion de l’extrémité carboxylique de la protéine 
SRP14. 
A ce jour, l’activité d’arrêt d’élongation de SRP a été observée uniquement chez les 
eucaryotes. Elle implique une liaison directe du domaine Alu avec les ribosomes. 
L’interaction de SRP avec le ribosome a lieu après la réaction de transpeptidylation, avant que 
le peptidyl-ARNt ne subisse sa translocation du site A vers le site P. Des expériences de 
cross-link réalisée dans le laboratoire ont permis de situer le domaine Alu de SRP à l’interface 
des deux sous unités ribosomiques. 
 
Le domaine Alu comprend deux sous domaines, le domaine 5’ qui contient la région la plus 
strictement conservée et qui constitue le site de liaison principal de SRP9/14, et le domaine 3’ 
qui consiste en deux segments hélicoïdaux connectés par une boucle interne asymétrique. 
Deux boucles de l’ARN du domaine Alu des mammifères sont appariées par des interactions 
tertiaires de type Watson-Crick. Le potentiel d’appariement de base entre ces deux boucles de 
l’ARN Alu est phylogénétiquement conservé, ce qui suggère un rôle de cette structure 
tertiaire dans la fonction de la particule. 
Dans le modèle de structure native du domaine Alu, les domaines 5’ et 3’ sont enserrés à 
l’intérieur de la surface en feuillet β de l’hétérodimère SRP9/14. Dans ce modèle, le 
domaine 3’ de l’ARN Alu est replié contre le domaine 5’, de sorte que la partie centrale de 
l’ARN SRP émerge du côté de l’extrémité carboxylique de la protéine SRP14. 
Bien que les structures cristallographiques de plusieurs sous unités de SRP soient disponibles, 
les mécanismes moléculaires conduisant à l’arrêt de l’élongation de la chaîne naissante en 
présence de SRP restent inconnus. Le domaine Alu est impliqué dans le processus, et au 
moins une sous unité, SRP14, joue un rôle dans cet arrêt d’élongation, mais qu’en est-il des 
autres sous unités du domaines Alu ? 
Dans la structure du domaine Alu, les protéines SRP9/14 et les deux boucles appariées de 
l’ARN sont exposées au solvant. Ainsi, protéines et ARN sont de potentiels candidats pour 
une interaction avec des composants de l’appareil traductionnel. Nous avons donc entrepris 
une analyse mutationnelle des composants du domaine Alu afin de déterminer leur rôle 
respectif dans l’activité d’arrêt d’élongation de SRP. 
 
 
 
 
 
 
 
 
 
Résultats 
 
 
 
Bien que les protéines SRP9 et SRP14 soient des homologues structurels, les mutations de 
leur séquence n’ont les mêmes conséquences. Les fonctions de la protéine SRP14 requièrent 
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une séquence relativement intacte et seuls des changements mineurs sont tolérés. En fait, 
seules deux régions de SRP14 peuvent être mutées sans incidence notable sur la dimerisation 
ou sur la liaison à l’ARN. Il s’agit de l’extrémité carboxylique et d’une boucle interne 
localisée entre les feuillets β1 et β2.  
Selon les résultats obtenus préalablement dans notre laboratoire, les vingt derniers acides 
aminés de SRP14 sont nécessaires à l’activité d’arrêt d’élongation de SRP. Toutefois, les 
quinze derniers acides aminés de SRP14 ne sont pas visibles dans la structure 
cristallographique du domaine Alu. Par contre, les résidus des positions 93, 94 et 95 de 
SRP14 sont visibles et font partie de l’interface de l’hétérodimère. Il est donc concevable que 
les effets observés précédemment, avec la délétion des vingt derniers acides aminés de 
SRP14, puissent indirectement résulter de changement de conformation au sein du complexe 
ARN/protéines. 
Afin d’explorer le rôle de l’extrémité carboxylique de SRP14, nous avons réalisé une nouvelle 
délétion de la protéine, ne gardant que les acides aminés visibles dans la structure. Ce qui fut 
réalisé par l’introduction d’un codon stop juste après la lysine 95 de SRP14. Basé sur la 
structure du domaine Alu, cette protéine devrait contenir tous les éléments nécessaires à 
l’assemblage du domaine Alu de SRP. 
Des particules furent donc assemblées avec des protéines SRP19, SRP54 et SRP9/14K95 
recombinantes, ainsi qu’avec des protéines SRP68/72 et de l’ARN SRP purifiés de pancréas 
de chien. Les particules reconstituées furent introduites dans des réactions de traduction in 
vitro à base d’extrait de germe de blé, en présence d’ARN messagers codant pour une 
protéine sécrétée, la préprolactine bovine, et pour une protéine cytoplasmique, la cycline D 
d’oursin de mer. Les particules de type sauvage, reconstituées avec des protéines non mutées, 
inhibent spécifiquement la traduction de l’ARN messager codant pour la préprolactine, alors 
que la traduction du messager codant pour la cycline n’est pas affectée. Au contraire, les 
particules reconstituées avec la protéine tronquée SRP9/14K95 ne réduisent plus la traduction 
de la préprolactine, indiquant que ces particules sont déficientes pour l’activité d’arrêt 
d’élongation. 
Puisque l’arrêt d’élongation dépend de la présence d’une séquence signal sur la chaîne 
naissante, nous avons également étudié l’efficacité de translocation de la préprolactine dans 
des microsomes. Il en résulte que les deux types de particules, sauvage et mutée, sont 
capables d’induire la translocation de la préprolactine dans les microsomes, comme indiqué 
par l’apparition d’une bande de prolactine, résultant du clivage de la séquence signal de la 
préprolactine par la signal peptidase présente à l’intérieur des microsomes. Toutefois, la 
particule reconstituée avec la protéine SRP9/14K95 ne présente que 50 % de l’activité de 
translocation de la particule sauvage. Ce résultat est en accord avec tous les résultats 
précédents, qui démontraient qu’une particule déficiente pour l’arrêt d’élongation ne 
présentait plus que la moitié de l’efficacité de translocation par rapport à une particule de type 
sauvage. 
Afin de nous assurer que c’était bien la présence de la protéine SRP9/14K95 dans nos 
reconstitutions qui engendrait la perte de l’activité d’arrêt d’élongation, nous avons réalisé des 
expériences de compétitions. Dans ces expériences, la particule fut reconstituée avec des 
composants de type sauvage, mais en présence de quantités croissantes de protéines tronquées 
SRP9/14K95. La protéine mutée devant entrer en compétition avec la protéine sauvage dans 
le cadre de l’assemblage de la particule et ainsi abolir l’activité d’arrêt d’élongation de la 
particule de type sauvage. De fait, des concentrations croissantes de la protéine mutée 
diminuent l’activité d’arrêt d’élongation ainsi que l’efficacité de translocation des particules 
reconstituées. C’est donc bien la présence de SRP9/14K95 qui induit le phénotype. 
En présence de SRP9/14, deux régions de la partie centrale de l’ARN SRP sont protégées du 
clivage par des radicaux hydroxyles. Puisque l’extrémité carboxylique de SRP14 se trouve à 
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proximité de la partie centrale de l’ARN dans la structure du domaine Alu, nous avons décidé 
de vérifier si la protéine mutée SRP9/14K95 produisait les mêmes sites de protections que la 
protéine SRP9/14 sauvage. A cette fin, nous avons marqué radioactivement un ARN Alu de 
151 nucléotides, contenant toutes les fonctionnalités du domaine Alu de l’ARN SRP. Cet 
ARN a été utilisé pour reconstituer le domaine Alu de SRP, en présence de protéine SRP9/14 
sauvage ou mutée. Les complexes ainsi formés ont été soumis au clivage par des radicaux 
hydroxyles. Il en résulte que la protéine mutée SRP9/14K95 présente exactement les mêmes 
sites de protection de la partie centrale de l’ARN SRP que la protéine de type sauvage, à 
savoir les régions G48-G51 et G58-G62. 
 
 
La seule autre partie de la protéine SRP14 pouvant être mutée sans interférer avec les 
fonctions de dimerisation et de liaison à l’ARN est une boucle interne d’une vingtaine de 
résidus, située entre les feuillets β1 et β2. Cette boucle interne ne présente que peu de 
conservation phylogénique ; seuls quatre acides aminés basiques aux positions 31, 32, 42 et 
43 sont conservés. La majorité des résidus de cette boucle ne sont pas visibles dans la 
structure cristallographique. La mutation ou la délétion des quatre résidus conservés conduit à 
une perte de liaison de la protéine avec l’ARN SRP. Toutefois, la mutation de seulement deux 
de ces résidus à la fois ne diminue pas la liaison à l’ARN. Comme il s’agit de résidus basiques 
et qu’ils ne sont pas tous visibles dans la structure du domaine Alu, il est possible que ces 
acides contribuent à l’activité d’arrêt d’élongation de SRP par le biais d’une interaction avec 
un composant ribosomique. Nous avons donc produit une protéine SRP14 tronquée dans 
laquelle nous avons supprimé tous les résidus de la boucle interne qui ne sont pas visibles 
dans la structure ; à savoir les acides aminés compris entre l’arginine en position 36 et l’acide 
aspartique en position 53. La protéine SRP14sloop ainsi obtenue a été utilisée dans des 
expériences de reconstitution de SRP. L’activité d’arrêt d’élongation de telles particules a été 
testée comme décrit précédemment. Il en résulte que la délétion des acides aminés compris 
entre l’arginine 36 et l’acide aspartique 53 n’a aucune incidence sur la fonction d’arrêt 
d’élongation. En effet, les particules reconstituées avec la protéine SRP14sloop ont un 
phénotype de type sauvage. 
 
 
Le modèle de structure native du domaine Alu, résultant de la structure cristallographique, est 
supposé exister sous une forme relâchée ou sous une forme compacte, dans laquelle le 
domaine 3’ de l’ARN Alu se replie de 180° sur le domaine 5’. La protéine SRP9 est supposée 
jouer un rôle dans ce processus, car le domaine 3’ du domaine Alu de l’ARN SRP établit 
principalement des contacts avec cette protéine SRP9. En outre, dans la structure 
cristallographique, la chaîne latérale de la lysine 41 de SRP9 est insérée entre les domaines 3’ 
et 5’ de l’ARN Alu, où elle est supposée établir des contacts avec les nucléotides U23 et G58. 
Des mutations préalables de cette lysine 41 ont montré qu’elles réduisaient la formation de la 
structure compacte des complexes Alu formés avec un ARN de 86 nucléotides. Afin de 
vérifier l’incidence de cette conformation compacte du domaine Alu de SRP, nous avons 
produit des protéines SRP9 mutées en position 41. La lysine qui est normalement présente à 
cette position a été substituée par une alanine, qui doit normalement abolir les interactions 
avec l’ARN, ou par une arginine, qui doit elle restaurer l’interaction. Comme précédemment, 
ces protéines tronquées ont été introduites dans des particules par reconstitution in vitro, puis 
nous avons testé l’activité d’arrêt d’élongation de ces particules. Mais ni la protéine 
SRPK41A, ni la SRP9K41R n’ont le moindre effet sur l’arrêt de l’élongation de la 
préprolactine en présence de particules reconstituées. 
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A l’exception de la particule chloroplastique, tous les SRPs comprennent une molécule 
d’ARN. Toutefois, le rôle joué par cet ARN dans les fonctions de SRP reste inconnu. 
Dans la structure du domaine Alu, deux boucles distantes de l’ARN sont appariées par trois 
interactions de type Watson-Crick. De plus, d’après la structure cristallographique, les 
protéines et les boucles appariées de l’ARN sont exposées au solvant. Ce sont donc des cibles 
potentielles pour une interaction avec la machinerie traductionnelle, pouvant conduire à l’arrêt 
de l’élongation des chaînes naissantes présentant une séquence signal. 
Afin d’étudier le rôle de la structure tertiaire de l’ARN SRP du domaine Alu, nous avons 
produit des ARNs synthétiques, dans lesquels nous avons interrompu les appariements de 
base entre les boucles par des mutations dans l’une ou l’autre des boucles. Nous avons 
également restauré ces appariements par des mutations introduites dans les deux boucles, 
restaurant la structure tertiaire mais sans conserver la séquence primaire des deux boucles. 
L’activité d’arrêt d’élongation de SRP nécessitant la présence du dimère SRP9/14, la première 
étape de l’étude de nos ARNs mutés consistait en l’étude des capacités de ces ARNs à lier 
SRP9/14. 
L’analyse comparative des séquences d’ARN SRP de différentes espèces a conduit à 
l’élaboration d’un modèle d’appariement anti-parallèle entre quatre nucléotides de chacune 
des boucles de l’ARN du domaine Alu. La résolution de la structure cristallographique du 
domaine Alu montre que seuls trois appariements de base de type G-C ont lieu entre les 
boucles L2 et L1.2 de l’ARN, impliquant les nucléotides G13, G14, C15 et C37, C34, G33 
respectivement. Nous avons donc produit des mutants de l’ARN SRP dans lesquels nous 
avons interrompu deux ou trois des appariements de base entre les boucles L2 et L1.2. 
Spécifiquement, nous avons muté deux ou trois nucléotides dans chacune des boucles, en 
remplaçant les guanidines par des cytidines et vice versa. Les mutations complémentaires 
introduites dans les deux boucles, restaurent donc trois appariements de base de type G-C. 
Nous avons examiné les effets de ces mutations sur la liaison de SRP9/14 en utilisant des 
ARNs biotinylés. Concrètement, la protéine SRP14, traduite in vitro en présence de [35S]-
méthionine, est complémentée avec de la protéine SRP9 recombinante, puis mise en présence 
des ARNs mutés. Les complexes ARN/protéines sont séparés des protéines seules par leur 
liaison à des billes magnétiques de streptavidine. Nous avons ainsi vu que tous les ARNs 
mutés étaient capable de lier l’hétérodimère 9/14. Les mutations introduites dans la boucle 
L1.2 et les deux mutants compensatoires (qui restaurent les trois appariements de base) n’ont 
pas d’effet sur la liaison de la protéine à l’ARN. Par contre les deux ARNs présentant des 
mutations exclusivement dans la boucle L2 ont une efficacité de liaison de l’hétérodimère qui 
est réduite de moitié par rapport à l’ARN de type sauvage. Ceci s’observe également avec des 
mutations additionnelles dans lesquelles nous avons changé les nucléotides C13C14 et G33G34 
en différentes combinaisons d’uridines et d’adénines. Ainsi, la formation d’interactions 
tertiaires entre les boucles L2 et L1.2 de l’ARN Alu de SRP semble nécessaire pour une 
liaison efficace de SRP9/14. Pour quantifier les interactions de SRP9/14 avec les ARNs 
mutés, nous avons combiné des expériences de compétition et de retard sur gel. Cette 
combinaison nous permet de comparer directement les constantes de dissociation des ARNs 
mutés et de la protéine SRP9/14 avec celle de l’ARN de type sauvage. En raison de la grande 
taille de l’ARN SRP (300 nucléotides) par rapport aux protéines SRP9 et SRP14, il n’est pas 
aisé de distinguer clairement l’ARN seul du complexe sur un gel natif. Nous avons donc 
introduit nos mutations dans un ARN Alu de 86 nucléotides, précédemment décrit comme le 
domaine minimum liant l’hétérodimère de façon efficace. Cet ARN est suffisamment petit 
pour permettre la distinction non équivoque du complexe ARN/protéine et de l’ARN seul. Cet 
ARN de 86 nucléotides a été radiomarqué au [32P], combiné avec SRP9/14 dans des 
conditions permettant la saturation de la liaison ARN/protéine, et incubé avec des quantités 
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croissantes d’ARN compétiteur non marqué. Le complexe a été séparé de l’ARN seul par 
électrophorèse en conditions natives. La quantité d’ARN radiomarqué en complexe avec 
SRP9/14 a été évaluée pour chacune des concentrations de compétiteur. La valeur obtenue a 
été intégrée mathématiquement afin d’obtenir une valeur finale représentant le rapport de la 
constante de dissociation du compétiteur avec celle de l’ARN de type sauvage. Les résultats 
ainsi obtenus sont en adéquations avec les résultats des ARNS biotinylés, puisque seuls les 
ARNs mutés exclusivement dans la boucle L2 ont une efficacité de liaison de SRP9/14 qui est 
réduite. Toutefois, les constantes de dissociation des ARNs mutés sont très peu différentes de 
celle de l’ARN de type sauvage. Cette différence par rapport aux expériences avec les ARNs 
biotinylés résulte probablement d’un problème technique qui conduit à une perte exagérée du 
complexe lors des étapes de lavage, alors que le retard sur gel ne présente pas de telles étapes 
de lavage. 
Néanmoins, les ARNs mutés présentent au maximum une diminution de seulement 50 % de la 
liaison à SRP9/14. Or, la constante de dissociation de l’ARN SRP pour l’hétérodimère 9/14 a 
été mesurée comme étant une valeur subnanomolaire. Il en résulte que cette réduction de 
50 % de la liaison à SRP9/14 ne doit pas interférer avec la reconstitution des particules 
utilisées pour les expériences d’arrêt d’élongation. Nous avons donc testé la capacité 
d’induction d’arrêt d’élongation de particules reconstituées avec nos ARNs mutés. Ces 
expériences nous montrent que la rupture des appariements de base entre les boucles, par 
mutations de nucléotides de la boucle L2, conduit à une réduction significative mais non 
complète de l’activité d’arrêt d’élongation ; et ceci indépendamment du fait que la rupture 
touche deux ou trois des appariements de base. Par contre, les mutations compensatoires 
introduites dans la boucle opposée et restaurant les interactions sont capable de restaurer 
pleinement la fonction d’arrêt d’élongation de SRP. Au contraire, les mutations de la seule 
boucle L1.2 n’ont qu’un effet modéré, puisque la rupture de deux appariements est sans effet, 
et celle de trois appariements réduit faiblement l’arrêt d’élongation. Ces effets sont confortés 
par la mesure de l’efficacité de la translocation de préprolactine dans les microsomes. Ainsi 
les particules qui contiennent des ARNs mutés uniquement dans la boucle L2 ont une 
translocation réduite par rapport aux particules sauvages, alors que toutes les autres particules 
se comportent comme des particules de type sauvage. 
Seuls les ARNs mutés qui présentent une réduction de liaison de SRP9/14 ont une réduction 
de leur activité d’arrêt d’élongation. Nous avons donc voulu nous assurer que les effets 
observés sur la fonction d’arrêt d’élongation ne procédaient pas d’une diminution de la liaison 
de SRP9/14. A cette fin, nous avons reconstitué des particules avec des ARNs mutés, en 
présence de quantités croissantes de protéine SRP9/14, puis testé l’activité d’arrêt 
d’élongation et l’efficacité de translocation de ces particules. Il en résulte que la réduction de 
l’arrêt d’élongation observée précédemment n’est pas affectée par l’utilisation de 
concentrations croissantes de SRP9/14. Les valeurs mesurées stagnent autour d’une valeur 
similaire à celle mesurée précédemment, et ce quelle que soit l’excès de 9/14 utilisé. 
De même puisque nous travaillons avec des ARNs synthétisés in vitro, qui peuvent adopter 
plusieurs conformations différentes, nous avons voulu vérifier si l’ARN était limitant dans nos 
mesures, conduisant ainsi indirectement à la réduction de la fonction d’arrêt d’élongation 
observée. Pour cela, nous avons utilisé des quantités croissantes d’ARNs mutés dans les 
expériences de reconstitution de SRP, tout en gardant les quantités de protéines constantes. 
Comme pour l’excès de 9/14, l’augmentation des quantités d’ARNs ne permet pas de 
restaurer le phénotype. 
Enfin pour écarter définitivement l’hypothèse d’une influence de la protéine et d’une certaine 
conformation de l’ARN, nous avons décidé de purifier nos particules après reconstitution sur 
une colonne DE53. Cette colonne nous permet de séparer les particules complètement 
reconstituées de celles qui ne le sont que partiellement grâce à leur élution différentielle en 
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présence de sels. Cette méthode nécessitant l’utilisation de grandes quantités de protéines, 
nous avons limité notre étude à trois particules, une de type sauvage, servant de contrôle 
positif, une où deux appariements de base sont rompus par des mutations dans la boucle L2, et 
enfin la mutation complémentaire qui restaure les interactions. 
Les particules purifiées sont introduites à différentes concentrations dans des réactions de 
traduction in vitro. Aux  concentrations les plus hautes, la particule mutée seulement dans la 
boucle L2 présente une activité d’arrêt d’élongation réduite par rapport aux deux autres 
particules. En accord avec nos précédents résultats, l’arrêt d’élongation est réduit mais pas 
totalement aboli. La mesure de l’efficacité de translocation montre que les particules sauvages 
et le mutant compensatoire atteignent une valeur plateau dès la concentration de 40 nM. Le 
mutant L2 quant à lui montre une courbe de translocation qui n’a pas encore atteint son 
plateau à la concentration maximale utilisée de 80 nM. Cependant, sa valeur d’efficacité de 
translocation est en constante augmentation et laisse présager qu’elle pourrait atteindre un 
niveau équivalent à celui de la particule sauvage à des concentrations supérieures à 80 nM. 
 
 
 
 
 
 
 
 
 
 
 
Discussion  
 
 
Protéines du domaine Alu 
 
 
 
L’analyse mutationnelle entreprise ici nous a permis de confirmer le rôle primordial de 
l’extrémité carboxylique de la protéine SRP14 dans la fonction d’arrêt d’élongation de SRP. 
Nous avons ainsi démontré que la délétion du domaine carboxylique de SRP14 conduit à une 
complète abolition de l’activité d’arrêt d’élongation de la particule. De plus nous avons pu 
réduire le champ d’investigation à cinq acides aminés, localisé entre les positions 95 et 100. 
Cette perte de fonction peut être corrélée à la perte d’une interaction avec un composant 
ribosomique. Ainsi, alors que la protéine SRP14 sauvage est capable de lier un complexe 
formé de l’ARN ribosomique du centre associé aux GTPases (rGAR) et de la protéine 
ribosomique L12, la protéine tronquée SRP14K95 a perdu cette capacité de liaison. La 
délétion des quinze derniers acides aminés de SRP14 n’abolit pas complètement la liaison de 
SRP au ribosome, puisqu’une certaine efficacité de translocation est toujours observée, mais il 
est concevable de voir une corrélation entre la perte de la fonction d’arrêt d’élongation et la 
perte de liaison au complexe rGAR/L12. 
 
Le rôle de la boucle interne de SRP14 reste inconnu, mais elle ne semble pas être impliquée 
dans l’arrêt d’élongation. Au contraire de l’extrémité carboxylique de SRP14, la boucle 
interne est très peu conservée, ce qui va à l’encontre d’un important rôle fonctionnel. Seuls 
quatre acides aminés de type basique sont conservés et ils sont impliqués dans la liaison à 
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l’ARN SRP. Pourtant la boucle n’est pas entièrement visible dans la structure 
cristallographique du domaine Alu de SRP. Les résidus manquant dans la structure (de 36 à 
53) comprennent deux des quatre résidus basiques conservés, les deux autres étant visibles et 
contactant l’ARN SRP. Il est fort probable que la boucle interne de SRP14 interagisse en fait 
avec l’ARN SRP dans la région où celui-ci se replie. Ainsi cette boucle serait impliquée dans 
la formation de la conformation compacte du domaine Alu de SRP. Cette interaction n’est pas 
visible dans la structure cristallographique car cette dernière ne résulte pas de l’observation 
directe du repliement du domaine 3’ sur le domaine 5’. En effet, dans la structure ce sont deux 
molécules d’ARN distinctes qui interagissent avec l’hétérodimère 9/14. L’une par son 
domaine 5’ et l’autre par son domaine 3’. Cependant, les données biochimiques sont en 
accord avec un modèle de structure native dans lequel les domaines 5’ et 3’ d’une seule 
molécule d’ARN seraient côte à côte dans une conformation compacte du domaine Alu de 
SRP. Il est donc probable que la délétion de la boucle interne de SRP14 n’est pas suffisante 
pour abolir complètement la formation de cette forme compacte du domaine Alu, expliquant 
pourquoi la protéine mutée SRP14sloop n’a pas d’incidence sur l’activité d’arrêt d’élongation 
de la particule. De même, nous avons vu que les mutations de la lysine 41 de SRP9 
n’affectaient pas non plus l’arrêt d’élongation. 
La présence de la chaîne latérale de la lysine 41 de SRP9 dans un cas, et celle de la boucle 
interne de SRP14 dans l’autre est donc probablement suffisante pour induire le repliement du 
domaine 3’ de l’ARN Alu sur le domaine 5’. Ce repliement réduit la longueur de la particule 
d’environ 50 Å. Ainsi la formation ou non de la forme compacte devrait avoir une influence 
sur l’interaction de SRP avec le ribosome. L’absence de phénotype observée avec les mutants 
SRP14sloop et SRPK41A conforte donc l’hypothèse selon laquelle ces mutations, prises 
indépendamment, ne sont pas suffisantes pour abolir la conformation compacte du domaine 
Alu au point d’interférer avec la fonction d’arrêt d’élongation de la particule. 
 
 
ARN du domaine Alu 
 
 
Nous avons démontré pour la première fois que l’ARN du domaine Alu de SRP joue un rôle 
actif dans le processus d’arrêt d’élongation. La présence de trois appariements de base entre 
les boucles L2 et L1.2 est nécessaire pour obtenir une liaison efficace de l’hétérodimère 9/14, 
ainsi que pour la fonction d’arrêt d’élongation de la particule. Nous avons montré que la 
rupture de deux, ou des trois, appariements de base entre les boucles L2 et L1.2 résultait en 
une diminution de l’activité d’arrêt d’élongation de SRP. Les effets observés sont cependant 
différents selon la boucle qui est mutée, les mutations introduites dans la boucle L2 ayant le 
plus grand effet. Cet effet différentiel peut être expliqué par les différences de structure des 
deux boucles. Ainsi, alors que la boucle L2 est rigidifiée par des interactions internes, la 
boucle L1.2 est beaucoup plus flexible du fait de l’absence de telles interactions. 
La réduction de la fonction d’arrêt d’élongation ne découle pas d’une réduction de l’efficacité 
de l’assemblage des particules mutées car ni des concentrations croissantes de protéines, ni 
des concentrations croissantes d’ARN, ne parviennent à restaurer le phénotype. Le seul 
moyen de restaurer le phénotype consiste à restaurer les appariements de base entre les deux 
boucles. 
Le rôle critique de la structure tertiaire de l’ARN est corroboré par une étude phylogénique 
qui démontre la conservation du potentiel d’appariement des boucles chez les archéobactéries, 
les plantes et chez les métazoaires. 
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Modèle pour l’activité d’arrêt d’élongation de SRP 
 
 
La compilation de toutes les informations disponibles à ce jour en ce qui concerne les 
interactions entre SRP et le ribosome, nous a fourni des indications pour placer la structure 
cristallographique du domaine Alu dans celle du ribosome. En prenant ces informations en 
considération, j’ai placé manuellement la structure du domaine Alu dans celle du ribosome 
bactérien. Ainsi, la position du domaine Alu à l’interface des deux sous unités ribosomiques, 
avec l’extrémité carboxylique de SRP14 à proximité du centre associé aux GTPases, et le 
positionnement de la partie centrale de l’ARN SRP en direction du site de sortie de la chaîne 
naissante, nous conduit à un positionnement des deux boucles appariées de l’ARN Alu en 
direction de la petite sous unité ribosomique, à proximité de la protéine ribosomique S23. 
La particule pourrait donc interférer avec l’élongation de la chaîne naissante en bloquant 
l’interaction du facteur d’élongation deux avec le ribosome, ou en gênant le mouvement des 
deux sous unités ribosomiques l’une par rapport à l’autre. 
Du fait de notre positionnement du domaine Alu dans le ribosome, nous favorisons un 
interaction de l’ARN du domaine Alu avec un composant protéique de la petite sous unité du 
ribosome. Cette interaction ferait intervenir le squelette phosphate de la boucle L2, car elle 
peut être restaurée sans conservation de la séquence primaire de la boucle, ce qui sous entend 
qu’elle ne résulte pas d’une interaction avec un nucléotide donné de la boucle. 
Les fonctions de la protéine S23 au sein du ribosome en font un excellent candidat pour une 
interaction avec l’ARN du domaine Alu de SRP, dans le cadre de l’activité d’arrêt 
d’élongation de la particule. 
 
Nous avons donc élaboré le modèle suivant pour l’activité d’arrêt d’élongation de SRP. La 
liaison préalable du domaine Alu au ribosome permet celle du domaine S de SRP à proximité 
du site de sortie de la chaîne naissante. SRP54 peut alors interagir avec la séquence signal dès 
que celle-ci émerge du ribosome. L’interaction de l’extrémité carboxylique de SRP14 avec 
l’ARN ribosomique du centre associé aux GTPases, et l’interaction des boucles appariées de 
l’ARN Alu avec la protéine S23 conduisent au blocage de la liaison du facteur d’élongation 
deux au ribosome. En conséquence, la translocation de l’ARNt du site A vers le site P de la 
petite sous unité ribosomique n’a pas lieu, ce qui conduit à un arrêt de la traduction de la 
chaîne naissante. 
 
Ce modèle est une hypothèse de travail intéressante car il suppose une interaction du domaine 
Alu de SRP avec deux partenaires importants du cycle d’hydrolyse de GTP des facteurs 
d’élongation : le centre associé aux GTPases de la grande sous unité ribosomique, et le centre 
de décodage de l’ARN messager de la petite sous unité ribosomique. 
Ce modèle peut aussi être corrélé à un processus d’évolution dans lequel l’acquisition du 
domaine Alu aurait conduit à la fusion des deux effets distincts de l’ARN SRP des bactéries 
sur la traduction des protéines en une seule et même entité : la particule de reconnaissance du 
signal des mammifères. 
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ABSTRACT 
 
Abstract 
The Signal Recognition Particle (SRP) plays an essential role in the cotranslational targeting 
of membrane proteins and secreted proteins to the endoplasmic reticulum membrane. 
Mammalian SRP is composed of a 300 nucleotide-long RNA and of six polypeptides named 
according to their apparent molecular mass: SRP9; SRP14; SRP19; SRP54; SRP68; SRP72. 
The particle is divided in two functionally distinct domains, the S and the Alu domains. 
Binding of SRP to ribosomes that synthesise a nascent chain bearing a signal sequence leads 
to an arrest or retardation of translation that is referred to as the elongation arrest activity of 
SRP. The arrest is released when the SRP-ribosome-nascent chain complex is engaged at the 
endoplasmic reticulum membrane. Elongation arrest has only been observed in Eukaryotes 
and involves direct contacts between the Alu domain and the ribosome. 
The crystal structure of the Alu domain shows that proteins as well as RNA are solvent 
exposed and therefore accessible for putative interactions with components of the translational 
machinery. We investigated the role of the components of the SRP Alu domain in the 
elongation arrest activity by a mutational analysis. 
We confirmed the critical role played by the SRP14 carboxyl-terminus for the elongation 
arrest function and narrowed down the residues involved in the loss of function to five amino 
acids located between K95 and K100. 
We demonstrated that weakening the formation of the closed conformation of the Alu domain 
through truncation of the SRP14 internal loop between β1 and β2, or through mutation of 
SRP9 lysine 41 does not significantly affect the elongation arrest activity of the particle.  
We provided for the first time evidence that a specific structure of the SRP RNA Alu domain 
is required for elongation arrest activity. The presence of three base pairs between two distant 
loops of the Alu domain RNA is important for high efficiency binding of the SRP9/14, as 
well as for the elongation arrest function itself. We showed that the disruption of two or three 
of the base pairs between loops L2 and L1.2 results in a decreased elongation arrest activity of 
the reconstituted particles. The effects observed are different depending on which loop the 
mutations are introduced into. Disruption of the tertiary interactions through mutations in 
L1.2 only has a minor effect on elongation arrest activity. The effects can be rescued by 
compensatory mutations, introduced in the opposite loop, restoring the three Watson-Crick 
base pairing but with a different primary sequence. 
The reduced elongation arrest activity does not result from the reduced binding of SRP9/14, 
since neither increasing the amount of protein, nor increasing the amount of RNA in 
reconstitution are able to rescue the phenotype. Furthermore, purified mutant particles have 
the same reduced elongation arrest activity. We were only able to rescue the phenotype by 
restoring the tertiary interactions in the RNA loops, even without conserving the primary 
sequence.  
Finally, compiling all information regarding SRP-ribosome interactions, I placed the Alu 
domain in the ribosome structure and proposed a model for SRP-mediated arrest of nascent 
chain elongation. The Alu domain of SRP binds to ribosomes, allowing the S domain binding 
near the nascent chain exit site and the interaction with the signal sequence as soon as it 
emerges from the ribosome. Through interaction of the SRP14 carboxyl-terminus with the 
ribosomal RNA of the GTPase associated centre and through interaction of the base paired 
loops of Alu domain RNA with ribosomal protein S23, elongation factor 2 is prevented from 
binding to the ribosome. This results in blocking tRNA translocation in the small subunit 
from the A site to the P site, therefore arresting translation of the nascent chain. 
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INTRODUCTION 
 
Introduction 
Since the first cell appeared on Earth about 3.5 billion years ago, life generated an enormous 
number of living organisms. These organisms are highly diversified and adapted to life’s 
conditions as different as deep oceans and African deserts. Throughout their evolution, living 
organisms increased in complexity as they constantly adapted to their environment, the 
highest degree of complexity being obtained in multi-cellular organisms. A key feature of this 
increasing complexity is the appearance of highly compartmentalised cells: the Eukaryotes. In 
these cells the compartmentalisation is achieved by the acquisition of several organelles 
separated by membranes such as the nucleus, the mitochondrion and the endoplasmic 
reticulum. Despite this high level of complexity, all cells share at least two main features: 
their genetic information is stored in the form of nucleic acids and the majority of their 
physiological functions relies on proteins. This raised the problem of targeting the proteins to 
their proper place of function. Indeed as the cells are functionally compartmentalised, protein 
production is achieved in only one place: the cytoplasm. In the early seventies, Blobel and 
Sabatini, 1971 postulated that the cells overcome this problem through the addition of specific 
signal sequences on the newly translated proteins. The signal sequence is the key to the 
localisation of the protein to its specific place of function and consists of short amino acid 
sequences. These sequences can be either dispersed along the proteins as it is the case for 
nuclear localisation signals; or they can be localised specifically in the amino-terminus of the 
nascent chains in case of mitochondrial or endoplasmic reticulum localisation signals. 
In eukaryotes, the endoplasmic reticulum is an intriguing organelle in which proteins 
translocation takes place cotranslationally (Blobel and Dobberstein, 1975b; Blobel and 
Dobberstein, 1975a). Extensive biochemical analysis of cotranslational targeting ended with 
the identification of a soluble factor: the Signal Recognition Particle (SRP) (Walter and 
Blobel, 1980; Matlin, 2002). Since this first characterisation of SRP by Walter and Blobel, the 
particle has been found in all organisms investigated to date (Rosenblad et al., 2003). Except 
for the notable case of the chloroplast SRP (Keegstra and Cline, 1999), all particles are 
ribonucleoprotein complexes composed of an RNA and at least one protein.  
 
1.1 SRP cycle 
 
The SRP cycle is initiated in the cytoplasm by the low affinity binding of the particle to all 
translating ribosomes (Figure 1, step 1). If the newly synthesised nascent chain bears a signal 
sequence, SRP remains tightly associated with the ribosome-nascent chain complex through 
interaction of SRP54 with the signal sequence as soon as it emerges from the ribosome 
(Walter and Blobel, 1981b; Walter and Blobel, 1981a; Walter et al., 1981). SRP interaction 
with the ribosome leads to an arrest or a retardation of the polypeptide chain translation (step 
2), which is referred as “elongation arrest” (Walter and Blobel, 1981b; Ibrahimi, 1987; Lipp et 
al., 1987; Rapoport et al., 1987; Wolin and Walter, 1989). The SRP-mediated translation 
arrest increases the efficiency of protein translocation by enlarging the time window during 
which the nascent chain is in a translocation-competent form. The SRP-ribosome-nascent 
chain complex is then addressed to the endoplasmic reticulum membrane through interaction 
with an SRP-specific receptor (SR) on the membrane (step 3 and 4) (Meyer and Dobberstein, 
1980a; Meyer and Dobberstein, 1980b; Gilmore et al., 1982a; Gilmore et al., 1982b). The 
interaction between SRP54 and the alpha subunit of SR stimulate both proteins to bind GTP 
(step 4). 
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Figure 1: Mammalian SRP cycle (see text for detail). 
 
At the reticulum membrane, SRP bound to its receptor is released from the ribosome-nascent 
chain complex (Connolly and Gilmore, 1989) and translation resumes at its normal speed 
(step 5). The ribosome, which is now engaged to the translocon, translates its nascent chain 
across the reticulum membrane; directly through the translocon (step 6) (Pohlschroder et al., 
1997; Matlack et al., 1998; Johnson and van Waes, 1999; Menetret et al., 2000; Beckmann et 
al., 2001). SRP is released from its receptor through GTP hydrolysis that dissociates the 
complex (step 6) (Connolly et al., 1991; Miller et al., 1993 ). The particle returns then to the 
cytoplasm where it initiates new targeting rounds (step 7). Hence, by a strict coupling of 
protein synthesis to translocation, SRP ensures that nascent chains, destined to be inserted into 
the membranes, or secreted cannot misfold in the cytosol. 
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1.2 Structure and functions 
 
The mammalian particle is composed of a 300 nucleotide-long RNA and of six polypeptides 
named according to their apparent molecular mass: SRP9; SRP14; SRP19; SRP54; SRP68; 
SRP72 (for recent review see Keenan et al., 2001; Koch et al., 2003). 
 
 
Figure 2: Schematic representation of mammalian signal recognition particle. 
 
The particle can be divided into two functionally distinct domains by micrococcal nuclease 
digestion (Ullu et al., 1982; Gundelfinger et al., 1983) (Figure 2). The S domain is the 
functional unit required for signal sequence recognition. It comprises of the central part of the 
SRP RNA, the SRP19, SRP54, SRP68 and SRP72 proteins. The other domain, the Alu 
domain, contains the 3’ and 5’ end of SRP RNA as well as the SRP9 and SRP14 proteins. The 
sequence of the SRP RNA Alu domain constitutes the phylogenetic precursor of the Alu 
family of repetitive DNA sequences in Rodents and Primates (Ullu and Tschudi, 1984). 
 
1.2.1 The different subunits of mammalian SRP 
1.2.1.1 SRP RNA 
 
Canine SRP RNA was among the first one to be discovered and is the most extensively 
characterised. To date the RNA has been found in all SRPs except in chloroplasts whose 
particle is composed of only two proteins (Keegstra and Cline, 1999). The RNA size varies 
from 519 nucleotides in yeast Saccharomyces cerevisiae (Hann and Walter, 1991) to 77 
nucleotides in Mycoplasma mycoides (Samuelsson and Guindy, 1990). The role of the RNA 
in the particle remains poorly characterised. It may either serve as a scaffold to ensure proper 
three dimensional orientation of SRP proteins, or it may play an active role in the particle as 
expected by the extensive structural rearrangements it undergoes during the SRP cycle (Zwieb 
and Ullu, 1986; Andreazzoli and Gerbi, 1991).Based on the bacterial SRP crystal structure, 
the SRP RNA was proposed to play a role in signal sequence binding (Batey et al., 2000). 
Based on phylogenetic analyses, the SRP RNA can be divided into four different structural 
domains (I-IV) using the 300-nucleotide long 7S RNA from human SRP as reference 
(Gundelfinger et al., 1984; Poritz et al., 1988a). This secondary structure comprises eight 
helices numbered from 1 to 8 (Larsen and Zwieb, 1991) (Figure 3). 
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Figure 3: Secondary structure comparison for SRP RNAs from Bacteria to Mammals. Domains are 
numbered in Roman numerals according to Poritz et al., 1988b, helices are numbered according to Larsen and 
Zwieb, 1991, and missing helices are depicted in red. 
 
Domain I comprises two short hairpins and a short stem, forming a three-way junction, as 
well as a single-stranded region and it comprises helices 1 to 4. The domain I comprises the 
SRP9/14 binding sites (Strub et al., 1991). Interestingly, this domain is absent in almost all 
bacterial SRP RNAs (Larsen and Zwieb, 1991). Domain II is a long helix, helix 5, linking 
domain I and domain III and IV. Domain III (comprising helix 6) and domain IV (comprising 
helix 8) can be folded as hairpin structures. Domain IV is universally conserved and contains 
the majority of deleterious mutations (Althoff et al., 1994).  
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Each of the bacterial homologues of canine SRP RNA is missing at least one structural 
domain. In Escherichia coli the SRP RNA, named 4.5S RNA, is 114 nucleotide-long and 
folds into a single hairpin which shares significant sequence identity with domain IV of 
human SRP RNA (Hsu et al., 1984; Poritz et al., 1988b; Struck et al., 1988), but lacks the 
structure of domain I and III. rRNA phylogeny comparisons showed that bacterial SRP RNA 
derived from a molecule containing at least three of the four domains of mammalians SRP 
RNA, and that it was reduced in size via at least three independent events throughout bacterial 
evolution (Althoff et al., 1994).  
In contrast to bacterial SRP RNA which shows great size diversity, archaeal RNAs closely 
resemble mammalian SRP RNA and are quite homogenous in size with all known examples 
containing around 300 nucleotides. Archaeal SRP RNAs can be folded into secondary 
structures with helices identical to the human RNA, except for the presence of an additional 
helix formed by the pairing of the 3’ and 5’ ends: helix 1 (Kaine, 1990). This structure is also 
shared with Bacillus subtilis.  
In the three fungi Saccharomyces cerevisiae, Schizosaccharomyces pombe and Yarrowia 
lipolytica, only one part of domain I is conserved. A severe truncation of domain I occurred 
subsequently to the divergence of the Fungi from the other Eukaryotes lineage, in which most 
of the first and second hairpin loops were lost. The ubiquity of the domain IV structure 
together with the presence of conserved nucleotides implies that this domain constitutes the 
essential core of the particle. 
Mammalian SRP RNAs are 300 nucleotides long and comprise all four domains, lacking only 
the archaeal specific helix 1. 
Interestingly, despite the differences in size and sequences, archaeal RNA can functionally 
replace Escherichia coli 4.5S RNA (Brown, 1991). This is also true for human SRP RNA, 
though with less efficiency, nevertheless it was shown that human SRP RNA can extend the 
viability of cells in which 4.5S RNA synthesis is repressed (Ribes et al., 1990). 
In the trypanosomal particle, an additional t-RNA like RNA molecule is associated with the 
SRP RNA; its role remains unknown (Beja et al., 1993; Liu et al., 2003). 
Electron microscopy imaging has been used to localise the SRP RNA within the particle 
(Andrews et al., 1987). The mass of the RNA was found to be concentrated at the two ends of 
the particle, suggesting that the RNA spans the length of SRP, forming an extended stem 
structure which serves as a backbone for SRP assembly. 
1.2.1.2 SRP proteins 
1.2.1.2.1 SRP68 and SRP72 
 
Little information is available to date concerning the two biggest protein subunits of SRP: 
SRP68 and SRP72. This lack of information is mostly due to the failure of all attempts made 
to produce recombinant proteins. These proteins are only found in Eukaryotes, no 
homologues were found in Archaea despite the conservation of their binding site in the RNA. 
Both proteins have an overall basic character. In SRP68, basic amino acids cluster in a region 
near the amino-terminus, whereas the regions outside are weakly acidic (Lütcke, 1995). In 
SRP72, positively charged amino acids are found clustered in the carboxyl-terminus (Lütcke 
et al., 1993). 
SRP68/72 can be detached from SRP as a stable heterodimer in solutions of high ionic 
strength and reassembled alone with 7S RNA at reduced ionic strength (Walter and Blobel, 
1983a; Scoulia et al., 1987). Limited proteolysis experiments made on canine SRP revealed 
that a very basic fragment near the amino-terminus of SRP68 remained bound to the particle 
and was hence concluded to constitute an RNA binding domain (Scoulia et al., 1987; Lütcke 
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et al., 1993). This was confirmed by the use of SRP68 truncated mutants that positioned the 
RNA binding domain in the amino-terminal region of the protein, coinciding exactly with the 
high positively charged region found in this part of SRP68. 
Canine and yeast SRP68 proteins have a stretch of conserved amino acids near the carboxyl-
terminus (Brown et al., 1994), which for the canine SRP68 is important for the assembly of 
SRP72 (Lütcke et al., 1993). While SRP68 alone is able to interact with SRP RNA, it seems 
that SRP72 is only linked to the particle through its interaction with SRP68 (Scoulia et al., 
1987). This interaction of SRP72 with SRP68 involves the carboxyl-terminal part of both 
proteins (Lütcke et al., 1993). 
The SRP68/72 heterodimer binds the SRP RNA in the S domain independently of SRP19 and 
of SRP54 (Siegel and Walter, 1988b). The function of the heterodimer in the particle remains 
elusive, but it might be involved in translocation since inactivation of SRP68/72 by 
alkylation’s results in SRP that has lost the ability to promote translocation but which can still 
arrest elongation (Siegel and Walter, 1988c; Siegel and Walter, 1988d). In the central region 
and near the carboxyl-terminus of the canine SRP68, three motifs have been identified which 
resemble loosely conserved motifs of guanine nucleotide dissociation stimulators of Ras-
related GTPases (Althoff et al., 1994). SRP68 and SRP72 are detected in the nucleolus of 
transfected rat fibroblasts (Politz et al., 2000) and are therefore assembled early in the 
particle. Interestingly a 6 kDa carboxyl-terminal fragment of SRP72 is cleaved off during 
programmed cell death, but this does not interfere with the protein transport activity (Utz et 
al., 1998). 
1.2.1.2.2 SRP54 
 
The SRP54 subunit is by far the most important of all subunits. This subunit represents the 
core of the signal recognition particle, as illustrated by its conservation in all SRPs 
investigated to date, even chloroplast SRPs, which lack the RNA, have a homologue of 
SRP54. The protein is subdivided in three domains: The carboxyl-terminus M domain and the 
amino-terminus consisting of the N domain followed by the G domain. The amino-terminal 
part of the protein comprises of a GTP binding region, the G domain, which allows the 
interaction of SRP54 with the SRP receptor α subunit (SRα) on the reticulum membrane. 
This interaction requires both proteins to be in their respective GTP bound state (Rapiejko and 
Gilmore, 1992). The carboxyl-terminus of the protein is enriched in methionine residues and 
is responsible for signal sequence recognition and for RNA binding (Kurzchalia et al., 1986; 
Römisch et al., 1990; Lütcke et al., 1992; Zopf et al., 1993). In bacteria, the protein is the 
only one present and together with the 4.5S RNA represents a minimal particle. In eukaryotes 
SRP54 binding to the RNA requires the previous binding of the SRP19 subunit (Walter and 
Blobel, 1983a). 
Bernstein et al., 1989 postulated that the methionine residues of the M domain reside on a 
single face of several α helices, which form together a hydrophobic signal sequence binding 
pocket. The presence of these methionines endows a great structural plasticity which may 
explain how the particle is able to bind signal sequences of variable lengths and sequences. 
This methionine “bristles” model was later supported by the crystal structure of the Thermus 
aquaticus M domain (Keenan et al., 1998), revealing a domain consisting of four α helices 
organised around a small hydrophobic core and a large hydrophobic groove formed by three 
of the α helices together with a flexible loop of 19 amino acid residues (Figure 4). 
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Figure 4: Crystal structure of Thermus aquaticus Ffh M domain from Keenan et al., 1998. 
 
The groove is lined almost entirely with large hydrophobic amino acids, and is clearly large 
enough to bind signal peptides that are in the α helical conformation. Bacterial and human 
SRP54 M domains contain both a hydrophobic pocket proposed to bind the signal peptide, but 
significant differences are observed. In Ffh, as aforementioned, the groove binding the signal 
peptide is wide and short and binds a loop (Keenan et al., 1998), whereas in human SRP54 M 
domain this groove is deep and elongated and binds α helices (Clemons et al., 1999). 
The M domain is also responsible for the binding of SRP54 to the SRP RNA. This is initiated 
by a conserved, arginine-rich helix-turn-helix motif located opposite the hydrophobic groove, 
and the binding of SRP54 to SRP RNA stabilises the structure of the M domain (Kurita et al., 
1996). The bacterial protein Ffh uses the first helix, as well as the turn, to recognise a specific 
minor groove structural element in the SRP RNA. The interaction is realised through non-
canonical base pairs and through one potassium ion (Batey et al., 2000). RNA binding is 
achieved in a similar manner in bacteria and human. In fact the comparison of both structures 
revealed that the majority of RNA-protein contacts are conserved from bacteria to human and 
this despite the differences in RNA secondary structure and in the protein sequences (Batey et 
al., 2000; Kuglstatter et al., 2002). 
Isolated M domains exhibit a lower affinity for signal sequences than the intact protein, which 
suggests that the NG domain of the SRP54 subunit also plays a role in signal sequence 
recognition (Zopf et al., 1993). Crystal structures are available for Thermus aquaticus 
(Freymann et al., 1997) and for Escherichia Coli (Montoya et al., 1997). These structures 
show that the NG domain possesses a subdomain not found in any other GTPase. It facilitates 
the formation of a network of interactions within the active site residues, which stabilise the 
nucleotide-free state of the protein. The N domain is a four-helix bundle which is closely 
associated with the G domain. The function of this N domain is unknown, but mutations in it 
result in a loss of signal sequence recognition (Newitt and Bernstein, 1997). A function of the 
N domain might be to link the binding of external factors to the SRP GTPase cycle (Lu et al., 
2001; Millman et al., 2001). The G domain contains four conserved sequence motifs involved 
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in nucleotide binding (Bourne et al., 1991) and it has a β/α fold with a five-stranded β sheet 
surrounded by α helices (Figure 5). A characteristic feature of the SRP subfamily of small 
GTPases is a unique insertion sequence within the G domain, called insertion box (I-box), 
which has an αβα structure (Freymann et al., 1997). This insertion is also present in the G 
domain of the SRP receptor and has been implicated in nucleotide exchange as well as in 
SRP-SR interactions (Freymann et al., 1997; Moser et al., 1997). 
 
 
 
Figure 5: Thermus aquaticus Ffh NG domain (Freymann et al., 1997). 
 
SRP54 and SRα interact primarily through their respective NG domains. Neither SRP RNA, 
nor the SRP54 M domain are required for the stimulation of the GTPase activity in vitro 
(Macao et al., 1997; Peluso et al., 2000). One of the conserved GTPase motifs of the 
G domain, which interacts with the guanine base of the bound nucleotide, is adjacent to the 
NG domain interface, suggesting that one function of the N domain could be to sense or to 
regulate the nucleotide-state of the G domain. One function of the I-box domain could be to 
sequester residues away from the active site prior to formation of the SRP-SR complex. In 
this way, the GTP-dependent formation of the complex could be coupled to conformational 
changes leading to reciprocal stimulation of GTP hydrolysis in SRP54 and SRα (Moser et al., 
1997; Jagath et al., 2000). 
Purified complexes of SRP54-SRα and of Ffh-FtsY are capable of multiple rounds of GTP 
hydrolysis in absence of any additional component (Miller et al., 1993; Miller et al., 1994). 
Hence no external GTP exchange factor (GEF) is required for the SRP-related GTPase, the 
stabilisation of the nucleotide-free state (a hallmark of GEF activity) seems to be achieved 
intrinsically in SRP GTPases, as suggested by the comparison of GDP-bound structure of Ffh 
NG domain (Freymann et al., 1997; Freymann et al., 1999) and of the Apo structure of 
Escherichia Coli FtsY (Montoya et al., 1997). 
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Interestingly, the binding of signal peptides to Escherichia Coli Ffh destabilises both M and 
NG domains, suggesting that both domains of SRP54 are in physical contact with the peptide 
(Zheng and Gierasch, 1997). 
Consistent with its critical role in SRP functions, the SRP54 subunit is found exclusively in 
the cytoplasm and might be assembled last into the particle (Grosshans et al., 2001). 
 
1.2.1.2.3 SRP19 
 
The SRP19 protein subunit is present in all organisms that contain helix 6 of SRP RNA 
(Zwieb and Larsen, 1997), which has been identified as the primary protein binding site. 
Helix 6 is closed by a tetranucleotide GNAR hairpin loop (where N represent any nucleotide 
and R either G or A); the adenosine in the third position is strictly conserved and is essential 
for hSRP19 binding (Zwieb, 1992). The protein is able to bind alone to SRP RNA 
(Lingelbach et al., 1988) and can be found in the nucleus (Politz et al., 2000). In addition to 
its essential role in mediating SRP54 binding, no other functions of SRP19 have been 
identified so far (Walter and Blobel, 1983a). The mediation of SRP54 binding is achieved by 
an SRP19-induced conformational change in the RNA (Gowda and Zwieb, 1997). 
No SRP19 has been found in bacterial SRP, but the protein is present in all Archaea 
characterised and sequenced so far (Eichler and Moll, 2001). In Archaea, like in Eukaryotes, 
SRP19 seems to be required for assembly of SRP, causing also a conformational change in 
the SRP RNA which favours the binding of SRP54 (Diener and Wilson, 2000). 
 
 
 
Figure 6: Human SRP 19 X-ray structure resolved by Wild et al., 2001. 
 
SRP19 has been structurally characterised from human (Wild et al., 2001; Kuglstatter et al., 
2002) and from two archaeal species: Archaeoglobus fulgidus (Pakhomova et al., 2002) and 
Methanococcus jannaschii (Hainzl et al., 2002; Oubridge et al., 2002). These different 
structures revealed that the protein belongs to the α/β folding class of RNA-binding proteins. 
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The core of the protein is structurally conserved and comprises three anti-parallel β strands 
packed against two α helices and four turns situated at two extended regions. (Figure 6) 
The crystal structure of human SRP19 bound to a distal fragment of helix 6, which includes 
the GNAR tetraloop has been resolved at 1.8 Å resolution (Wild et al., 2001). It shows that 
the protein-RNA recognition is achieved without direct base recognition. SRP19 binds the 
major groove of helix 6-tetraloop and the minor groove of helix 8 and clamps the two 
tetraloops together in agreement with biochemical studies (Zwieb, 1992; Zwieb, 1994). 
Binding of SRP19 to the RNA promotes the formation of an intricate network of hydrogen 
bonds that clamps the tetraloops of helices 6 and 8 together, resulting in both helices laying 
side by side (Figure 7). The juxtaposition of both helices upon binding of SRP19 stabilise the 
interaction of SRP54 M domain with the RNA, explaining why SRP19 binding is required for 
the interaction of SRP54 with the RNA. 
 
 
 
 
Figure 7: Methanococcus jannaschii SRP19 bound to SRP RNA S domain (Oubridge et al., 2002). 
 
The crystal structure of a tertiary complex comprising the human SRP19, the M domain of 
human SRP54 and the S domain of 7SL RNA showed no direct contact between SRP19 and 
SRP54 (Kuglstatter et al., 2002). 
 
1.2.1.2.4 SRP9 and SRP14 
 
SRP9 and SRP14 are the sole protein components of the SRP Alu domain; in Mammals they 
exist as a heterodimer that forms in absence of SRP RNA (Strub and Walter, 1990). The 
heterodimerisation of the two proteins is required for binding to SRP RNA. Binding occurs to 
a region comprising both 3’ and 5’ ends of mammalian SRP RNA through a primary binding 
site consisting of a highly conserved single-stranded region with the consensus sequence 
UGUAA (Strub et al., 1991). The primary binding site forms a U-turn in SRP9/14-Alu RNA 
complex (Weichenrieder et al., 2000). This binding is stoichiometric and of subnanomolar 
affinity (Walter and Blobel, 1983a; Strub et al., 1991; Janiak et al., 1992; Bovia et al., 1994). 
The heterodimer has been shown to be implicated in the elongation arrest activity of the 
particle (Thomas et al., 1997; Mason et al., 2000). Truncation in the carboxyl-terminal part of 
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SRP14 leads to a specific loss of the elongation arrest function both in vitro and in vivo. The 
proteins seem to be assembled early in the particle as suggested by their nuclear colocalisation 
with SRP68, SRP72, SRP19 and SRP RNA (Politz et al., 2000; Politz et al., 2002). 
 
 
 
Figure 8: Human SRP9/14 heterodimer (Weichenrieder et al., 2000). SRP9 is depicted as a red labelled 
ribbon and SRP14 as a green labelled ribbon.  
 
No SRP9 and SRP14 homologues have been identified in the prokaryotic kingdom, although 
their binding sites are conserved in archaeal SRP RNA. In Bacillus subtilis, an additional 
protein component has been identified. The HBsu protein is a 10 kDa protein, originally 
identified as member of the histone-like protein family, and has been shown to bind the Alu 
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domain of Bacillus subtilis SRP RNA (Nakamura et al., 1999b). In Rodents and Primates 
there is an excess of SRP9/14 over SRP RNA, and a fraction of the protein is bound to other 
cytoplasmic particles notably the Alu particles (Chang and Maraia, 1993; Chang et al., 1994; 
Bovia et al., 1995). 
SRP9 and SRP14 have very limited sequence homology but are indeed structural homologues. 
They both form a six-stranded anti-parallel β sheet stacked against four α helices (Birse et al., 
1997; Weichenrieder et al., 2000; Weichenrieder et al., 2001) (Figure 8). The heterodimer 
interface is composed mainly of residues from β1 strand and α2 helix of each protein, as well 
as of the carboxyl-terminal part of SRP14 (Birse et al., 1997; Bui et al., 1997; Weichenrieder 
et al., 2000). The β sheet concave surface is highly positive due to the abundance of exposed 
basic residues (Birse et al., 1997). Two domains of SRP14 are not ordered in the crystals: the 
fifteen last amino acids of the carboxyl-terminus and an internal loop between β1 and β2, 
which was shown to be important for specific binding to SRP RNA (Bui et al., 1997) (Figure 
8). Both proteins contribute to the formation of the heterodimer RNA-binding domain 
explaining why heterodimerisation is a prerequisite for RNA binding. Despite their structural 
homology the proteins differ in their requirements for dimerisation: an internal fragment of 
forty three amino acids in SRP9 being sufficient to allow dimerisation, whereas SRP14 
tolerates only minor changes, such as removal of the internal loop region (Bui et al., 1997). A 
mutational analysis identified two regions critical for RNA binding, comprising α1 and the 
adjacent turn in SRP9 and the first half of SRP14 internal loop (Bui et al., 1997). 
The positively charged concave β sheet of the heterodimer is the RNA primary binding site. 
Contacts with the RNA are achieved through basic residues interaction to the RNA backbone; 
no specific base-stacking interactions are found (Weichenrieder et al., 2000).  
No SRP9 homologue has been identified in yeast were the single stranded region constituting 
SRP9/14 primary binding site is conserved. In fact the SRP14 homologue which is present 
has been shown to bind to the RNA as a homodimer in Saccharomyces cerevisiae (Strub et 
al., 1999; Mason et al., 2000). 
 
1.2.1.3 SRP receptor 
 
The mammalian SRP receptor is composed of two subunits SRα and SRβ. Like SRP54, both 
subunits of SR are GTPases. This receptor is localised at the endoplasmic reticulum 
membrane (Gilmore et al., 1982a; Gilmore et al., 1982b). It functions as a docking protein 
that links the SRP-ribosome-nascent chain complex to the translocon, allowing the 
cotranslational targeting of membrane and/or secreted proteins. The SRα subunit is a 69 kDa 
protein and homologues have been found in Eubacteria, Archaea and Eukaryotes (see SRP 
database at: http://psyche.uthct.edu/dbs/SRPDB/SRPDB.html). It is peripherally associated to 
the endoplasmic reticulum membrane via interactions with the smaller SRβ subunit (30 kDa), 
which is an integral membrane protein (Tajima et al., 1986). The GTPase domains of SRP54 
and SRα are related and constitute the SRP-related GTPase subfamily, whereas SRβ GTPase 
domain is distinct and belongs to the Arf GTPase subfamily (Miller et al., 1995). In 
Escherichia coli the homologue of the SRα subunit, FtsY, is the only one present. Like 
SRP54, FtsY is subdivided into two domains: an amino-terminal acidic domain (A) and a 
carboxyl-terminal GTPase domain (NG) (Montoya et al., 1997; Moser et al., 1997). 
Comparison of the crystal structure of Ffh and FtsY NG domains reveals a similar shape 
(Freymann et al., 1997; Montoya et al., 1997) (Figure 5). 
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Figure 9: Saccharomyces cerevisiae SRα/SRβ complex from Schwartz and Blobel, 2003. 
 
The crystal structure of Saccharomyces cerevisiae SRβ-GTP in complex with the SRα 
interacting domain has been resolved recently (Schwartz and Blobel, 2003). According to this 
structure, the SRβ subunit consists of six β sheets surrounded by five α helices (Figure 9), 
sharing canonical features of the Arf GTPase subfamily as previously predicted (Miller et al., 
1995). The structure revealed an intricate hydrogen bond network which ties both proteins 
together, allowing high affinity binding. As previously shown, the binding of SRα to SRβ 
requires both hydrophobic and hydrophilic sequences located within the amino-terminal part 
of SRα (Young et al., 1995).  
In order to interact with each other, SRP54 and SRα have to be in their GTP-bound state 
(Rapiejko and Gilmore, 1992). In this state, both proteins act as GTPase-activating proteins 
for each other, this is a unique feature among GTPases (Powers and Walter, 1995). Interaction 
between the two subunits of SR is nucleotide dependent and requires SRβ in its GTP-bound 
state (Legate et al., 2000). A chemical cross-link between SRβ and a 21 kDa ribosomal 
protein has been identified (Fulga et al., 2001). This cross-link is only obtained with the GDP-
bound state of SRβ and suggests that the ribosome might play the role of SRβ GTPase-
activating protein (GAP) (Bacher et al., 1996; Bacher et al., 1999). SRα and SRP54 do not 
require any additional factors in order to dissociate GDP (Miller et al., 1993; Miller et al., 
1994). Contrary to the case of SRα and SRP54, SRβ is a rather typical GTPase and requires 
therefore a GAP and a GEF in order to fulfil its function. As aforementioned it is likely that 
the ribosome is responsible for SRβ GAP activity, and the translocon could serve as GEF 
according to a model presented by Keenan et al., 2001. 
-30- 
Introduction 
1.3 Elongation arrest activity 
1.3.1 Functional description 
 
SRP interaction with ribosomes that synthesise a nascent-chain bearing a signal sequence 
leads to an arrest or retardation of translation (Walter and Blobel, 1981b; Ibrahimi, 1987; 
Rapoport et al., 1987), which is referred to as the elongation arrest activity of SRP. This 
function was first observed in a heterologous in vitro system, in which the addition of canine 
SRP to wheat germ ribosomes translating a secretory protein caused a complete arrest of 
elongation (Walter and Blobel, 1981b; Walter and Blobel, 1981a; Walter et al., 1981). The 
arrest is transient and occurs at multiple sites during chain elongation (Lipp et al., 1987). A 
similar retardation of secretory protein translation was observed in a homologous mammalian 
in vitro system (Wolin and Walter, 1989), it was also observed in vivo in yeast (Yaver et al., 
1992; Mason et al., 2000). An arrest in elongation may occur once the newly synthesised 
nascent-chain contains at least seventy amino acids (Walter and Blobel, 1981b; Meyer et al., 
1982). At that moment, about thirty amino acids, a length which includes the entire signal 
sequence, have emerged from the ribosome (Wolin and Walter, 1988). The arrest is released 
when the SRP-ribosome-nascent chain complex is engaged at the endoplasmic reticulum 
membrane (Gilmore et al., 1982a; Meyer et al., 1982). Elongation arrest is not a requisite for 
protein translocation (Siegel and Walter, 1985), but it increases the efficiency of protein 
translocation (Thomas et al., 1997). This is achieved by enlarging the time window during 
which the nascent chain is maintained in a translocation-competent state, as demonstrated by 
the addition of microsomal membranes at various times to synchronised translation reactions 
(Siegel and Walter, 1988a). 
To date, the elongation arrest activity has only been observed in Eukaryotes, and it involves 
the Alu domain of the particle. The first indications that the Alu domain may be implicated in 
elongation arrest activity came from Siegel and Walter, 1986. Removal of the entire Alu 
domain leads to particles that are defective for elongation arrest but still able to translocate 
proteins across the reticulum membrane. 
Thomas et al., 1997 showed that the arrest of nascent chain elongation is achieved through 
direct contacts between the Alu domain and the ribosome. These contacts require the 
carboxyl-terminal residues of the SRP14 protein. Hence, particles reconstituted with a 
truncated SRP14, lacking twenty amino acids on its carboxyl-terminus, were unable to arrest 
the nascent chain elongation. In contrast, signal recognition, targeting and ribosome binding 
of such reconstituted particles remained unaffected. 
Elongation arrest activity of the particle is a conserved function; the yeast SRP, like its 
mammalian counterpart, is able to delay the initial appearance of full-length secreted proteins 
(Mason et al., 2000). In Saccharomyces cerevisiae, the process also involved the SRP14 
subunit. As observed in the mammalian system, amino acid deletion in the carboxyl-terminal 
part of yeast SRP14 reduced the elongation arrest activity of the particle. Strikingly, whereas 
the elongation arrest defective mutant had compromised targeting function in vitro, they only 
show slight translocation defects in vivo. These defects result in a constitutive failure to 
couple translation and translocation. 
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1.3.2 Structure of the Alu domain 
 
It has been shown previously that SRP interacts with ribosomes after the transpeptidylation 
reaction and before the peptidyl-tRNA is translocated from the A-site to the P-site (Brown, 
1989; Ogg and Walter, 1995). SRP54, which binds signal sequence is located near the 
polypeptide exit site, as seen by its cross-link to ribosomal proteins L23 and L29 (Pool et al., 
2002; Gu et al., 2003). With regard to the shape and size of the particle observed by electron 
microscopy (50-60 Å wide and 220-240 Å long) (Andrews et al., 1985), the location of the S 
domain protein SRP54 near the exit site is consistent with a position of the Alu domain at the 
interface of ribosomal subunits, possibly near the A-site (Bui et al., 1997; Bui and Strub, 
1999). This position of the Alu domain was confirmed by cross-linking experiments (Terzi et 
al., see manuscript below). At the ribosomal subunit interface the Alu domain might impair 
translation by interfering with tRNA and/or elongation factor functions. Hence, it was 
suggested that elongation arrest activity was achieved through a mimicry-based mechanism of 
the Alu domain with tRNA or elongation factors. However this is not supported by the Alu 
RNP crystal structure (Weichenrieder et al., 2000).  
 
 
 
Figure 10: Alu RNP crystal structures (Weichenrieder et al., 2000). A: 5’ domain of Alu SRP RNA 
complexed with SRP9/14. B: 5’ domain and 3’ domain SRP RNA complexed with SRP9/14. The protein 
primary binding site (U-turn) and the two interacting hairpin loops (L2 and L1.2) are highlighted. C: proposed 
model for the assembly of the Alu RNP Weichenrieder et al., 2000. Upon binding of the SRP9/14, the RNA 3’ 
domain folds back onto the 5’ domain, resulting in a closed Alu RNP conformation. SRP9 and SRP14 are shown 
as red and green labelled ribbon, respectively. 
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The model proposed for the native Alu domain structure has no obvious structure similarities 
with tRNA or elongation factors. The Alu domain RNA comprises two domains: the 5’ 
domain and the 3’ domain (Figure 10). The 5’ domain contains the most highly conserved 
region of the Alu RNA (Strub et al., 1991) and is the primary binding site of the SRP9/14 
heterodimer. The crystal structure showed that the 5’ domain is compactly folded into two 
helical stacks, between helices H1.2 and H2, connected by a central U-turn (Figure 11): a 
tertiary structure the authors named τ-junction (Weichenrieder et al., 2000). This structure is 
also found in two others three-way junction RNAs, the hammerhead ribozyme (Pley et al., 
1994; Scott et al., 1995) and the rRNA 23S binding-site for the ribosomal L11 protein (Conn 
et al., 1999; Wimberly et al., 1999).  
 
 
 
Figure 11: Structure of the Alu RNA 5’ domain. A: secondary structure of the Alu SRP RNA 5’ domain. 
B: three-dimensional ribbon representation of A. Helices and loops are named according to Weichenrieder et al., 
2000. 
 
The 3’ domain consists of two helical segments connected by an internal asymmetric loop and 
contributes also to SRP9/14 binding, as previously observed by footprints (Strub et al., 1991). 
As suggested by their conserved potential for base pairing in Mammals, Archaea, Clostridium 
and Bacillus subtilis, the stem loops of the mammalian Alu RNA are connected by three 
tertiary interactions. 
The protein binds asymmetrically to the 5’ domain, with the majority of contacts made to the 
concave β sheet surface of SRP14 (Figure 10A). These interactions are mediated primarily 
through positively charged side chains that directly contact the RNA phosphate backbone. G24 
and U25 are key residues of the τ-junction, these nucleotides are the most extensively 
contacted and the only base-specifically recognised nucleotides, highlighting the previous 
observation of G24 being crucial for high efficient binding of SRP9/14 (Chang et al., 1997). In 
the model of the Alu domain native structure, SRP9/14 clamps the 5’ and the 3’ domain 
within its β sheet surface (Figure 10B), resulting in the two domains lying side by side. The 
3’ domain is packed against the 5’ domain and makes extensive contacts with the concave 
β sheet surface of SRP9, consistent with chemical footprints (Strub et al., 1991). Most of 
these 3’ domain contacts are made between the minor groove of the asymmetrical loop of the 
RNA and the β2-β3 loop of SRP9. According to the model, in complex with the SRP9/14, the 
RNA folds back on itself such that the central stem of SRP RNA, leading to the S domain of 
the particle, emerges from the SRP14 carboxyl-terminal side of the heterodimer (Figure 10C). 
A sequential assembly pathway of the SRP Alu domain has been proposed (Weichenrieder et 
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al., 2001). After SRP9 and SRP14 heterodimerisation, the heterodimer associates with the 
free Alu RNA 5’ domain. Binding of the protein to the U-turn rigidifies the structure and 
promotes the formation of tertiary Watson-Crick interactions between the loops. 
Subsequently, the 3’ domain flips to contact a surface of the 5’ domain complex composed of 
both SRP9 and of the 5’ domain RNA. The specific behaviour of the 3’ domain shed light on 
the previously observed requirement of flexibility between the 5’ and the 3’ domains, in order 
to achieve high affinity binding of the heterodimer to the RNA (Weichenrieder et al., 1997). 
 
1.3.3 Aim of the study 
 
Although crystal structures of several SRP subunits are available, the molecular mechanisms 
involved in SRP-mediated elongation arrest remain unidentified. We know that the Alu 
domain is responsible for the elongation arrest and that at least one subunit, the SRP14 
protein, plays a role in the process, but what about the other components of the Alu domain? 
From the Alu RNP structure we learned that proteins as well as RNA are solvent exposed 
(Weichenrieder et al., 2000). All three components of the Alu domain are therefore accessible 
for putative interactions with components of the translational machinery. We decided to 
investigate their implication in the elongation arrest process, using a mutational analysis of 
the SRP14, SRP9 and of the Alu domain RNA.  
The extensive analysis of mutations in SRP14 showed that only minimal modifications are 
supported without loss of function (Bui et al., 1997). Thus, we limited our analysis to regions 
of the protein that are not seen in the crystal structure: the last fifteen amino acids and the 
internal loop between β1 and β2. 
The folding of the RNA central stem onto the 5’ domain that is observed in the Alu RNP 
structure is intriguing. This folding bends the central stem up to 180°, bringing the S domain 
in a completely different orientation. Since it is the SRP9 subunit that makes contact with the 
central stem, we wanted to investigate whether complete folding of the Alu domain was a 
prerequisite for elongation arrest activity. To this end we introduced mutations into SRP9 that 
are expected to weaken the interactions between the 3’ and the 5’ domain. 
In the Alu domain SRP RNA, the potential to form tertiary base pairs between the two hairpin 
loops L1.2 and L2 (Figure 10A) is conserved in Metazoans, Archaea, Clostridium and 
Bacillus (see SRP database at http://www.psyche.uthct.edu/dbs/SRPDB/SRPDB.html). In the 
Alu RNP model derived from the structure, these loops are located on the opposite side of the 
proteins. They are exposed to the solvent and thus accessible to components of the 
translational apparatus. We decided to address the role of this specific tertiary structure in the 
elongation arrest activity. To that purpose we introduced mutations in the loop sequences in 
order to disrupt these interactions. 
 
Through this study of the SRP elongation arrest activity, we confirmed previous results 
showing the critical role played by SRP14 carboxyl-terminus (Thomas et al., 1997; Mason et 
al., 2000), and narrowed down the residues implicated to five amino acids located between 
K95 and K100. We demonstrated that the SRP14 internal loop between β1 and β2 is 
dispensable for elongation arrest activity, since its truncation results in a particle with a wild 
type phenotype. 
We showed that the disruption of the interaction with the RNA 3’ domain, resulting in the 
weakening of the closed conformation of the Alu RNP, does not significantly affect the 
functions of the reconstituted particles, indicating that this closed conformation of the Alu 
domain is not required for the proper activity of the Alu domain in the context of a complete 
particle.  
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Finally, for the first time, we showed that the RNA of the Alu domain is implicated in the 
elongation arrest activity. We demonstrated that the disruption of the base pairing between 
loops L2 and L1.2 in the SRP RNA Alu domain, results in a defect in elongation arrest 
activity. This defect is fully rescued by mutations that restore the base pairing without 
conserving the RNA primary sequence.  
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Results SRP14 
Despite their structural homology, SRP9 and SRP14 respond equally to the mutation of their 
sequences. SRP14 relies on a largely intact protein sequence for its functions and tolerates 
only minor changes in its sequence, whereas in SRP9 an internal fragment of forty three 
amino acids has been shown to be sufficient for dimerisation (Bui et al., 1997). In fact only 
two regions of the protein can be modified without impairing the SRP14 dimerisation 
function: the carboxyl-terminus and an internal loop of eighteen amino acid residues located 
between β1 and β2. Mutation of any other region of SRP14 leads to a dimerisation defect, even 
if the regions modified are not part of the dimer interface; amino and carboxyl-terminal 
α helices for example cannot be removed. 
 
1.3.1 SRP14 carboxyl-terminus 
 
We know from previous studies in our laboratory, that the removal of amino acid residues 
91-110 at the carboxyl-terminus of murine SRP14 abolished elongation arrest activity of 
reconstituted SRP (Thomas et al., 1997). In the meantime, the crystal structure of an Alu RNP 
complex revealed that amino acid residues 93, 94 and 95 are part of the heterodimer interface 
(Weichenrieder et al., 2000). It is therefore conceivable that the observed defect of elongation 
arrest activity might be indirectly due to conformational changes occurring in the complex. 
Alternatively, the conserved basic amino acids lying outside of the Alu RNA binding site 
(Figure 12) may directly contact the ribosome. In order to reinvestigate the role of this critical 
region of the SRP14 protein, we engineered a human SRP14 which lacked all amino acids not 
ordered in the structure. We decided to truncate all amino acids of the SRP14 carboxyl-
terminus that are not ordered in the crystal structure. This was achieved by the introduction of 
a stop codon in the protein sequence after lysine 95 (h14K95, Figure 13). Based on the 
structure of the Alu RNP complexes, this h14K95 comprises all the elements required for the 
assembly of the SRP Alu domain.  
 
 
 
Figure 12: Sequence alignment of SRP14 carboxyl-terminal part. Region 96 to 105 comprises at least six 
basic amino acid residues in all species. 
 
Recombinant proteins were produced in bacteria and the heterodimeric complexes h9/14 and 
h9/14K95 purified to homogeneity (Materials and Methods). As expected, the truncated 
protein h9/14K95 could efficiently bind to SRP RNA and was able to compete with the wild 
type protein for assembly into SRP. 
Particles were assembled with recombinant SRP19, SRP54, SRP9/14, canine SRP68/72 and 
canine SRP RNA using either h9/14 or h9/14K95 (RCwt, RC14K95, Materials and Methods). 
The reconstituted particles were added to wheat germ translations programmed with synthetic 
mRNAs of bovine preprolactin, a secreted protein, and sea urchin cyclin D, a cytoplasmic 
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protein. The samples were analysed by SDS-PAGE and quantified by phosphorescence 
imaging (Figure 13).  
As expected for an active reconstituted particle, the RCwt specifically inhibited the 
accumulation of full-length preprolactin as compared to the accumulation of full-length cyclin 
(Figure 13, compare lane 1 to lanes 2 and 3). In contrast, RC14K95 did not specifically 
reduce the preprolactin signal as compared to the cyclin signal indicating a lack of elongation 
arrest activity (Figure 13, compare lane 1 to lanes 4 and 5). 
 
 
 
Figure 13: Truncation of SRP14 lysine 95 abolishes the elongation arrest activity. Particles, reconstituted 
with canine and recombinant SRP proteins, including wild type hSRP9/14 (RCwt) or hSRP9/14K95 (RC14K95) 
were assayed for elongation arrest and translocation activities. In translocation assays, SRP-depleted canine 
microsomes were added to the translation reactions. In elongation arrest assays, we determined the relative 
inhibition of preprolactin synthesis as compared to cyclin. For the processing assays, the percentage of prolactin 
compared to the total amount of preprolactin and prolactin was determined. Processing [%] Stand. to –RC: 
Amount of processing due to endogenous SRP in the microsomes (lane 1) was set to 0. Lane 1: buffer; lanes 2 
and 3: 100 and 50 nM RCwt; lanes 4 and 5: 100 and 50 nM RC14K95. 
 
Since elongation arrest activity is dependent on the signal recognition function of SRP, we 
investigated the signal recognition as well as the targeting functions of the reconstituted 
particles. To that end we assayed their capacities to translocate preprolactin into SRP-depleted 
canine microsomes. RCwt and RC14K95 can promote preprolactin translocation across the 
membranes. Particles that are defective in elongation arrest activity exhibit only half the 
translocation efficiency of wild type particles (Thomas et al., 1997). Consistent with its defect 
in elongation arrest, we observed that the translocation activity of RC14K95 was intact, but its 
efficiency was reduced to half the one of RCwt (Figure 13 compare lanes 2 and 3 with lanes 4 
and 5, respectively). Hence, the signal recognition and targeting functions of RC14K95 were 
intact, and it lacked exclusively elongation arrest activity. 
To further establish that it is the presence of the truncated protein in the reconstituted particle 
that caused the defect in elongation arrest activity, we set up competition experiments. SRP 
components including wild type h9/14 were combined at equimolar ratios in the presence of 
increasing amounts of the truncated heterodimer. Similar competition experiments were 
previously done with wild type SRP9/14 protein without affecting the elongation arrest 
activity of the particle, confirming that the excess of protein by itself did not affect the 
function of the particle (Thomas et al., 1997). The h9/14K95 is expected to compete with the 
wild type protein for SRP RNA assembly, thereby abolishing elongation arrest activity of the 
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particle. Indeed increased competitor concentrations diminished the elongation arrest activity 
of the reconstituted particle (Figure 14). It also reduced the translocation efficiency to almost 
the same level as observed for particles lacking h9/14 (Figure 14, compare lanes 2 and 7). 
Hence, the presence of h9/14K95 in the particle specifically abolished its elongation arrest 
activity. 
 
 
 
Figure 14: h9/14K95 competition experiments. A: increasing amounts of h9/14K95 were introduced into the 
reconstitution reactions in presence of a constant amount of h9/14, equimolar to the other SRP proteins 
concentration. The relative inhibition of preprolactin synthesis in presence of the reconstituted particles is 
shown. Lane 1: buffer; lane 2: partially reconstituted particle lacking the SRP9/14; lane 3: reconstitution with 
wild type h9/14; lane 4 to 7: 1x, 3x, 9x and 21x molar excess of the truncated h9/14K95 in the reconstitution 
assay, respectively. The relative inhibition obtained for the wild type reconstitution, in absence of any truncated 
h9/14K95 (lane 3) was standardised to 100%. B: same competition assay as in A, except for the presence of 
SRP-depleted canine microsomes in the translation reaction. Processing activity is determined as the percentage 
of prolactin compared to the total amount of preprolactin and prolactin. The ratio obtained with the wild type 
reconstitution, in absence of the truncated heterodimer, is standardised to 100%. 
 
The effects on elongation arrest and on translocation efficiency were lower than expected for 
a competitor with equal affinity for SRP RNA. This might be due to a slightly reduced 
affinity of particles lacking elongation arrest activity for the ribosome. Nevertheless, our 
results, as well as previous results from Thomas et al., 1997, clearly showed that truncation in 
the carboxyl-terminus of SRP14 did not abolish the capacity of reconstituted SRP to bind to 
ribosomes and to promote translocation. We found later that h9/14K95 was contaminated by a 
small amount of wild type h9/14 (below 5%), resulting from ribosomal read-through at the 
stop codon in bacteria (Materials and Methods). 
In presence of SRP9/14, two hydroxyl radical protection sites were observed on the SRP 
RNA central stem (G48-G51 and G58-G62, Strub et al., 1991). According to the native structure 
model of the Alu domain, derived from the crystal structure (Weichenrieder et al., 2000), G48-
G51 protection results from protein-induced RNA tertiary contacts, whereas G58-G62 protection 
is caused by a combination of both induced RNA tertiary contacts and direct protein contacts. 
Since SRP14 carboxyl-terminus might be close to the RNA central stem, we decided to 
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investigate the structure of a particle reconstituted with our truncated heterodimer using 
hydroxyl radical cleavage assays. For that purpose, we used a synthetic Alu RNA consisting 
of 151 nucleotides (Figure 15). This RNA was designed to contain all features of the SRP 
RNA Alu domain. 
 
 
 
Figure 15: Secondary structure of Alu151 synthetic RNA. Helices are displayed as Roman numerals and 
numbered according to Larsen and Zwieb, 1991. 
 
Wild type SRP9/14, truncated SRP9/14K95 and bovine serum albumin as a control, were 
incubated with [32P]-labelled Alu151 SRP RNA under conditions allowing the binding of the 
proteins to the RNA. Subsequently, the RNA was cleaved by hydroxyl radicals (see Materials 
and Methods) and the cleavage sites were investigated on polyacrylamide sequencing gel. The 
hydroxyl radicals cleaved the RNA at almost every nucleotide in the control reactions with 
the RNA alone (Figure 16, lane R) or with RNA in presence of bovine serum albumin (lanes 3 
and 4). As previously observed, the wild type complex, composed of wild type SRP9/14 
bound to the RNA, exhibits two sites on the 3’ domain that are protected from cleavage by the 
radicals (Figure 16, lanes 1 and 2, Strub et al., 1991). In presence of the truncated 
SRP9/14K95 heterodimer, the same protection sites are observed as for the wild type complex 
(Figure 16, compare lanes 5 and 6 with 1 and 3). This indicates that the complexes, formed 
between h9/14K95 and SRP RNA, were also able to fold into a compact structure.  
The finding that h14K95 abrogated elongation arrest activity of the particle provided evidence 
that the small region outside the Alu RNA-binding domain in SRP14 plays a direct role in 
effecting elongation arrest. A critical functional role for this region is also supported by its 
high conservation (Figure 12). This region, together with the SRP9/14 binding site in SRP 
RNA (Strub et al., 1991), represents the most highly conserved features in the Alu domain. Its 
basic character is consistent with a role in binding ribosomal RNA. In fact, Terzi et al. (see 
manuscript below), showed that the carboxyl-terminal part of the SRP14 is critical for binding 
to the ribosomal RNA of the GTPase associated region. The loss of a critical contact with this 
ribosomal RNA through truncation of this region of the SRP14, could explain the strong 
effect observed on elongation arrest activity. 
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Figure 16: Alu RNP hydroxyl radical footprints. A: hydroxyl radical cleavage pattern of SRP Alu151 RNA in 
presence of SRP9/14 proteins. [32P]-labelled Alu151 RNA was incubated with wild type SRP9/14, truncated 
SRP9/14K95, or with bovine serum albumin, under conditions allowing complex formation. Alu RNPs were 
subsequently submitted to hydroxyl radical cleavage. The cleavage products were separated on an 8M Urea-6% 
polyacrylamide gel and displayed by autoradiography. A sequencing reaction, using RNases T1, U2, B. cereus, as 
well as an alkaline hydrolysis RNA ladder, were run in parallel to map the extension (data not shown). Regions 
protected from cleavage in the presence of the heterodimer are labelled I and II. Lane R: cleavage pattern of the 
naked RNA; Lanes 1 and 2: cleavage pattern of the RNA in presence of a 1:1 or 1:3 molar ratio of wild type 
SRP9/14, respectively. Lanes 3 and 4: same pattern as for lanes 1 and 2 except that bovine serum albumin 
replaces the SRP9/14; Lanes 5 and 6: same pattern as lane 1 and 3, except that the truncated SRP9/14K95 
replaces the wild type protein. B: secondary structure of the Alu151 RNA; regions protected from cleavage in 
the presence of either wild type or truncated heterodimer are outlined in grey. 
-42- 
Results SRP14 
1.3.2 SRP14 internal loop 
 
Through extensive mutational analysis, Bui et al., 1997 showed that although they are 
structural homologues, the SRP9 and SRP14 have different requirements for dimerisation. As 
mentioned before, many changes in SRP9 do not affect its function, whereas SRP14 tolerates 
only minor changes. The internal loop between β1 and β2 (Figure 8) is dispensable for the 
hSRP14 dimerisation function and shows little primary sequence conservation, except for four 
basic residues at position 31, 32, 42 and 43 (Figure 17). Furthermore, most of the loop is not 
ordered in the protein crystal structure, residues from position 36 to 53 are not seen (Birse et 
al., 1997). Mutations, or removal of all four of the conserved basic residues (K31, K32, K42 
and K43 in human SRP14) leads to a loss of RNA-binding activity (Bui et al., 1997); 
however, replacing only two of these conserved residues, failed to diminish the RNA binding 
activity. Since the missing part of the internal loop contains two of the four conserved basic 
residues, it is thought to be involved in contacting the SRP RNA. Still, in the Alu RNP crystal 
structure, this internal loop is also not ordered, despite the presence of the SRP RNA 
(Weichenrieder et al., 2000). In the context of the translating ribosome we wondered whether 
this internal loop of SRP14 might contribute to the elongation arrest function of the particle. 
To test this hypothesis we engineered a human SRP14 protein where we deleted the residues 
of the loop that are not ordered in the structure. Only two of the conserved basic amino acid 
residues (K42 and K43) were removed in this truncated protein and according to Bui et al., 
1997, it should not interfere with the binding to the SRP RNA. The truncated protein 
(hSRP14sloop) results in the truncation of eighteen amino acids, from arginine 36 to aspartate 
53, within the internal loop (Figure 17). 
 
 
 
Figure 17: Sequence alignment of SRP14 internal loop between β1 and β2. Deletion of amino acids R36 to 
D53 leading to the hSRP14sloop construct are marked by the grey box. 
 
Recombinant hSRP14sloop protein was produced in bacteria and the heterodimeric 
complexes h9/14sloop purified to homogeneity (Materials and Methods). Particles were 
assembled through combination of recombinant and canine proteins, together with in vitro 
transcribed synthetic SRP RNA (Materials and Methods). The reconstituted particles were 
added to wheat germ translations programmed with synthetic mRNAs of preprolactin, and sea 
urchin cyclin D, as for SRP9/14K95 (see Figure 13). The samples were analysed by SDS-
PAGE and quantified by phosphorescence imaging (Figure 18).  
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Figure 18: Truncation of amino acid residues R36 to D53 in the internal loop of SRP14 do not affect the 
elongation arrest activity of reconstituted particles. Particles, reconstituted with canine and recombinant SRP 
proteins, including wild type hSRP9/14 (RCwt) or hSRP9/14sloop (RCsloop) were assayed for elongation arrest 
(A) and translocation activities (B). The particles were added to an in vitro translation reaction at 100 nM final 
concentration. In translocation assays, SRP-depleted canine microsomes were added to the translation reactions. 
In elongation arrest assays, we determined the relative inhibition of preprolactin synthesis as compared to cyclin 
synthesis. For the processing assays, the percentage of prolactin compared to the total amount of preprolactin 
and prolactin was determined. Processing Stand. to –RC: Amount of processing due to endogenous SRP in the 
microsomes (Buffer) was set to 0. RC-9/14: wild type particles reconstituted in absence of the hSRP9/14 
heterodimer. RCwt: particles reconstituted with wild type proteins; RC-10Ct: particles reconstituted with a 
truncated SRP14, lacking ten amino acids in the carboxyl-terminus; RCsloop: particles reconstituted with the 
hSRP9/14sloop protein; SD: standard deviation. 
 
As expected, the RCwt specifically inhibited the accumulation of full-length preprolactin as 
compared to the accumulation of full-length cyclin, leading to a 58% inhibition of 
preprolactin synthesis (Figure 18A). Particles reconstituted with a truncated SRP14, lacking 
ten amino acids in its carboxyl-terminus, leads to a 61% inhibition of preprolactin synthesis, 
corresponding to wild type particle levels, as previously shown (Bovia et al., 1994). Adding 
RCsloop to the translation reaction, results in a 76% inhibition of preprolactin translation as 
compared to cyclin (Figure 18A, lane RCsloop). Hence, its elongation arrest activity is 
comparable to the two controls (RCwt and RC-10Ct).  
We also investigated the capacities of the particle reconstituted with the SRP14sloop protein 
to translocated preprolactin into SRP-depleted canine microsomes (Figure 18B). As expected 
from the results obtained for the elongation arrest activities, wild type and truncated particles 
could promote preprolactin translocation across the membranes to similar levels, whereas a 
particle lacking the SRP9/14 heterodimer had only 50% translocation efficiency as compared 
to the wild type (Figure 18B, compare RC-9/14 with RCwt).  
These results showed that the truncation of amino acids R36 to D53 in the SRP14 internal 
loop between β1 and β2 did not affect the functions of the Alu domain; elongation arrest, and 
translocation are as efficient in the context of RCsloop as they are for wild type reconstituted 
particles. As a result we can conclude that the SRP14 internal loop does not play a critical role 
in the SRP mediated translational arrest.  
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1.3.3 Summary 
 
With this study of SRP14 role in the elongation arrest activity of SRP, we confirmed the 
critical role played by the carboxyl-terminus of SRP14. We narrowed down the residues 
implicated to five amino acids located between K95 and K100. In addition, we ruled out a 
function of the internal loop of SRP14 in the elongation arrest. 
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The crystal structure of the Alu RNP revealed a striking feature. The RNA 3’ and 5’ domains 
are align side by side underneath the curved β sheet structure of the protein (Weichenrieder et 
al., 2000). In complex with the SRP9/14, the RNA of the 3’ domain folds back onto the 5’ 
domain, resulting in a closed conformation where the S domain bends up to 180° and emerges 
from the SRP14 carboxyl-terminus side of the heterodimer (Figure 10C). The packing of the 
3’ domain onto the 5’ domain is consistent with the observed chemical footprints (Strub et al., 
1991). It also explains the requirement for flexibility between the 5’ and the 3’ ends of the 
SRP RNA in order to achieve high affinity binding of the SRP9/14 (Weichenrieder et al., 
1997). The SRP9 protein plays a key role in the folding of the 3’ domain, since the folded 
structure is stabilised through contacts established between SRP9 and the RNA. The β2-β3 
loop of SRP9 is inserted into the minor groove of helix H3.2 (Weichenrieder et al., 2000). In 
the closed conformation of the Alu RNP, the side chain of SRP9 lysine 41 is positioned 
between the 5’ domain and the 3’ domain RNA backbones. Although the crystal resolution is 
not sufficient to precisely map the interactions, the ε-amino nitrogen of lysine 41 is close to 
U23 of the 5’ domain, and G58 of the 3’ domain (Figure 19).  
 
 
 
Figure 19: The Alu RNP closed conformation is presumably stabilised by interaction of SRP9 lysine 41 
side chain with both 5’ and 3’ domains of SRP RNA. 
 
Weichenrieder et al., 2001 showed that mutations of lysine 41 and cysteine 39 into alanine, in 
SRP9, results in a complex which is specifically deficient in the Alu RNA 3’ domain binding. 
Competition experiments with RNA constructs where the 3’ and 5’ ends are flexibly or rigidly 
bound, as well as electromobility shift assays, revealed that the complex formed with the 
SRP9K41A/C39A is in a more open conformation than the wild type complex. This 
behaviour is most likely due to the mutation of lysine 41 into alanine, since cysteine 39 is 
located more than 5.5 Å away from the RNA in the crystal structure and its substitution with 
serine does not have any effect (Weichenrieder et al., 2001).  
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We decided to investigate the function of these open or closed conformations of the Alu 
domain in the elongation arrest activity of the particle. To that end we produced mutated 
SRP9 proteins in which we substituted lysine 41 into alanine, to disrupt the interaction with 
the RNA, or arginine, to restore the interaction (Figure 20B and C). 
 
 
 
Figure 20: Enlargement of SRP9 interaction with SRP RNA 3’ and 5’ domain. A: wild type Alu RNP 
complex. B: mutated SRP9K41A complex. C: mutated SRP9K41R complex. The side chains of residues at 
position 41 of SRP9 and nucleotides U23 and G58 of the 3’ and 5’ domain are depicted as wireframe. The 
structure of the complexes with the mutated SRP9 (B and C) were realised with the Swiss PDB Viewer program. 
 
Recombinant SRP9 proteins were produced in bacteria and the heterodimeric complexes 
h9K41A/14 and h9K41R/14 purified to homogeneity (Material and Methods). Particles were 
assembled with a combination of recombinant and canine proteins, together with canine SRP 
RNA using either h9/14, h9K41A/14 or h9K41R/14 (RCwt, RCK41A, RCK41R, see 
Materials and Methods for details). The reconstituted particles were added to wheat germ 
translations programmed with synthetic mRNAs of bovine preprolactin, a secreted protein, 
and sea urchin cyclin D, a cytoplasmic protein. The samples were analysed by SDS-PAGE 
and quantified by phosphorescence imaging (Figure 21).  
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Figure 21: Alu RNP closed or open conformation does not affect the elongation arrest activity of the 
particle. Particles, reconstituted with canine and recombinant SRP proteins, including wild type hSRP9/14 
(RCwt), hSRP9K41A/14 (RCK41A) or hSRP9K41R/14 (RCK41R) were assayed for elongation arrest and 
translocation activities. In translocation assays, SRP-depleted canine microsomes were added to the translation 
reactions. In elongation arrest assays (A), the relative inhibition of preprolactin synthesis as compared to cyclin 
was determined. For the processing assays (B), the percentage of prolactin compared to the total amount of 
preprolactin and prolactin was determined. Processing Stand. to –RC: Amount of processing due to endogenous 
SRP in the microsomes (Buffer) was set to 0. Reconstituted particles, as labelled on top of each lane, were added 
to the translation reaction at a final concentration of 100 nM. 
 
The wild type reconstitution, RCwt, when introduced into the translation reaction leads to a 
specific 96% inhibition of full length preprolactin synthesis, as compared to the cytoplasmic 
cyclin D (Figure 21A). Despite the fact that it is expected to weaken the binding of the 
3’ domain (Weichenrieder et al., 2001), the SRP9K41A protein had no significant effect as its 
elongation arrest activity was only slightly reduced from 96 to 88% as compared to wild type 
(Figure 21A, lane RCK41A). The loss of the 3’ domain interaction only slightly reduces the 
elongation arrest activity of the particle (Figure 21A, compare the 88% inhibition obtained 
with RC41A to the 96% inhibition obtained with RCwt). Restoration of the interaction with 
the 3’ domain through the K41R substitution, allowing the formation of the closed 
conformation of the Alu RNP, leads to a 96% inhibition of preprolactin translation, as for 
wild type reconstitution (Figure 21A, compare RCK41R with RCwt). 
To further establish the phenotype of this SRP9K41A mutated proteins, we investigated the 
processing activity of reconstituted particles (Figure 21B). Wild type and mutated particle 
were able to translocate preprolactin into SRP-depleted canine microsomes. We observed that 
the translocation efficiencies were similar for wild type and mutated particles (Figure 21B, 
compare the 59% obtained with RCwt to the 63% and 69% achieved with RCK41A and 
RCK41R respectively). 
1.3.4 Summary 
 
Taken together, the results demonstrated that stabilising the Alu structure through interactions 
of the highly conserved lysine 41 with the RNA is not required for elongation arrest activity 
of SRP. 
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Except for the sole chloroplast SRP, all SRPs contain a RNA moiety. The role of the RNA in 
the particle remains unclear but it seems to be more than just a scaffold holding the proteins 
together. Indications that mammalian SRP RNA could play an active role in particle functions 
derived from the observation that the presence of SRP RNA enhances SRP54 and SRα 
mediated GTP hydrolysis (Miller et al., 1993). Furthermore, bacterial SRP RNA has been 
shown to facilitate the assembly and disassembly of the Ffh-FtsY complex (Peluso et al., 
2000; Peluso et al., 2001).  
The crystal structure of bacterial SRP to a very high resolution (1.8 Å) indicated that the 
signal peptide binding site may lie alongside the RNA backbone (Batey et al., 2000), 
suggesting that the signal sequence recognition surface is composed of both SRP54 (or Ffh) 
and of SRP RNA. Such a binding site of both RNA and protein will neatly accommodate the 
binding to signal sequences which vary in sequence but are characterised by a hydrophobic 
region of six to fifteen amino acids flanked by two or five positively charged residues. The 
hydrophobic residues may then be recognised through interaction with the protein 
hydrophobic pocket, whereas the positively charged amino acids may bind to the SRP RNA. 
In addition to its role in SRP function, bacterial 4.5S RNA is also implicated in the translation 
process. Hence, a threshold level of 4.5S RNA is required to maintain a normal rate of 
translation (Bourgaize and Fournier, 1987; Jensen et al., 1994). The role of the 4.5S RNA in 
translation is due to its binding to the bacterial homolog of elongation factor 2 (Nakamura et 
al., 1999a; Suzuma et al., 1999; Nakamura et al., 2001). Cross-linking studies identified two 
distinct interactions of the 4.5S RNA with bacterial ribosome, one is obtained with the 23S 
rRNA and is dependent on the presence of Ffh and of the nascent chain, whereas the other 
one, achieved with the 16S rRNA, is independent of Ffh (Rinke-Appel et al., 2002 Brunelli et 
al., 2002). 
The RNA of the Alu domain folds into two hairpins that are joined by a stem (Figure 3). 
These two hairpins have a potential for anti-parallel base pairing which is phylogenetically 
conserved in Bacillus, Clostridium, Archaea, and in Metazoans (Larsen and Zwieb, 1991; 
Zwieb et al., 1996; Gorodkin et al., 2001). The tertiary interaction between the two distant 
loops of the SRP Alu RNA was confirmed in the Alu RNP crystal structure (Weichenrieder et 
al., 2000). Three Watson-Crick base pairing were observed to occur between G13, G14, C15 
and C37, C34 and G33, respectively (Figure 22).With regard to the structure, the SRP9/14 binds 
to the opposite site of the base paired loops (Figure 22B). These loops are solvent exposed in 
the crystal and could therefore play a role in the events leading to the arrest in the nascent 
chain elongation. Consistent with a role of SRP RNA in elongation arrest, Andreazzoli and 
Gerbi, 1991 showed that 7SL RNA undergoes conformational changes upon binding of SRP 
proteins, and upon binding of the particle to polysomes. Thomas et al., 1997 showed that in 
addition to loss of elongation arrest function, a particle reconstituted with human SRP14 
lacking twenty amino acids of its carboxyl-terminal part, exhibits an increase sensitivity of 
nucleotides from the loop to hydroxyradical cleavage.  
 
In order to address the role of these tertiary base pairs in the SRP-mediated translation arrest, 
we produced synthetic SRP RNAs with individual mutations in each loop that would disrupt 
base pairing, or with mutations in both loops that would restore base pairing with a different 
primary sequence. The same approach has been successfully used to defined interactions 
between RNAs in pre-mRNA splicing (Kandels-Lewis and Seraphin, 1993), or to probe 
tertiary structure interactions in Escherichia coli 16S rRNA decoding domain (Vila-Sanjurjo 
and Dahlberg, 2001), as well as to demonstrate Watson-Crick base pairing interactions 
between tRNA and 23S rRNA in the peptidyl transferase centre (Noller et al., 1995). 
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Figure 22: Structure of the SRP Alu domain. A: secondary structure of SRP RNA Alu domain. L2 and L1.2 
loops that are base paired in the RNA protein complex are named according to Weichenrieder et al., 2000. 
Helices H2, H1.2 as well as the conserved primary sequence which links them (U-turn) are shown. Nucleotides 
protected from cleavage by hydroxyl radicals in the RNA protein complex are shown in bold, nucleotides that 
get base paired between the loops are displayed in red. Stretches of ten nucleotides are marked in blue. B: crystal 
structure of the SRP Alu domain (Weichenrieder et al., 2000). SRP9 and SRP14 are displayed as red and green 
ribbon respectively. Nucleotides from loops L2 and L1.2 that are involved in tertiary interactions between the 
loops are displayed as wireframe. C: enlargement of the tertiary interactions between loops L2 and L1.2. 
Nucleotides from the loops, oriented facing the opposite loop are displayed as wireframes. Hydrogen bond 
between the bases involved in base pairing are displayed as green dashed lines. 
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1.3.5 SRP9/14 binding to mutated SRP RNAs 
 
1.3.5.1 Mutations introduced in the RNA sequence based on biochemical 
data 
 
Elongation arrest activity of the particle requires the presence of the SRP9/14 heterodimer 
(Siegel and Walter, 1986; Strub et al., 1991). Therefore, the first step in the investigation of 
the mutated SRP RNAs consisted in studying their ability to bind SRP9/14. Before the 
resolution of the Alu RNP crystal structure, the tertiary model was based on phylogenetic 
conservation of four nucleotides in each of the loops in higher Eukaryotes (Zwieb et al., 
1996). Comparative sequence analysis of SRP RNAs from different species leads to a model 
of anti-parallel base pairing between the loops of the SRP RNA Alu domain. These 
interactions were supposed to take place between nucleotides U12, G13, G14 and C15 of loop L2 
and nucleotides G33, C34, U35 and A36 of loop L1.2 respectively. Biochemical data 
corroborated this sequence comparison analysis. Hence, nucleotides G13, G14, G16 and U35 
were shown to be sensitive to kethoxal or CMCT cleavage in naked RNA, but were protected 
from the same cleavage in SRP (Andreazzoli and Gerbi, 1991). These nucleotides are not part 
of the SRP9/14 protection sites (Strub et al., 1991) and their protection could be reasonably 
explain by formation of interaction with other nucleotides upon SRP9/14 binding. 
The investigation of the RNA tertiary interaction was started in the laboratory by Y. Thomas. 
Through a SELEX study of the loop sequences, he showed that nucleotides of the loops can 
influence the binding of the SRP9/14 to the RNA, although they do not belong to the protein 
binding site (unpublished results). 
Based on this information we engineered mutations in the RNA loop sequences, in order to 
disrupt two of the four putative base pairs between the loops (Figure 23). The binding 
efficiencies of the mutated RNAs for SRP9/14 were assayed through the use of biotinylated 
RNA and in vitro synthesised human SRP14 complemented with recombinant human SRP9 
(see Materials and Methods). SRP9/14 bound to the different RNAs was analysed by 
SDS-PAGE and quantified by phosphorescence imaging. The binding efficiencies obtained 
were normalised to the value of wild type synthetic RNA which was set to 100%. Consistent 
with the location of the loops on the opposite side of the SRP9/14 binding site, we found out 
that all the mutated RNAs tested were able to bind to the protein (Figure 23). A majority of 
the RNAs had similar binding efficiencies as wild type, indicating that these mutations had no 
effect on the protein binding. Only three RNAs exhibited decreased SRP9/14 binding 
efficiencies, reaching at maximum, a value that is half that of the wild type (Figure 23, RNAs 
AC, ACGU and AG having respective binding efficiency of 67, 48 and 45% as compared to 
the wild type). Effects on binding efficiencies were only observed with L2 and not with L1.2 
mutations.  
After the crystal structure became available (Weichenrieder et al., 2000), not four but three 
Watson-Crick base pairs were observed between the loops. Base pairing occurs between 
nucleotides G13, G14, C15 and C37, C34 and G33, respectively (Figure 22) and differs slightly 
from the one predicted (Figure 23). With regard to the structure, most of our mutations only 
affect one of the base pairs observed in the structure, instead of the two we supposed to 
disrupt. Each of the three mutations that affect the binding of SRP9/14 (Figure 23, lanes AC, 
ACGU and AG) included a modification of the U12, which is a key component for the proper 
structure of the L2 loop, where it forms a U-turn which stabilises the loop structure. The 
destabilisation of the L2 structure resulting from the mutation of U12 may explain why these 
three constructs reduced the protein binding efficiency. 
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Figure 23: Mutations introduced in the Alu RNA loops sequence. The mutations depicted here are based on 
the anti-parallel model of tertiary interactions between the loops proposed by Zwieb et al., 1996. The mutated 
RNAs are named accordingly to the modification of their primary sequence. The loops are named according to 
the crystal structure of the Alu RNP (Weichenrieder et al., 2000). Putative base pairing between nucleotides 
from both loops are displayed as vertical lines, the modified nucleotides are depicted in bold and the supposedly 
restored interactions are displayed by dashed lines. Binding efficiencies of the mutated RNAs for the SRP9/14 
are shown. In vitro synthesised [35S]-labelled SRP14 combined with recombinant SRP9 were bound to different 
biotinylated mutated SRP RNAs as indicated. The RNA-bound proteins, separated from free proteins with 
magnetic streptavidin beads, were submitted to SDS-PAGE and quantified by phosphorescence imaging. The 
percentage of protein binding obtained for wild type SRP RNA was standardised to 100%. 
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1.3.5.2 Mutations based on the crystal structure  
 
Once the Alu RNP structure became known, we constructed new mutated RNAs taking into 
account the three Watson-Crick interactions observed in the crystal. We introduced mutations 
in one loop that would disrupt base pairing, or in both loops that would restore base pairing 
with a different primary sequence. Specifically, we mutated two and three positions in each 
loop individually or in both loop together (Figure 24A). Guanidine was replaced by cytidine 
and vice versa. Hence, the complementary mutations restored three G-C base pairs. 
 
 
 
Figure 24: Binding efficiency of hSRP9/14 for mutated SRP RNAs. A: summary of the mutations introduced 
into the SRP RNA to disrupt and/or restore the base pairing between loop L2 and L1.2 (see Materials and 
Methods for nomenclature). The wild type sequence of the interacting bases is shown as a guideline on the right 
side of the table. B: in vitro synthesised [35S]-labelled human SRP14 combined with recombinant SRP9 were 
bound to biotinylated mutated RNAs as indicated on top of each lane. The RNA-bound proteins were submitted 
to SDS-PAGE followed by autoradiography. The input represents 1/3 of the total [35S]-labelled SRP14 used in 
the experiments. The lower panel represents the phosphoimager quantification of the SRP9/14 binding 
efficiency. The percentage of protein binding, normalised to wild type RNA, is indicated for each lane. Neg.: rat 
4.5S RNA previously shown not to bind the SRP9/14 heterodimer (Bovia et al., 1997). 
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As for the previous constructs, the effect of the mutations on SRP9/14 binding was examined 
using biotinylated RNA and in vitro synthesised human SRP14 complemented with 
recombinant human SRP9. SRP9/14 bound to the different RNAs was analysed by 
SDS-PAGE and quantified with the phosphoimager. Bovia et al., 1994 showed that in the 
biotinylated binding assays, wild type SRP RNA binds only 30% of the protein (Figure 24B, 
compare Input and WT). All of the mutated SRP RNAs were able to bind h9/14 (Figure 23). 
Mutations in loop L1.2 and two compensatory mutations in both loops had no effect on the 
binding efficiency as compared to wild type RNA, whereas three compensatory mutations in 
both loops increased the binding efficiency (Figure 24B, 2L1.2, 3L1.2, 2 Comp and 3 Comp). 
Both SRP RNAs with mutations in loop L2 showed a two-fold decrease in the binding 
efficiency to SRP9/14 (Figure 24B, 2L2 and 3L2). Surprisingly, one of our compensatory 
mutations supposed to restore the tertiary interaction had a decreased binding efficiency for 
SRP9/14 (Figure 24B, 1 Comp). It bound only 15% of the heterodimer as compared to the 
wild type. This result was quite puzzling but might be explained by the different conformation 
adopted by this mutated RNA. It migrates faster than all the other mutated RNAs in native 
acrylamide gel electrophoresis, indicating that it folds into a more compact structure. The 
conformational change might have interfered with the protein binding. In general, the changes 
in the primary sequences we introduced into the RNA loops did not abolish protein binding, 
but they had a modulating effect on the binding efficiencies. To confirm this observation, we 
made a new series of mutated RNAs where we changed G14C15 and G33C34 into uridines and 
adenines in various combinations (Figure 25). 
 
 
 
Figure 25: hSRP9/14 binding efficiency for additional mutated SRP RNAs. The RNAs are named 
accordingly to their changed nucleotides. The percentage of binding, measured with the use of biotinylated 
RNAs, is shown. 
 
With these additional mutations, we observed similar results as with previous mutations. All 
RNAs with complementary mutations and the L1.2/A33A34 RNA bound SRP9/14 like wild 
type. The L1.2/U33U34 RNA was reduced to 77% and the two RNAs with mutations in loop 
L2 were reduced by 41 and 44%. In addition, tertiary base pairing appears to be required for 
efficient binding, since the decreased binding efficiencies of 2L2 and 3L2 RNAs were rescued 
in the 2 Comp and 3 Comp RNAs. 
In summary, the formation of tertiary interactions between the RNA loops appears to be 
required for high-efficient binding of SRP9/14 to full length SRP RNA. This is illustrated by 
the fact that all RNAs with complementary mutations, except for the very specific 1 Comp 
RNA, bound the heterodimer like the wild type SRP RNA.  
In addition, mutations in loop L2 always reduced the efficiency by about 50%, whereas 
mutations in loop L1.2 had a smaller or no effect on protein binding.  
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1.3.5.3 Electromobility shift assay 
 
In order to quantify SRP9/14 binding, we decided to use competition experiments with 
electromobility shift assay. This method allows us to directly compare the dissociation 
constant of the mutated RNAs to the one of the wild type RNA. The complex was separated 
from free RNA by electromobility shift assay, but due to the relatively small size of the 
heterodimer as compared to the 300-nucleotide long SRP RNA, the protein-bound RNA will 
not be easily distinguished from the naked RNA in a native gel electrophoresis. Therefore, we 
introduced the mutations we wanted to study into a smaller SRP RNA of eighty six 
nucleotides (Sa86 RNA), described previously as the minimal Alu RNA folding domain 
(Weichenrieder et al., 1997). This RNA is sufficiently small to allow the separation between 
free and protein-bound RNA in a native acrylamide gel electrophoresis, as described in 
Weichenrieder et al., 2001. Specifically, [32P]-labelled wild type Sa86 RNA, under conditions 
allowing all the RNA to be in the protein-bound form, was mixed with increasing 
concentrations of unlabelled mutated Sa86 RNAs as cold competitor. Free and protein-bound 
complexes were then separated in a native 8% acrylamide gel electrophoresis and the amount 
of RNA/protein complex evaluated by a phosphoimager system (see Materials and Methods 
for details). The bound fraction was measured for each concentration of competitor and was 
further integrated into a linear regression plot where the slope represents the ratio between the 
competitor and the wild type RNA Kd for SRP9/14 (Figure 26B, see Materials and Methods 
for calculation details). Consistent with what would be expected for a competitor with equal 
binding efficiency for SRP9/14, the value we obtained for wild type Sa86 as competitor was 
close to 1 (Figure 26B), confirming the validity of the method. The results obtained by the 
quantification of mutated RNAs dissociation constant were in agreement with the results 
obtained in biotinylated RNA binding assays. The 2 Comp RNA showed a ratio value of 0.65, 
indicating that this RNA had a higher binding affinity for SRP9/14 as the wild type SA86 
RNA, which is in agreement with the biotinylated RNA binding assays (Figure 24B). We also 
obtained a lower binding affinity of 2L2 and 1 Comp mutated RNA, with ratios of 3 and 9.2 
respectively. 3 Comp RNA showed a ratio value of 1.25, indicating that it bound to the 
SRP9/14 with the same affinity as the wild type RNA. Mutation 2L1.2, which leads to the 
disruption of two base pairings through mutations in the L1.2 loop sequence, had a 2.2 fold 
decreased value of Kd as compared to wild type (Figure 26B).  
Additional mutations that we introduced in the Sa86 sequence, but not in the full length RNA, 
highlighted the critical role of the nucleotide at position fifteen for SRP9/14 binding. 
Mutating only C15 into G lead to a decrease binding of SRP9/14, as seen with a ratio of 1.49 
(Figure 26C). A similar decrease was obtained with the G15G34G37 mutation with a ratio of 
1.97. Mutations of the sole G33 into a C lead to a two-fold decrease in the Kd for SRP9/14 
binding as compared to the wild type, whereas the C13C14C33 behaved like wild type (Figure 
27C).  
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Figure 26: Electromobility shift assay of small mutated Alu RNA complexed with human SRP9/14. [32P]-
labelled Sa86 RNA, in conditions allowing 100% of SRP9/14 binding, was mixed with Sa86-derived cold 
mutated competitor RNAs. Protein-bound RNA was separated from the free RNA on an 8% acrylamide native 
gel electrophoresis. The amount of RNA-protein complex was evaluated by a phosphoimager system and 
integrated to allow the calculation of the ratio between the Kd of competitor and wild type RNA for SRP9/14 
binding. A: competition assay realised with increasing amount of cold 3 Comp RNA as competitor. The final 
concentrations of competitor used in the assay are marked on top of each lane. Free and protein-bound RNA are 
marked on the left. WT alone: wild type labelled RNA in absence of competitor and protein; WT + BSA: control 
without competitor where SRP9/14 was replaced with the same amount of bovine serum albumin; WT + h9/14: 
control in absence of competitor RNA. B: measure of dissociation constants for RNAs complexes comprising 
Sa86 mutated RNAs that shares mutations produced in the full length RNA. The value of the ratio between wild 
type and competitor dissociation complex, measured as described in Materials and Methods, are shown. 
C: measure of dissociation constant ratio obtained with additional mutated RNAs produced only in the small 
SA86 RNA. 
 
The remarkable effect on SRP9/14 binding we obtained with the biotinylated RNAs binding 
assay, despite the excess of RNA, might result from increased kinetic instability of the 
mutated RNAs where the base pairing are disrupted. Therefore the differences observed might 
have derived from a technical artefact resulting in the loss of binding during the extensive 
wash steps. No drastic changes in the mutated RNAs dissociation constant were observed in 
our electromobility shift assays. Alternatively, the effects of the mutations might be stronger 
in complete SRP RNA than in Alu RNA for reasons which are not yet understood. However, 
since the proteins have been shown to bind the RNA with subnanomolar affinity (Janiak et al., 
1992; Bovia et al., 1994), the minimal defect observed on SRP9/14 binding to the mutated 
SRP RNAs should not interfere with the assembly of the particle. 
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1.3.6 Functional analysis of particles containing mutated RNAs 
 
We reconstituted SRP with canine and recombinant SRP proteins together with synthetic SRP 
RNAs. The RNAs were produced in large scale transcriptions and purified away from DNA 
and nucleotides under non-denaturing conditions (see Materials and Methods). The 
reconstitution conditions were optimised by testing different protein and RNA concentrations 
(results not shown). Translocation and elongation arrest activities of the reconstituted particles 
were assayed in a wheat germ translation system. For elongation arrest activity, the 
differential effects of the reconstituted particle on synthesis of the secretory protein, 
preprolactin, and of the cytoplasmic protein, cyclin D, were compared. For translocation 
activity, we followed the processing of preprolactin to prolactin in the presence of salt-washed 
canine microsomes (Materials and Methods). The translation reactions were analysed by 
SDS-PAGE and quantified with the phosphoimager.  
Dog purified SRP and particle reconstituted with purified canine SRP respectively inhibited 
preprolactin translation to 94% and 91% (Figure 27A, lane 2 and 3). However, with particles 
reconstituted with in vitro transcribed wild type SRP RNA the inhibition of preprolactin was 
only 67% (Figure 27, compare lane 4 with lanes 2 and 3). Purified SRP and canine RNA 
reconstituted particles had similar translocation efficiencies values (85% and 81% 
respectively, Figure 27A lower panel, lane 2 and 3), whereas particles reconstituted with 
synthetic SRP RNA have only 55% processing activity (Figure 27 A, lower panel lane 4). 
Reannealing the synthetic SRP RNA under different conditions always lead to a complete loss 
of translocation activity of the reconstituted particles, suggesting an interference with the 
S domain assembly. The presence of several RNA conformations might account for the 
reduced function of particles reconstituted with synthetic RNA. 
In the following experiments, we always normalised elongation arrest activities and 
translocation efficiencies to particles with synthetic wild type RNA. 
As compared to the synthetic wild type RNA, disrupting base pairing through mutations in 
loop L2 resulted in a significant but not complete loss of elongation arrest activity, 
independently of whether two or three base pairs were affected (Figure 27B, lanes 2L2 and 
3L2). Restoring tertiary base pairing between the two loops with mutations in loop L1.2 
completely rescued the negative effect of the 3L2 mutation and significantly improved the 
2L2 phenotype (Figure 27B, lanes 3 Comp and 2 Comp). In contrast, two nucleotides 
mutation in loop L1.2 had no significant effect on the elongation arrest activity of the particle 
(lane 2L1.2). Three mutations in loop L1.2 slightly decreased elongation arrest activity of the 
particle as compared to the wild type (lane 3L1.2).  
To calculate the elongation arrest activity of the SRPs, the ratio of preprolactin to cyclin 
synthesis in the presence of buffer was used as 0% inhibition (see Materials and Methods for 
details). Compared to this buffer, the elongation arrest activity of SRP reconstituted without 
SRP9/14, used as negative control, was 20% as previously observed (Thomas et al., 1997).  
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Figure 27: Preprolactin elongation arrest and processing efficiency of particles reconstituted with mutated 
RNAs. A: autoradiogram of some reconstituted particles described in B. Lane 1: negative control, reconstitution 
in absence of SRP9/14; Lane 2: purified canine SRP; Lane 3: reconstitution with recombinant proteins and 
purified canine SRP RNA; Lane 4: particle reconstituted with synthetic wild type SRP RNA; Lane 5: particles 
reconstituted with 2L2 RNA; Lane 6: particles reconstituted with 2L1.2 RNA; Lane 7: particles reconstituted 
with 2 Comp. RNA. Upper panel: elongation arrest assay; lower panel: translocation assay. 
B: mutated particles elongation arrest assay. Reconstituted SRP, with mutated in vitro synthesised RNA, were 
added at 100 nM final to wheat germ translation reactions, programmed with sea urchin cyclin and bovine 
preprolactin mRNAs. The resulting [35S]-labelled proteins were analysed by SDS-PAGE and quantified by 
phosphoimager. Elongation arrest efficiency of the different reconstitutions, as marked for each lane, was 
evaluated as described in Materials and Methods. The specific inhibition of preprolactin synthesis observed in 
presence of wild type reconstituted particle was standardised to 100%. WT: particle reconstituted with wild type 
proteins and wild type synthetic RNA. All measures were done in duplicate. C: mutated particles processing 
efficiency. Reconstituted SRP are tested as in A, except for addition of SRP-depleted microsomes in the 
translation reactions. The efficiency of processing, as marked for each lane, was evaluated by exposure to a 
phosphoimager screen (see Materials and Methods for details). Preprolactin processing efficiency obtained with 
wild type reconstituted particles was standardised to 100%. WT: particle reconstituted with wild type proteins 
and wild type synthetic RNA.  
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All SRPs containing mutated synthetic RNAs were active in signal recognition and targeting, 
since they are all able to translocated preprolactin into the microsomes. Particles lacking 
elongation arrest have their translocation capacities reduced by about 50% as seen previously 
(Figure 13A, Thomas et al., 1997). Indeed, the processing activities we observed for our 
mutated reconstitutions confirmed the results of their elongation arrest activities. SRPs 
comprising 2L2 and 3L2 RNAs had reduced translocation efficiencies as compared to 
particles reconstituted with wild type synthetic RNA (Figure 27C, lanes WT, 2L2 and 3L2). 
All the other SRPs had activities comparable to wild type particles. The processing activity of 
the microsomes in the absence of exogenous SRP was 20%, resulting from contaminating 
particles in the microsomes preparation.  
Hence, the particles reconstituted with in vitro transcribed mutated SRP RNA were all active 
in signal recognition and in targeting, whereas 2L2 and 3L2 SRPs were specifically deficient 
in their elongation arrest activities. 
 
1.3.6.1 The elongation arrest activity observed with the mutated particles is 
not due to a reduced SRP9/14 binding 
 
Although unexpected, based on the RNA binding experiments, mutated RNAs which 
exhibited decreased binding efficiency for SRP9/14 were also the ones with defects in 
preprolactin translocation and elongation arrest. Thus we wondered whether it was 
conceivable that inefficient assembly of the h9/14 protein caused the phenotype. To test this 
hypothesis, we reconstituted 3L2 particles in the presence of increasing amounts of h9/14. Up 
to eight-fold excess of SRP9/14 over the other SRP components were used in the 
reconstitution experiments and this without improving elongation and translocation activities 
of these particles (Figure 28). Elongation arrest activity and preprolactin processing efficiency 
stagnated around an average value of 55 and 62% respectively, which is in agreement with the 
46 and 55% elongation arrest and processing activities observed previously for the 3L2 RNA 
(Figure 27B and C). Thus, the reduced SRP9/14 binding is not responsible for the observed 
reduction in elongation arrest and translocation activities of 3L2 mutated SRP RNA. This 
interpretation is supported by the facts that the dissociation constant of the 3L2-SRP9/14 
complex, like the wild type complex, is in the nanomolar range and that the protein 
concentration used in the assay was 200-800 nM (Figure 24). 
As previously mentioned, reannealed RNA cannot be used to reconstitute functional particles, 
and several conformations were observed for these RNAs in native acrylamide gel 
electrophoresis (data not shown). We then wanted to see, whether the observed decrease in 
elongation arrest could result in the presence of RNAs trapped in a conformation which did 
not allow proper binding of the SRP proteins. In order to address this question, we decided to 
reconstitute particles in presence of increasing amounts of synthetic RNAs. Up to eight-fold 
excess of RNA over the proteins were used in the reconstitution experiments. This was done 
for wild type RNA as well as for 2L2 and 3L2 RNAs (Figure 29).  
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Figure 28: Effect of increasing hSRP9/14 concentration on 3L2 reconstituted particles. A: elongation arrest 
assay. 3L2 particles reconstituted with increasing amounts of human SRP9/14 were added to wheat germ 
translation reactions programmed with sea urchin cyclin and bovine preprolactin mRNAs. The elongation arrest 
efficiency is marked for each lane, as measured by phosphoimager. WT: reconstitution with wild type synthetic 
SRP RNA; 1x: standard reconstitution of 3L2 particles (see Materials and Methods); 2x, 4x, 8x: reconstitution of 
3L2 particles in presence of a 2-fold, 4-fold, or 8-fold excess of recombinant hSRP9/14 as compared to 1x, 
leading to final SRP9/14 concentrations in the reconstitution of 1, 2 and 4 µM respectively. B: processing of 3L2 
particles reconstituted as in A. The processing efficiency is marked for each lane, as measured by 
phosphoimager. WT: reconstitution with wild type synthetic SRP RNA; 1x: standard reconstitution of 3L2 
particles; 2x, 4x, 8x: reconstitution of 3L2 particles in presence of a 2-fold, 4-fold, or 8-fold excess of 
recombinant hSRP9/14 as compared to 1x. All measures derived from duplicate experiments. 
 
 
 
Figure 29: Effect of increasing RNA concentration in reconstituted particles function. A: elongation arrest 
assay. particles, reconstituted with 0.5 to 8-fold excess of mutated RNAs as compared to the other SRP 
components, were added to wheat germ translation reactions programmed with sea urchin cyclin and bovine 
preprolactin mRNAs. The elongation arrest efficiency is marked for each lane, as measured by phosphoimager. 
B: processing activities of mutated particles reconstituted as in A. The processing efficiency is marked for each 
lane, as measured by phosphoimager. White bars: particles reconstituted with 0.5 to 2-fold excess of wild type 
synthetic RNA; black bars: particles reconstituted with 0.5 to 2-fold excess of 2L2 RNA; grey bars: particles 
reconstituted with 1 to 8-fold excess of 3L2 RNA. 2L2 and 3L2 measures derived from duplicate experiments. 
 
Increasing the amount of 3L2 RNA up to eight-fold in the reconstitution did not improve the 
elongation arrest activity of the particle, which reached values oscillating around an average 
40% specific inhibition of preprolactin synthesis (Figure 29A, grey bars). This is consistent 
with the 46% inhibition observed for this mutated particle under standard conditions 
(Figure 27B, lane 3L2). Preprolactin processing efficiency gave similar results, with a value 
fluctuating around 60% (Figure 29B, grey bars), as compared to the 55% observed previously 
(Figure 27C, lane 3L2). The elongation arrest activity seemed to be improved with a two-fold 
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excess of RNA, reaching a value of 51% (Figure 29A, black bars). However, the preprolactin 
processing pattern showed that the excess of RNA did not rescue the phenotype of the 2L2 
mutated particles, since the average value is close to 50% (Figure 29B, black bars) in 
agreement with the value obtained under standard condition (Figure 27C, lane 2L2).  
Hence, increasing the protein or the RNA concentrations in our reconstitution assays did not 
rescue the phenotype observed for 2L2 and 3L3 mutated particles. However, to further 
establish that the mutated RNAs affect the function of the SRP Alu domain directly and not 
through a reduced binding of SRP9/14, we decided to purify reconstituted particles. Since this 
purification requires relative large amounts of canine proteins, we limited our analysis to wild 
type, 2L2 and 2 Comp RNAs. 
 
 
 
Figure 30: Purification of particles reconstituted with mutated RNAs. Particles reconstituted with canine 
proteins and in vitro transcribed RNA, were purified on a DE53 column as described in Materials and Methods. 
Aliquots, taken at each step, are submitted to 5-20% gradient SDS-PAGE and revealed by silver nitrate staining. 
A: DE53 purification pattern of particles reconstituted with canine proteins and wild type synthetic RNA. 
S: input of proteins used in the reconstitution prior to the column purification, corresponding to 5 pmole of each 
protein; FT: DE53 flow through; W: wash fraction; 1 and 2: first and second elution of the column at 600 mM 
potassium acetate, corresponding to the elution of complete particles; 3 and 4: first and second elution of the 
column at 1000 mM potassium acetate, corresponding to partially reconstituted particles. The position of each 
canine SRP protein is marked on the right side of the gel. B: comparison of the different reconstituted particles 
after purification on DE53 as labelled on the top of each lane. 2 pmole of each purified particles, as evaluated 
from comparison of the elution with the input fraction, are submitted to 5-20% gradient SDS-PAGE and dyed 
with silver nitrate. St: standard consisting of 2 pmole of recombinant SRP proteins. C: western blot analysis of 
the purified particles. A fraction corresponding to 0.5 pmole of the purified particle, as evaluated from the gel in 
B, were submitted to 5-20% SDS-PAGE, followed by western blot with antibodies against human SRP14. The 
concentrations of the respective purified particles were evaluated as compared to a standard consisting of 0.25, 
0.5, 0.75 and 1 pmole of hSRP14. 
 
Particles, reconstituted with canine proteins and synthetic SRP RNA, are loaded onto a DE53 
column to remove non-bound proteins and partially reconstituted particles (Materials and 
Methods). Fully assembled SRP is eluted from the column at a 600 mM potassium acetate 
concentration (Chang et al., 1997). Particles eluted from the column were analysed by silver 
staining and quantified by immunoblotting with anti-SRP14 (Figure 30).  
The purified particles were added at different concentrations into translation and translocation 
assays. Below 25 nM, none of the reconstituted particle exhibited a significant elongation 
arrest activity (Figure 31A). At higher concentrations, 2L2 particles had again a reduced 
-63- 
Results SRP RNA 
elongation arrest activity as compared to wild type or to 2 Comp SRPs (Figure 31A, compare 
dotted line with filled and dashed lines). Interestingly, the 2 Comp SRP appeared to work 
better than wild type SRP (Figure 31A, compare dashed lines with filled lines), confirming 
the notion that base pairing, and not the primary sequence, is essential for activity. As 
previously observed, measurement of low level elongation arrest activities lead to large 
variations of the standard deviation for 2L2 particles (Figure 31A, dotted lines). In agreement 
with our previous experiments, the elongation arrest activity of the 2L2 particle is not 
completely abolished but reaches at maximum half the level of the 2 Comp activity. 
 
 
 
Figure 31: Functional analysis of DE53 purified mutated particles. A: inhibition of preprolactin synthesis in 
presence of increasing amount of purified reconstitutions. Particles reconstituted with canine proteins and 
mutated synthetic SRP RNA were purified on DE53 prior to their addition into wheat germ translation reactions 
at final concentrations ranging from 20 to 80 nM. The produced [35S]-labelled protein were analysed by SDS-
PAGE and quantified by phosphoimager. For each reconstitution, the elongation arrest activities are displayed as 
function of the concentration of mutated particles used in the assays. Filled lane: particle reconstituted with wild 
type synthetic RNA; dotted lane: particle reconstituted with 2L2 RNA; dashed lane: particle reconstituted with 2 
Comp RNA. B: preprolactin processing activities in presence of increasing amount of purified reconstitutions. 
Particles are tested for their processing activities by addition of SRP-depleted microsomes to translation 
reactions described in A. Filled lane: particle reconstituted with wild type synthetic RNA; dotted lane: particle 
reconstituted with 2L2 RNA; dashed lane: particle reconstituted with 2 Comp RNA. 
Elongation arrest and processing values displayed in the figure results from four different experiments. 
 
Bovine preprolactin processing, which is more accurate to monitor than elongation arrest 
activity at low SRP concentrations, yielded results in agreement with the elongation arrest 
assays. The processing activity of the 2L2 particle increased more slowly than the ones of 
wild type and 2 Comp SRPs (Figure 31B, compare dotted line with filled and dashed lines). 
Notably, 2 Comp and wild type particles reached maximal translocation activities at 
concentrations of 40 nM, whereas the one of 2L2 SRP had not yet reached its plateau at the 
maximal concentration of 80 nM used in the assay. The curve of the processing activity of 
2L2 SRP, predicted that it could reach the same processing efficiency as the wild type SRP, 
confirming that the elongation arrest activity of SRP is not required for translocation (Siegel 
and Walter, 1985). However, a higher concentration of active particle is necessary to ensure 
efficient targeting in time to allow translocation.  
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1.3.7 Summary 
 
We have seen that the mutations introduced in loops L2 and L1.2 of the SRP RNA Alu 
domain, results in a defect in elongation arrest activity. Individual mutations in loop L2 
always had stronger effects on elongation arrest activity of SRP and, to a much lower extend, 
also on h9/14 binding, than mutations in loop L1.2. However, the negative effects of 
mutations in loop L2 were always completely rescued by complementary mutations in loop 
L1.2. 
We have seen that the decreased SRP9/14 binding efficiency cannot be accounted for the 
elongation arrest defect.  
Hence, we demonstrated that the SRP Alu RNA is involved in the particle’s elongation arrest 
activity of SRP, playing a functional role which can be distinguished from the one of 
SRP9/14. 
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Discussion 
1. Alu SRP proteins 
 
The mutational analysis we undertook in this study allowed us to confirm the critical role 
played by the SRP14 in the elongation arrest function. In agreement with previous studies 
(Thomas et al., 1997; Mason et al., 2000), we showed that deletion in the carboxyl-terminus 
of SRP14 leads to a complete loss of elongation arrest activity. Furthermore, we narrowed 
down the amino acids involved in the process to five residues located between lysine 95 and 
lysine 100. Deletion of ten residues in the carboxyl-terminus of SRP14 had no effect on the 
elongation arrest (Bovia et al., 1994), whereas deletion of twenty (Thomas et al., 1997) and of 
fifteen residues (Figure 13) results in a complete loss the elongation arrest function of the 
reconstituted particles. This loss of function is correlated with binding to ribosomal rRNA., 
Terzi et al., (see manuscript below) demonstrated that whereas wild type SRP14 is able to 
bind to a complex composed of the ribosomal L12 protein and of GAR rRNA, both 
representing the GTPase-associated centre of the ribosome, SRP14K95 did not bind anymore.  
The short carboxyl-terminal motif of SRP14 that we showed to be essential for elongation 
arrest activity is the most highly conserved feature in the SRP14 proteins, suggesting an 
essential functional role. Indeed we showed that four of these five conserved residues that 
were critical for the function are basic amino acids, which strongly suggests that they play a 
role in RNA binding. These residues are unlikely to bind SRP RNA, since they do not contact 
the SRP RNA in the Alu RNP crystal structure (Weichenrieder et al., 2000), and since all of 
the protein footprints observed on SRP Alu RNA (Strub et al., 1991) can be explained by the 
contacts seen in the crystal structure. Consistent with this, the hydroxyl radical footprints on 
the SRP RNA central stem that we obtained with SRP9/14K95 were exactly the same as the 
one obtained with the wild type heterodimer. 
The truncation of SRP14 did not abolish the binding of the reconstituted particles to 
ribosomes since translocation is still observed (Figure 13). Therefore it is conceivable that the 
loss of elongation arrest activity is correlated with the loss of rGAR RNA binding. Hence the 
arrest in nascent chain elongation might be achieved through an interaction of the SRP14 
carboxyl-terminus with the ribosomal GTPase-associated centre, taking place between GAR 
rRNA and amino acids K96, R97, E98, R99 and K100 of human SRP14. Consistent with this 
putative interaction, the competition experiments we made with the truncated SRP14K95 
resulted in elongation arrest activity and translocation efficiency that were lower than 
expected for a competitor with equal affinity for ribosome. Hence, the deletion of SRP14 
carboxyl-terminus, abolishing one interaction of SRP with the ribosome, might result in a 
higher dissociation rate of particles reconstituted with the truncated protein as compared to the 
wild type particles. This might explain why up to nine-fold excess of SRP14K95 was required 
to observe decreased elongation arrest and translocation in our competition experiments 
(Figure 14). Whereas the mutated protein binds the SRP RNA as efficiently as the wild type 
protein, the particles containing wild type protein might be bound for a much longer time to 
ribosome as compared to the truncated particles. Thus higher concentrations of truncated 
particles are required to displace the wild type particle from the ribosome.  
 
The role of the SRP14 internal loop, between β1 and β2, remains unknown, but it does not 
seem to be involved in the elongation arrest activity. Unlike the carboxyl-terminal region of 
SRP14, the internal loop shows only little primary sequence conservation, which argues 
against a critical role in SRP functions. In fact, only four basic amino acid residues (K31, 
K32, K42 and K43 in human SRP14) are conserved and these residues have been shown to be 
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involved in binding to SRP RNA (Bui et al., 1997). This is confirmed by the determination of 
SRP14sloop-Alu RNA dissociation constant by Biacore analysis. Whereas the wild type 
protein binds to the wild type RNA with a Kd of 0.55 nM ± 0.19, the SRP9/14sloop has a Kd 
value of 7.33 nM (J. Hasler, personal communication). Yet the internal loop of SRP14 is not 
entirely seen in the Alu RNP crystal structure despite the presence of the RNA 
(Weichenrieder et al., 2000). The missing residues (36 to 53) include two of the conserved 
basic amino acid residues (K42 and K43). The two others conserved basic residues (K31 and 
K32) are seen in the structure and they contact the SRP RNA. Thus, the internal loop of 
SRP14 might interact with the Alu RNA in the region of the bend, and therefore participate in 
the closed conformation of the Alu RNP. Hence the internal loop is not ordered in the crystal 
because the bending of the RNA 3’ domain onto the 5’ domain is not directly observed in the 
structure. In their crystals, Weichenrieder et al., 2000 observed two RNA molecules bound to 
one SRP9/14, one engaging its 5’ domain, whereas the other one engaged its 3’ domain. 
However, their model for the native Alu domain structure, where the 3’ domain folds back 
onto the 5’ domain is consistent with biochemical data. It explains the requirement for 
SRP9/14 dimerisation (Strub and Walter, 1990), the protection of SRP9 cysteines 39 and 48 
from alkylation in the RNA-protein complex (Siegel and Walter, 1988c), as well as all the 
hydroxyl radicals footprints (Strub et al., 1991). Furthermore their model is in agreement with 
the size of the particle, measured by electron microscopy (Andrews et al., 1985). 
Thus, the internal loop of SRP14 might be involved in the assembly of the particle, leading to 
the closed conformation of the Alu RNP, but we showed that it is dispensable for elongation 
arrest. This might be because the interaction of the basic residues of SRP14 internal loop with 
the Alu domain SRP RNA is not the only one involved in the RNA bend. Thus, the truncation 
of the internal loop in SRP14sloop is not sufficient to abolish the formation of the Alu RNP 
closed conformation, explaining why this truncation did not significantly affect the elongation 
arrest activity of the particle. 
Furthermore, we saw that the mutation of SRP9 lysine 41, which contacts the 3’ and the 
5’ domain of the Alu SRP RNA, did not influence the elongation arrest activity of the particle. 
This might also reflect that the weakened interactions produced by the SRP9 mutations, are 
not sufficient to completely abolish the closed conformation of the particle Alu domain.  
In Weichenrieder et al., 2001 investigations of the role of the RNA 3’ domain in SRP9/14 
binding were achieved by the use of circularly permuted Alu RNAs. In these RNAs, the 
original 3’ and 5’ ends of the SRP RNA were connected with a linker of one or four uridines, 
respectively. A linker of one uridine was too rigid to allow the formation of the closed 
conformation, whereas the four uridines linker was sufficiently flexible to allow it. With these 
RNAs, the authors showed that the rigidly bound Alu RNA had a 50-100 lower affinity for 
SRP9/14 binding as compared to the wild type RNA. The abolition of the closed 
conformation by the one uridine linker was confirmed by RNase V1 cleavage. 
However, we investigated SRP9K41 mutations in particles reconstituted with canine purified 
SRP RNA. Therefore, the RNA 3’ and 5’ ends are the native ones, meaning that flexibility is 
allowed between 3’ and 5’ domains. The presence of the internal loop of SRP14 and the 
flexibility of the RNA might be sufficient for the 3’ domain to fold back onto the 5’ domain, 
even in absence of lysine 41 interactions with the RNA central stem. Throughout the particle 
assembly process, conformational changes that allow the formation of the closed 
conformation might also be introduced in the RNA. Therefore the weakened interactions 
resulting from the SRP9K41A mutations might be overcome by these conformational 
changes, which bring the 3’ and the 5’ domain in closed proximity, allowing the formation of 
RNA-protein and/or RNA-RNA interactions. Indeed, in addition to SRP14sloop and 
SRP9K41 interaction with the RNA, the crystal structure revealed previously observed 
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footprints (Strub et al., 1991) as protein induced RNA-RNA interactions (G5-G10; G48-G51) or 
as both induced RNA tertiary contacts and direct protein contacts (C17-C29; G58-G62). These 
interactions might be sufficiently strong to hold the Alu domain into a closed conformation in 
the full length particle, despite the disruption of SRP9 lysine 41 or SRP14sloop interactions. 
Furthermore, the folding of the 3’ domain onto the 5’ domain leads to a 25 Å shortening of 
the particle’s length. Upon interaction with ribosomes, such a difference in the particle’s 
length would most likely interfere with SRP functions.  
The involvement of the Alu domain switch, from an open to a closed complex, might be of 
functional importance for the elongation arrest activity of the particle. Since the mutation of 
SRP9K41 is not sufficient to completely abolish the closed conformation, we propose to 
achieve this by the use of a SRP RNA construct in which native 3’ and 5’ ends will be rigidly 
bound in order to abolish the folding of the 3’ domain. Previous observations have shown that 
the flexibility between the two domains is required for high efficiency SRP9/14 binding 
(Weichenrieder et al., 1997). The reduced binding of the SRP9/14 for a RNA where native 3’ 
and 5’ ends are bound together, can be overcome through the purification of the reconstituted 
particles. We showed that the reduced efficiency of synthetic RNA in the particle 
reconstitution can be surmounted by purification of the fully reconstituted particles on DE53 
chromatography. Wild type SRP9/14 has been shown to bind the RNA with subnanomolar 
affinity (Janiak et al., 1992; Bovia et al., 1994) with a Kd of 0.55 nM measured by Biacore as 
aforementioned. Thus a 100-fold reduced affinity for SRP9/14 of a rigidly bound RNA would 
result in a Kd value around 50 nM, which is relatively close to the 100 nM final concentration 
of SRP used in our elongation arrest assays. However, this can be overcome through the 
purification of the reconstituted particle and through the addition of an excess of SRP9/14 in 
the translation reaction, assuring that the effects that one might observe would not result from 
the reduced affinity of the rigidly bound RNA for SRP9/14. 
 
2. Alu SRP RNA 
 
In this study we provided the first evidence that a specific structure of the SRP RNA Alu 
domain is required for elongation arrest activity. The presence of three base pairs between the 
two distant loops is important for high efficient binding of SRP9/14, as well as for proper 
elongation arrest function. 
We showed that the disruption of two or three of the base pairs between loops L2 and L1.2 
resulted in a decreased elongation arrest activity of the reconstituted particles. The effects 
observed are different depending on which loop the mutations are introduced into. Mutations 
in L2 decreased the binding of the SRP9/14, whereas mutations introduced in L1.2 had no 
effect on the protein binding. 
Based on Andreazzoli and Gerbi, 1991 experiments, the RNA tertiary structure is stabilised 
upon binding of the protein. Nucleotides of L2 and L1.2 loops were sensitive to chemical 
modifications in naked RNA, whereas they were protected from the same chemical 
modifications in the particle. Thus, binding of the SRP9/14 to the Alu domain stabilises the 
base pairing interactions between the loops. This results in an energetically favoured 
conformation, thereby explaining why disruption of the loops tertiary interaction can have a 
slight effect on SRP9/14 binding. 
The two loops have a different structure which might explain the differential effect of their 
mutations. L2 is constrained by a U-turn at position U12 and by a shared G11-G16 base pair, 
-69- 
Discussion 
whereas loop L1.2 lack any internal stabilisation. The flexibility of it structure might allow 
L1.2 nucleotides to form alternative base pairs with loop L2 (e.g. G13 with U35 in 2L1.2), 
whereas loop L2 is too constrained to allow alternative base pairing after mutations.  
The changes introduced in loop L2 results in the presence of four pyrimidines between both 
loops. These two pyrimidine rings would be too far away to form hydrogen bonds, which is 
not the case in the 2L1.2 RNA where four purines are facing each other, leading to a reduced 
distance which might allowed alternative tertiary interactions. 
In the crystal structure, positions 15 and 33 of the RNA are located in a region where L2 and 
L1.2 are the closest, suggesting that their mutations strongly affect the structure. Thus, 
mutation G15 might interfere with the G11-G16, which together with the U-turn at U12 
participates in the stabilisation of the L2 loop. The G15 and G15G34G37 might have decreased 
SRP9/14 binding efficiencies because they destabilise the whole folding of the Alu RNA 
through an effect on the L2 loop. Consistent with this, the mutation of G33 into a C might form 
a base pair with G16, interfering then with the shared G11-G16 pair, resulting in a decreased 
SRP9/14 binding. C13C14C33 on the other hand binds the protein to wild type levels, possibly 
because the interference of C33 with the shared G11-G16 pair is counterbalanced by the 
presence of two additional Cs in the L2 loop. These Cs at position thirteen and fourteen could 
contribute to the stabilisation of the L2 structure through an internal G11-Cx base pair. From 
that point of view, the 1 Comp mutation should result in a more compactly folded RNA 
because it results in the presence of five Gs among the six nucleotides of loop L2. These five 
guanines might allow a different stabilisation of the L2 loop since several nucleotides are 
available for a shared pair with G11 as well as for G-C base pairing with loop L1.2. The 
resulting RNAs structure might be too compactly folded to allow proper binding of the 
heterodimer. 
We have seen that the effects on SRP9/14 binding were different in the full length SRP RNA 
and in a small eighty-six nucleotide-long Alu RNA. The higher effect on the protein binding 
observed with the full length RNA might derive from a technical artefact. SRP9/14 primary 
binding site is located in the RNA 5’ domain (Strub et al., 1991; Weichenrieder et al., 2000), 
and the protein can bind to the RNA in absence of tertiary interactions between the loops. 
However, since the tertiary base pairs most likely stabilise the complex, it is feasible that their 
disruption increases the dissociation rate of the complex. Hence, the bound protein may be 
lost during the washing procedure in the biotinylated assay. In agreement, the same mutations 
had only a minimal effect in the electromobility shift assay. The absence of extensive wash 
steps as well as the polyacrylamide gel caging effect explains the reduced effect of the 
mutation on the protein-RNA dissociation constant. The differences might also be due to 
interference of the S domain RNA with the folding of the Alu domain. Binding assays were 
done in absence of proteins from the S domain and the S domain RNA may interfere with the 
folding of the Alu domain RNA. Specifically, helices 6 and 8 are free in absence of SRP19, 
whereas they get clamped together upon binding of SRP19 (Kuglstatter et al., 2002). The free 
movement of these helices may interfere with the folding of the Alu domain, especially once 
it has been weakened through the disruption of L2 and L1.2 base pairing. This is also 
consistent with previous data showing that the proteins bind the RNA in a cooperative manner 
(Walter and Blobel, 1983a). 
Nevertheless, except for the specific effect observed on the 1 Comp RNA, in which the 
mutations unexpectedly modified the RNA structure, the mutated RNAs have only at 
maximum half the SRP9/14 binding efficiency as compare to wild type RNA. Yet, the 
SRP9/14 heterodimer has been shown to bind the Alu RNA with subnanomolar affinity 
(Janiak et al., 1992; Bovia et al., 1994), and in the reconstitution assay the particles are 
assembled from individual component at a final 0.5 µM concentration. Hence, the reduced 
protein binding efficiency observed with our mutated RNAs should not impair the 
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reconstitution of particles with these mutated RNAs. This is further supported by the result 
that 14sloop protein confers full elongation arrest activity to reconstituted particles despite the 
fact that the dissociation constant of 14sloop-Alu complex is 13-fold higher that wild type 
complex. 
Disruption of the base pairing between the loops reduces the elongation arrest activity of the 
reconstituted particles. However the contributions of loop L2 and L1.2 are not the same. 
Disruption of the tertiary interactions through mutations in L1.2 had only a minor effect on 
elongation arrest activity. The effects could be rescued by compensatory mutations, 
introduced in the opposite loop, restoring the three Watson-Crick base pairing but with a 
different primary sequence.  
The reduced elongation arrest activity did not result from the reduced binding of the SRP9/14, 
since neither increasing the amount of protein, nor increasing the amount of RNA in 
reconstitution are able to rescue the phenotype. Furthermore purified particles have the same 
reduced elongation arrest activity. We were only able to rescue the phenotype by restoring the 
tertiary interactions in the RNA loops, without conserving the primary sequence. 
The effect on elongation arrest function could result from conformational changes in the 
SRP9/14 protein due to the mutated loops. However, we think that this is unlikely to be the 
case since the formation of the RNA binding surface of SRP9/14 requires a largely intact 
protein complex (Weichenrieder et al., 2000) and only very small changes in the C-terminal 
regions of SRP14 and SRP9 are tolerated without interfering with RNA binding (Bui et al., 
1997). It is therefore unlikely that the structure of the SRP9/14 protein in the complex was 
changed significantly by the mutations in the RNA. The tertiary structure is most likely 
induced by protein binding (Andreazzoli and Gerbi, 1991; Weichenrieder et al., 2001) and it 
therefore contributes to the stability of the complex. The small changes in the dissociation 
constants and in the RNA binding efficiency are therefore plausibly explained by a slightly 
diminished stability of the complex. It is also unlikely that the mutations in the two loops 
interfered with the formation of the closed complex. Alu RNA variants with mutations that 
interfere with the formation of the closed conformation have their dissociation constants 
reduced by 50 to 100-fold (Weichenrieder et al., 2001), whereas in our case the dissociation 
constant was only reduced by 9-fold at maximum (Figure 26). 
In addition, the particles comprising the mutated RNAs have intact signal recognition and 
targeting functions, arguing against a significant influence of the mutations on the overall 
structure of SRP. Although it cannot be excluded entirely, it is therefore unlikely that 
conformational changes in SRP9/14 or in the overall structure of SRP account for the 
observed effects of the mutations on elongation arrest activity. 
We showed that the reduced efficiency of in vitro transcribed SRP RNA for reconstitution, as 
compared to purified canine SRP RNA, can be overcome through the purification of the 
particles on DE53 chromatography. Furthermore the reconstitution efficiency might also be 
increased by the addition of SRP protein in the transcription reaction. SRP9/14 primary 
binding site is located in the RNA 5’ domain (Strub et al., 1991; Weichenrieder et al., 2000; 
Weichenrieder et al., 2001), and the proteins, together with SRP19, SRP68 and SRP72 are 
found in the nucleus (Politz et al., 2000; Politz et al., 2002). Therefore these proteins are 
expected to be assembled early in the particle. Conformational changes resulting from the 
sequential binding of the proteins that are involved in the early stages of the SRP assembly 
might favour the folding of our synthetic SRP RNA into a native form, closely related to the 
one achieved in vivo, thus increasing the efficiency of the reconstitution. 
The critical role of the tertiary interactions between loops L1.2 and L2 in SRP function is 
corroborated by the phylogeny conservation for potential base pairing between the loops. SRP 
RNA Alu domain of Metazoa, Plantae and Archaea can be folded into the same secondary 
structure as human 7SL RNA Alu domain. Zwieb et al., 1996 showed that the capacity to 
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form anti-parallel base pairing between the loops of the RNA Alu domain is conserved. 
Taking into consideration the additional information that is now available since the Alu RNP 
crystal structure was solved, we revised the previously published alignment (Figure 32). This 
new alignment confirmed that the potential for base pairing between the loops is conserved in 
Metazoa, Plantae and Archaea. Despite this conservation, three groups can be distinguished. 
First, all metazoan SRP RNAs closely resemble the human 7SL RNA. Specifically, they 
contain all the features of the human RNA Alu domain: the U-turn residue and the shared G-
G base pair that stabilises loop L2 (Figure 32A, star and green labelling, respectively), the 
base pairing potential (Figure 32A, red labelling) and the two helical stacks (Figure 32B).  
 
 
 
Figure 32: Phylogeny conservation of base pairing potential between the loops of Alu SRP RNAs. A: loop 
L1.2 and loop L2 sequence alignments of a representative sample of Metazoan, Plantae and Archaea species. 
Loop sequences are labelled with a black bar and the adjacent helix sequences are outlined in bold italic, dotted 
line: borders of loop sequences not unambiguously identified. The U-turn residue is labelled by a black star 
B: secondary structure models. Green: shared G-G base pair, red: base paired nucleotides in the loops, blue: 
conserved nucleotide in Archaea. 
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Only minor sizes differences are observed in the second loop of Caenorhabditis elegans and 
in the two loops of Drosophila melanogaster.  
Second, loop L2 is highly conserved in plants, except the U-turn residue of Humulus 
japonicus, Humulus lupulus and Benincasa hispida which is replaced by a cytidine. However, 
a C-turn, sharing common feature with U-turn, has been shown in beet western yellow virus 
RNA pseudoknot structure (Su et al., 1999). Therefore the change of the U into a C in these 
three plants might results in the formation of a C-turn in the structure. Most specifically, loop 
L1.2 is always smaller than in Metazoa and helix 1.2 is one base pair shorter (Figure 32B). 
However, sequence conservation and complementary nucleotide changes support the 
formation of two base pairs between plants RNA loops. These two base pairs are adjacent to 
the G of the shared pair in loop L2 and the three bases are therefore expected to form a 
continuous stack like in human Alu RNA.  
Third, in Archaea, the U-turn residue is strictly conserved but the shared G-G pair is absent. 
However, the shared pair could be replaced by G-U or A-U base pair, which are often seen. 
The major features of this last group are the extended base pairing potential between the loops 
and the increased length of helix 1.2. The sequence complementarities allow four base pairing 
interactions between the loops. The remaining nucleotides of loop L1.2 have no apparent 
complementarities and may form a large loop of up to fifteen nucleotides. However, 
thermodynamic studies showed that loops containing four or five nucleotides are the most 
stable (Groebe and Uhlenbeck, 1988) and we therefore favoured a shorter loop (Figure 32B). 
Comparison of the Archaea Alu RNA sequences in this context exhibit an interesting 
conservation of a G residue, in helix 1.2. Its presence in all archaeal RNA sequences might 
highlight an important structural function. The structure we proposed might be a plausible 
hypothesis. Nucleotides of loop L1.2 that are not involved in base pairing with loop L2 may 
stack into a helical structure, thereby extending helix 1.2. In that case, the conserved G, by 
being bulged out of the helix might allow the proper bending of this longer helix 1.2, thus 
enabling base pairing between the loops despite the longer helix. 
Bacillus and Clostridium SRP RNAs have also an Alu-like domain which resembles the 
archaeal Alu domain. Protozoa and Fungi SRP RNAs have truncated Alu domain, lacking 
one or both stem-loop structures. Interestingly, Trypanosoma SRP acquired an additional 
RNA molecule that can be folded into a tRNA-like structure. The acquisition of this second 
RNA molecule might be an evolution compensation to the lack of specific tertiary structure in 
Trypanosoma SRP RNA Alu domain (Beja et al., 1993; Liu et al., 2003). 
The involvement of the Alu RNA base pairing structure in the elongation arrest function 
might not be surprising. In the crystal structure, these loops are located on the opposite side of 
SRP9/14, and both the proteins and the RNA loops are solvent exposed. The comparison of 
the Alu RNP structure (Weichenrieder et al., 2000) with Saccharomyces cerevisiae tRNA 
structure (Ladner et al., 1975) reveals that both complexes have a relatively similar length 
(Figure 33). This implies that the SRP Alu domain may fit into subunit interface of ribosomes 
like tRNA. Furthermore the CCA end and the anticodon loop of the tRNA are located on 
opposite side of the structure and exposed to solvent, allowing the interaction of the CCA end 
with the peptidyl transferase centre when charged with an aminoacyl residue, and of the 
anticodon with the mRNA. Since, the protein and the base paired RNA loops of the SRP Alu 
domain are also located on opposite side of the molecule; they may both interact with 
components of the translational machinery 
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Figure 33: Size comparison between Alu RNP and tRNA structure. Left panel: Alu RNP crystal structure 
from Weichenrieder et al., 2000. The protein SRP9 and SRP14 are shown as red and green ribbon respectively. 
Right panel: Saccharomyces cerevisiae Phe-tRNA crystal structure (Ladner et al., 1975). 
 
An active role of the RNA in SRP function is consistent with the high conservation of the 
RNA among particles of all kingdoms. With the notable exception of chloroplast SRP, all 
particles comprise at minimum a RNA and a fifty four homologue protein.  
3. Model for elongation arrest activity 
 
New information about the interaction of SRP with ribosomes has emerged during the last 
three years. Cross-linking studies in Mammals and Bacteria positioned the SRP54 subunit 
near the ribosome polypeptide exit site (Pool et al., 2002; Gu et al., 2003). In our laboratory 
we have shown that the Alu domain of mammalian SRP is located at the ribosome subunit 
interface, and that the SPR14 carboxyl-terminal region interacts with the ribosomal GTPase 
associated centre. Moreover, nucleotides 97-110 of 7SL RNA have been shown to be more 
protected from chemical modification in polysome-bound SRP than in soluble SRP 
(Andreazzoli and Gerbi, 1991), supporting an interaction of this region of the SRP RNA 
central stem with ribosomes. Compiling all this information provided us with some clues of 
how to position the Alu domain within the bacterial ribosomal structure described by 
Yusupov et al., 2001. I therefore introduced manually the structure of the Alu domain into the 
bacterial ribosome structure (Figure 34). 
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Figure 34: Modelling of SRP Alu domain in the ribosome. The Alu RNP crystal structure (Weichenrieder et 
al., 2000) was placed in Thermus thermophilus ribosome crystal structure (Yusupov et al., 2001) according to 
the latest biochemical data available (see text for detail). 1) Alu SRP proteins 2) Alu SRP RNA 3) ribosomal 
protein S12 4) ribosomal protein L12 5) A site tRNA 6) 23S rRNA 7) 16S rRNA. The ribosomal protein L12 is 
part of the ribosome GTPase associated centre. This figure was made with Rasmol. 
 
When placed in the ribosome, the Alu domain fits the ribosomal subunit interface (Figure 34), 
which was expected from the size comparison with Phe-tRNA (Figure 33). Interestingly, 
placing the protein moiety of the Alu domain toward the large ribosomal subunit 
(Figure 34 c), directed the RNA loops toward the small ribosomal subunit (Figure 34 d). 
According to the SRP RNA central stem interaction with the ribosome (Pool et al., 2002; Gu 
et al., 2003), our modelling places the RNA loops in the vicinity of the ribosomal protein S12 
(Figure 34 e). Our model leads to the orientation of the protein moiety of the Alu domain 
towards the large ribosomal subunit, whereas the RNA moiety faces the small subunit, a 
striking similarity with tRNA CCA end and anticodon localisation within the ribosome. 
Hence, SRP might interfere with the nascent chain elongation by blocking the elongation 
factors entry into the ribosome, or by impeding with the movement of the ribosomal subunits 
with respect to each other. 
An interference of SRP with the small ribosomal subunit function is in agreement to the 
particle’s time of action. By the use of different antibiotics that block the elongation at 
different steps, Ogg and Walter, 1995 showed that SRP binds to ribosome when it has just 
completed the transpeptidylation reaction, but before it has undergone translocation of the 
peptidyl tRNA from the A site to the P site. In Moazed and Noller, 1989 hybrid state model 
for translation (Figure 35), binding and movement of tRNA between the A and P sites of the 
small ribosomal subunit is uncoupled from its movement between A, P and E sites of the large 
subunit. Thus tRNA movement in the hybrid state model occurs in two steps: 1) movement 
with respect to the large subunit; 2) movement of both tRNA along with their bound mRNA 
with respect to the small subunit. Furthermore, movement into the hybrid states is 
spontaneous and occurs independently of elongation factor two (EF2) and GTP. The EF2 
however catalyses the movement of the anticodon ends of both tRNAs relative to the 30S 
subunit, moving peptidyl-tRNA into the P/P state and deacetylated tRNA in E state (Wilson 
and Noller, 1998). Hence a block of the elongation cycle, taking place between the 
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transpeptidylation reaction and the translocation of the peptidyl tRNA from the A site to the P 
site is likely to be achieved by interference with the small ribosomal subunit function. 
 
 
 
Figure 35: Hybrid state model for the translational elongation cycle (taken from Wilson and Noller, 1998). 
The tRNA binding sites on the 50S and 30S subunits are represented schematically by the upper and lower 
rectangles, respectively. The 50S subunit is subdivided into A (aminoacyl), P (peptidyl), and E (exit) sites; the 
30S subunit is subdivided into A and P sites. The tRNAs are represented by vertical bars and the nascent chain 
by a wavy line; aa represents the aminoacyl moiety and OH the deacylated 3’ end of tRNA; the circles represents 
elongation factors 1 and 2, EF-1 and EF-2 respectively. The binding states, indicated at the bottom of each panel, 
indicate the state of each ribosomal subunit. 
 
The rescue of elongation arrest function of SRP RNAs mutated in loop L2 and, to a lower 
extent in L1.2, without conservation of the loops primary sequence, suggests that it involves 
an interaction with the RNA structure, and not specific nucleotide recognition. Due to the 
position of the Alu RNA in our modelling, we favour an interaction with a protein component 
of the translational machinery rather than an interaction with a ribosomal RNA. The 
interaction might be achieved through recognition of the Alu RNA loop L2 phosphate 
backbone. We think that L2 is the target of the interaction because only mutations in L2 had a 
drastic effect on the elongation arrest function; hence, compensatory mutations might rescue 
the function by restoring the base stacking of loop L2. 
Bacterial protein S12 and its mammalian homologue, S23, are good candidates for a putative 
interaction leading to the arrest of the nascent chain elongation. The S12 has been shown to 
interact with the aminoacyl tRNA in the A-site (Stark et al., 2002). In fact the protein 
modulates the translation fidelity by stabilising tRNA binding during initial selection 
(Rodnina et al., 2002 and references therein). Discrimination between cognate and non-
cognate tRNA in the A site is coupled with EF1 GTP hydrolysis (Hopfield, 1974; Ninio, 
1975). Furthermore the cognate rate of EF1 GTP hydrolysis is four orders of magnitude 
higher than the non-cognate rate (Rodnina et al., 1996). Hence, binding of the cognate tRNA 
causes an increase rate of EF1-dependent GTP hydrolysis, leading to the preferential release 
of EF1-GDP from the ribosome. Less information is available about EF2 interactions, but it 
can be cross-linked with mammalian S23 protein (Uchiumi et al., 1986). Domain IV of EF2 
has structural similarities with the anticodon domain of the tRNA-EF1 ternary complex 
(Nissen et al., 1995; Nyborg et al., 1996). Indeed the orientation of EF2 in the ribosome is 
very similar to the one of EF1 (Stark et al., 1997), and EF2 domain IV is directed toward the 
decoding centre with its tip positioned closed to several rRNA elements of the small subunits 
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tRNA sites (Wilson and Noller, 1998 and references therein). Furthermore the domain IV of 
EF2 is important for coupling GTP hydrolysis to movement of tRNA since an EF2 where 
domain IV is truncated results in a 50-fold reduction in the rate of translocation, without 
affecting the binding of EF2 to ribosome (Rodnina et al., 1997). EF2 dependent GTP 
hydrolysis precedes and greatly accelerates the rearrangement that leads to tRNA 
translocation. Thus, interfering with this step is likely to affect the rate of the nascent chain 
elongation. Furthermore, EF2 hydrolysis takes place immediately after binding to ribosome 
(Rodnina et al., 1997). 
We therefore propose the following model for SRP-mediated arrest of nascent chain 
elongation. The Alu domain of SRP binds ribosomes, allowing S domain binding near the 
nascent chain exit site. Through the interaction of SRP14 carboxyl-terminal with rGAR RNA, 
and the interaction of the base paired RNA loops with S23, EF2 is prevented from binding to 
the ribosome, blocking tRNA translocation in the small subunit A site to the P site, therefore 
arresting translation.  
Thus, according to this model, the simultaneous mutations of SRP14 carboxyl-terminus and 
of the RNA L2 loop should impair the ability of the SRP Alu domain to interact with the 
ribosome. 
The continuous increase of preprolactin translocation in 2L2 SRP, despite the reduced 
elongation arrest activity can be correlated to primary binding of SRP14 to rGAR RNA, 
allowing S domain interaction with the ribosome. Therefore the translocation efficiency 
increased in correlation with the concentration of 2L2 SRP. The key role of SRP14 carboxyl-
terminal primary binding to ribosome is supported by the complete loss of elongation arrest 
function upon SRP14 carboxyl-terminal truncations.  
The interaction of the Alu RNA loops with S23 protein is supported by the conservation of 
the function without conservation of primary sequence. Interference of this interaction with 
translation is supported by a reduced rate of EF2 GTP hydrolysis, similar to that observed in 
non-cognate tRNA-EF1 (Rodnina et al., 1996). Elongation arrest is just transient in a 
homologous system (Lipp et al., 1987; Wolin and Walter, 1989), which is in agreement with 
our model since an EF2 where domain IV is truncated results in a reduction of tRNA 
translocation rate (Rodnina et al., 1997). Therefore, interfering with EF2 domain IV-mediated 
coupling of GTP-hydrolysis with tRNA movement in the small subunit should result in a 
reduced speed of the nascent chain translation. 
The model is an interesting working hypothesis in that it supposes an interaction of the SRP 
Alu domain with two partners which are critical for the GTP hydrolysis of elongation factors: 
the GTPase centre of the large subunit, and the decoding centre of the small subunit. 
Furthermore this model, where interactions with both ribosomal subunits lead to the arrest of 
nascent chain elongation, is supported by the role of bacterial 4.5S SRP RNA in translation. 
In Escherichia coli, 4.5S RNA has two different roles, one related to SRP and requiring Ffh 
binding and another one independent of Ffh and not related to SRP, required to maintain a 
normal rate of translation via its binding to EF2. Hence mutations in the large ribosomal 
subunit GTPase centre and in the 16S rRNA, altering the decoding fidelity, suppress 4.5S 
RNA requirement for translation (Brown, 1989; Prescott and Dahlberg, 1990; O'Connor et al., 
1995; Brunelli et al., 2002). 
Indeed, our model implies an SRP evolutionary process where the acquisition of the Alu 
domain results in the acquisition of an additional role of the particle that affects the nascent 
chain elongation. Interestingly, whereas bacterial 4.5S RNA was required for translation 
independently of SRP, the mammalian particle arrests the nascent chain elongation. It is even 
more striking to notice that the translational role of 4.5S RNA is achieved through binding 
with EF2, whereas in our model the elongation arrest is achieved by impairing EF2 binding to 
the ribosome. 
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1.4 Mutated RNAs genesis 
 
Mutations at specific sites in the RNA sequences were introduced by polymerase chain 
reaction (PCR) using the Quickchange™ method (Stratagene). DNA oligonucleotides, 
containing the desired mutation, flanked by 15 nucleotides, were used to produce the mutated 
SRP RNAs (Interactiva, Germany). 
The PCR reaction was done in 20 mM Tris-HCl pH 8.8, 10 mM KCl, 10 mM (NH4)2SO4, 
2 mM MgSO4, 0.1% (v/v) Triton® X-100, 0.1 mg/ml bovine serum albumin (BSA) containing 
4 ng of template DNA, 100 ng of sense and of antisense oligonucleotides, 0.25 mM dNTPs 
and 2.5 U of Pfu DNA polymerase (Promega). The following clones were produced, either in 
a small 86-nucleotide Alu RNA previously described: pSA86H Weichenrieder et al., 1997, or 
in the full length SRP RNA: 
pSaG15, pSaC33, and pSa2L1.2 were produced by mutation of pSA86H as template. 
pSa 1 Comp was produced by mutation of pSaG15 as template. pSa 2 Comp was produced by 
mutation of pSa2L1.2 as template. pSaG15G34G37 was produced by mutation of pSa2L1.2 as 
template. pSa 3 Comp was produced by two step mutations: first on pSA86H, then on the 
clone obtained in the first step. pSa2L2 was derived from p2L2 by ligation: the fragment of 
2L2 containing the desired mutation is exchanged with the corresponding fragment in the 
pSA86H. pSaC13C14C33 was produced by mutation of pSa2L2. 
p2L2, p2L1.2, p3L2, p3L1.2 clones were obtained by the introduction of mutations p7Sswt 
sequence (Strub et al., 1991). p2 Comp was generated using p2L2 as template. p3 Comp was 
generated using p3L2 as template. p1 Comp was produced from pSa1 Comp and p2Sswt by 
ligation: the fragment of pSa1 Comp containing the desired mutation was exchanged with the 
corresponding fragment of p7Sswt.  
pAC, pGU, pGG, pAG, pCU, pU14U15, pA33A34, pA14A15, and pU33U34 were produced from 
p7Sswt as template. pACGU, pCCGG, pAGCU, pU14U15A33A34, and pA14A15U33U34 were 
derived from the following template respectively: pAC, p2L2, pAG, pU14U15 and pA14A15. 
All clones sequences were verified by automatic sequencing using Sp6 primer 
(5’-accttatgtatcatacacat-3’). 
 
1.5 Nomenclature used for the mutated RNAs 
 
To facilitate the understanding of the mutations introduced in the SRP RNA sequence we 
used a specific nomenclature. The names are given such that the first part refers to the number 
of base pairing disrupted (or restored), whereas the last part referred to the loops in which the 
mutations where introduced (e.g. 2L2 means that 2 base pairing where disrupted in loop L2). 
In case of compensatory mutations the first part referring to the number of base pairing 
involved in the mutation is followed by the comp suffix.  
 
1.6 Large scale transcription 
 
Plasmids obtained in Escherichia coli strain XL1-blue, purified on Qiagen Midi cartridge, 
were linearized with Xba (Gibcobrl) before in vitro transcription with T7 RNA polymerase. 
Plasmid pMR7wt (kind gift from Dr Mallet Arnaud et al., 1997) was used to produce T7 
RNA polymerase. Reactions were done in 100 µl of 40 mM Tris-HCl, pH 8.1, 20 mM MgCl2, 
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1 mM spermidine, 5 mM dithiothreitol (DTT), 4 mM of each rNTPs, 1 µg/µl BSA, 100 ng/µl 
DNA template and 22 U/µl T7 RNA polymerase. Nucleotides were obtained from Sigma and 
stored as 50 mM solutions at -80°C. 
After two hours at 37°C, the transcription reaction was submitted to RQ1 RNase free DNase 
treatment (Promega). The mix was then phenol extracted and purified through a 1 ml 
Sephadex G50 fine column (Pharmacia). After ethanol precipitation, the RNAs are kept in 
sterile water. Their concentrations were measured by OD260 nm, and verified on a denaturing 
acrylamide gel. 
 
1.7 Protein purification 
 
1.7.1 Human SRP9/14  
 
Plasmids pEh9 and pEh14, described in Bovia et al., 1997, were used to produce the human 
SRP 9/14 heterodimer. Proteins were overexpressed separately in BL21 Escherichia coli 
cells. Bacterial pellets were lysed separately in a French® pressure cell press (Sim Amincon) 
and combined together. Dimerisation was allowed for thirty minutes at 4°C and the 
heterodimer was purified with HiTrap Heparin (Amersham Pharmacia Biotech), 
hydroxylapatite (BioRad) and Superdex 200 (Amersham Pharmacia Biotech) 
chromatography. 
The purified protein concentrations were determined by spectrophotometry at 280 nm, using 
the specific molar extinction coefficient: 15 130 M-1 cm-1 calculated from the protein 
sequence as described (Gill and von Hippel, 1989). 
 
1.7.2 Human SRP9/14K95  
 
The clone ph14K95 encoding human SRP14 truncated at lysine 95 was obtained with the 
Stratagene QuickChange™ mutagenesis kit, by replacing the lysine 96 codon (AAG) in 
pBH14HS with a stop codon (TAA). The plasmid pBH14HS encodes the human SRP14 
protein without alanine tail and with a carboxyl-terminal histidine tag. SRP9 was expressed in 
BL21 Escherichia coli cells and h14K95 was overexpressed in Tuner™ cells (Novagen). 
Bacterial pellets were lysed separately in a French® pressure cell press (Sim Amincon). SRP9 
lysates were then combined with h14K95 lysates. The heterodimer h9/14K95 was purified 
with HiTrap heparin and MonoS (Amersham Pharmacia Biotech) chromatography. Although 
not visible by Coomassie-staining, western blot analysis revealed that h9/14K95 contained 
low amounts of h14his most likely produced by ribosomal read-through of the introduced stop 
codon in bacteria. Protein concentrations were determined by spectrophotometry at 280 nm 
using the following molar extinction coefficients: 15 130 M-1cm-1. 
 
1.7.3 Human SRP9K41A/14 and SRP9K41R/14 
 
Mutations of lysine forty one were introduced in plasmid pEh9 sequence by the Stratagene 
QuickChange™ mutagenesis kit. For SRP9K41A the lysine 91 codon AAA in pEth9 was 
replaced by the GCG codon, the same AAA codon was replaced by CGC to produce the 
SRP9K41R. SRP9K41A and SRP9K41R were expressed in Tuner™ cells (Novagen). 
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Bacterial pellets were lysed separately in a French® pressure cell press (Sim Amincon) and 
purified with HiTrap heparin chromatography (Amersham Pharmacia Biotech). SRP14 was 
expressed in BL21 Escherichia coli cells and bacterial pellets were lysed in a French® 
pressure cell press (Sim Amincon). The heparin purified SRP9K41A and SRP9K41R were 
combined with SRP14 lysates and the heterodimers were purified with MonoS (Amersham 
Pharmacia Biotech) and hydroxylapatite (BioRad) chromatography. Protein concentrations 
were determined by spectrophotometry at 280 nm using the following molar extinction 
coefficients: 15 130 M-1cm-1. 
 
1.7.4 Human SRP9/14sloop  
 
Plasmid pBh14sloop encoding human SRP14 truncated between arginine 35 and aspartate 53 
was obtained from pBH14HS with the Stratagene QuickChange™ mutagenesis kit. SRP9 was 
expressed in BL21 Escherichia coli cells and h14sloop was overexpressed in Tuner™ cells 
(Novagen). Bacterial pellets were lysed separately in a French® pressure cell press (Sim 
Amincon) and combined together to form the SRP9/14sloop heterodimer. This heterodimer 
was purified with His-Bind (Novagen) and MonoS (Amersham Pharmacia Biotech) 
chromatography. Protein concentrations was determined by Bradford and verified by 
Coomassie staining against wild type SRP9/14 as standard. 
 
1.7.5 Human SRP9/14-10Ct purification 
 
Plasmids pEh9 and pBH14K100 were used to produce the human SRP 9/14-10Ct 
heterodimer. Proteins were overexpressed separately in Tuner™ cells (Novagen). Bacterial 
pellets were lysed separately in a French® pressure cell press (Sim Amincon) and combined 
together. Dimerisation was allowed for thirty minutes at 4°C and the heterodimer was purified 
with HiTrap Heparin, and Superdex 200 (Amersham Pharmacia Biotech) chromatography. 
The purified protein concentrations were determined by spectrophotometry at 280 nm, using 
the specific molar extinction coefficient: 15 130 M-1 cm-1 calculated from the protein 
sequence as described (Gill and von Hippel, 1989). 
 
1.7.6 SRP54 purification 
 
Hauser et al., 1995 construct of canine SRP54 was expressed in the baculovirus system 
according to their protocol, SF21 cells were used to amplify the virus encoding for SRP54, 
whereas the protein was produced in Tn5 cells. Following lysis of the cells in a homogenizer, 
the protein was purified on a CM and on Hi-Trap Heparin column (Amersham, Pharmacia, 
Biotech). The purified protein was quantified by spectrophotometry at 280 nm, with the use of 
its specific molar extinction coefficient : 22 220 M-1 cm-1. 
 
1.7.7 SRPφ19 purification 
 
Plasmid pEφ19 encoding human SRP19 with a φ tagged, was overerexpressed in BL21 
Escherichia coli BL21 cells. Bacterial pellet was lysed in a French® pressure cell press (Sim 
Amincon) and the protein was purified on Hi-Trap Heparin (Amersham, Pharmacia, Biotech), 
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and CM chromatography as previously described (Thomas et al., 1997). The purified protein 
was quantified by spectrophotometry at 280 nm, with the use of its specific molar extinction 
coefficient: 12 570 M-1 cm-1. 
 
1.8 SRP reconstitutions 
 
All SRP were tested in at least two independent experiments. 
 
1.8.1 h9/14K95 
 
SRP was reconstituted with canine SRP RNA, canine SRP68/72 and recombinant 
SRP9/14K95 (or SRP9/14), SRPφ19 and SRP54 proteins. Reconstitutions were done in 8 µl 
at 0.5 µM and 1 µM final concentrations of all the proteins and purified canine SRP RNA, 
respectively, in 20 mM HEPES-KOH pH 7.5, 500 mM potassium acetate pH 7.5, 5 mM 
magnesium acetate, 0.01% (v/v) Nikkol, 1 mM DTT (HKMN buffer). Samples were 
incubated for 10 minutes on ice and 10 minutes at 37°C. Reconstituted SRP was then added at 
the desired concentrations to a 10 µl wheat germ translation reactions, programmed with 
synthetic preprolactin and sea urchin cyclin D transcripts as described in Strub and Walter, 
1990. Translation reactions were stopped after 30 minutes at 26°C, proteins precipitated with 
10% (w/v) trichloroacetic acid and analysed by 12% SDS-PAGE. Preprolactin, prolactin and 
cyclin D were quantified by the use of a phosphorescence imaging system (BioRad). To 
monitor translocation, the 10 µl wheat germ translation reactions were complemented with 
SRP-depleted canine microsomes (0.15 eq./µl) prepared as described in Walter and Blobel, 
1983b. Elongation arrest and translocation efficiencies were evaluated as follows: 
100]
/
/1[ ×⎟⎠
⎞⎜⎝
⎛−=
CoPo
CsPsEA  where EA is percent elongation arrest activity, Ps and Cs are the 
amounts of preprolactin and cyclin quantified in the sample and Po and Co the amounts of 
preprolactin and cyclin present in the negative control (SRP buffer or SRP reconstituted 
without h9/14). ⎟⎟⎠
⎞
⎜⎜⎝
⎛
+= PpP
PT *100  were T is percent translocation, P is the amount of 
prolactin and pP the amount of preprolactin quantified in each sample. T is about 20 % in the 
absence of SRP.  
 
1.8.2 hSRP9/14K95 competition in reconstitution 
 
For SRP9/14K95 competition, particles were reconstituted with canine SRP RNA, canine 
SRP68/72 and recombinant SRP9/14, SRPφ19 and SRP54 proteins, in presence of 
SRP9/14K95. Reconstitutions were done in 8 µl at 0.5 µM and 1 µM final concentrations of 
the proteins and purified canine SRP RNA, respectively, in 20 mM HEPES-KOH pH 7.5, 
500 mM potassium acetate pH 7.5, 5 mM magnesium acetate, 0.01% (v/v) Nikkol, 1 mM 
DTT. SRP9/14K95 final concentrations of 0.5, 1.5, 4.5 and 10.5 µM were used as competitor 
against constant 0.5 µM wild type SRP9/14. Samples were further treated as described for 
standard reconstitution. 
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1.8.3 h9/14sloop and h9/14-10Ct 
 
Reconstitution, elongation arrest and translocation were performed as for h9/14K95, except 
that SRP was reconstituted with in vitro transcribed SRP RNA, canine SRP68/72 and 
recombinant SRP9/14sloop (or SRP9/14), SRPφ19 and SRP54 proteins.  
 
1.8.4 SRP9K41A/SRP14, SRP9K41R/SRP14  
 
Reconstitution, elongation arrest and translocation were performed as for h9/14K95, except 
that SRP was reconstituted with purified canine SRP RNA, canine SRP68/72 and 
recombinant SRP9K41A/14 (or SRP9K41R/14, or SRP9/14-10Ct), SRPφ19 and SRP54 
proteins.  
 
Canine SRP68/72 proteins and canine SRP RNA were purified from the disassembly of 
canine SRP as previously described (Walter and Blobel, 1983a). Canine SRP was a kind gift 
of Dr A.E Johnson. 
 
1.8.5 Reconstitution with mutated SRP RNAs 
 
Reconstitution, elongation arrest and translocation were performed as for h9/14K95, except 
that SRP was reconstituted with in vitro transcribed mutated SRP RNA, canine SRP68/72 and 
recombinant SRP9/14, SRPφ19 and SRP54 proteins.  
For purification by ion exchange chromatography, SRP was reconstituted, with purified 
canine SRP proteins, in 50 µl reactions at final concentrations of 2 µM of each protein and 12 
µM of synthetic SRP RNA in 50 mM HEPES-KOH pH 7.5, 500 mM potassium acetate pH 
7.5, 5.5 mM magnesium acetate, 0.01% (v/v) Nikkol, 1 mM DTT, 0.5 mM EDTA pH 7.5, 
10% (v/v) glycerol (RC buffer). Fully reconstituted particles were purified away from 
incomplete particles through a 50 µl DE53 column essentially as described in Chang et al., 
1997. Samples were eluted twice with 50 µl 50 mM HEPES-KOH pH 7.5, 600 mM potassium 
acetate pH 7.5, 6.5 mM magnesium acetate, 0.01% (v/v) Nikkol, 1 mM DTT, 0.5 mM EDTA 
pH 7.5, 10% (v/v) glycerol and twice with 50 µl of the same buffer comprising 1000 mM 
potassium acetate and 10 mM magnesium acetate. Aliquots of all fractions were precipitated 
with 10% (w/v) trichloroacetic acid and analysed by 5-20% SDS-PAGE followed by silver 
staining. Complete particles eluted at 600 mM potassium acetate, whereas incompletely 
reconstituted particles eluted at 1000 mM potassium acetate. 
The concentrations of the purified particles were first evaluated by silver staining. However, 
for greater accuracy we verified the quantification of the SRP samples by western blot 
analysis using affinity-purified antibodies against SRP14. Elongation arrest and translocation 
efficiency results derived from four separated experiments. 
Canine SRP proteins used in the purification assays was a kind gift of Dr H. Bernstein. 
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1.8.6 hSRP9/14 titration in 2L2 reconstitution 
 
Particles were reconstituted with 3L2 RNA, canine SRP68/72 and recombinant SRP9/14, 
SRPφ19 and SRP54 proteins. Reconstitutions were done in 8 µl at 0.5 µM and 1 µM final 
concentrations of proteins and 3L2 RNA, respectively as described, in presence of 0.5, 1, 2 or 
4 µM final concentration of recombinant SRP9/14. Samples were further treated as described. 
Results derived from duplicate experiments. 
 
1.8.7 mutated RNA titration in reconstitution  
 
Particles were reconstituted with either 2L2, 3L2 or wild type synthetic RNA, canine 
SRP68/72 and recombinant SRP9/14, SRPφ19 and SRP54 proteins. Standard reconstitutions 
were done in 8 µl at 0.5 µM and 1 µM final concentrations of proteins and RNA, respectively. 
In vitro transcribed 2L2, 3L2 or wild type RNA were added to final concentration of 0.5, 1, 
1.5 or 2 µM for wild type and 2L2 RNA, and  1, 2, 4 or 8 µM for 3L2 RNA. Samples were 
further treated as described.  
 
1.9 RNA binding assay 
 
hSRP14 was synthesised in 10 µl wheat germ translation reactions in presence of 1 pmole of 
recombinant hSRP9 as described (Bovia et al., 1997). The heterodimer h9/14 was bound to 
2 pmole of biotinylated SRP RNAs in 50 mM HEPES-KOH pH 7.5, 350 mM potassium 
acetate pH 7.5, 3.5 mM magnesium acetate and 0.01% (v/v) Nikkol. The bound protein was 
purified away from unbound protein by the use of Streptavidin magnetic beads (Dynal) as 
described in Bovia et al., 1994. Bound protein was analysed by 15% SDS-PAGE, visualised 
by autoradiography and quantified by phosphoimager (BioRad). 
 
1.10 Hydroxyl radical cleavage reaction 
 
Alu151 RNA was labelled at its 3’ end with [32P]pCp (γ[ 32P] 370 kBq/µl) and RNA ligase as 
described (England et al., 1980). Binding of labelled Alu151 RNA to recombinant 
hSRP9/14K95 or hSRP9/14 was performed in 4 µl reactions in final salt concentrations of 
20 mM HEPES-KOH pH 7.5, 300 mM potassium acetate pH 7.5, 3.5 mM magnesium acetate, 
1 mM DTT and 0.01% (v/v) Nikkol. In parallel sample, which serves as negative control, 
SRP9/14 was replaced by equal amount of bovine serum albumin. Protein-to-RNA ratios 
were 1:1 or 1:3. After binding, the samples were diluted to 20 µl in final salt concentrations of 
20 mM HEPES-KOH pH 7.5, 300 mM potassium acetate pH 7.5, 3 mM magnesium acetate, 4 
mM DTT and 0.01% (v/v) Nikkol. To perform the cleavage of the RNA, the following four 
solutions were combined in a drop at the side of the tube in the given order: 1) 25 mM ferrous 
ammonium sulfate [Fe(NH4)2(SO4)2], 2) 50 mM EDTA, 3) 125 mM sodium ascorbate, and 
4) 2.5% (v/v) hydrogen peroxide. The drop was spun into the samples, which were then 
incubated on ice for 3 minutes. The reaction was stopped by the addition of 25 µl of 0.1 M 
thiourea and 10 µl of 3 M sodium acetate, 1 µg of Escherichia coli tRNA, and 40 µl of TE, 
followed by phenol extraction and precipitation in ethanol. The samples were dissolved in 
4 µl of sample buffer and the reaction products were analysed by autoradiography following 
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separation on a 6% sequencing gel. To trace the sequence of the RNA, sequencing reaction 
were created with either 0.1 U RNase T1 (Pharmacia) for guanosine, 1 U RNase U2 
(Pharmacia) for adenosine, and RNase B. cereus (Pharmacia) for cytosine and uracile. A 
complete ladder was also obtained by partial alkaline hydrolysis in 0.1 M NaHCO3, pH 9.5 
for 3 minutes at 95°C. All sequencing samples contained 1 µg of unlabeled Escherichia coli 
tRNA. 
 
1.11 Electromobility shift assay 
 
The electromobility shift assay was derived from Weichenrieder et al., 2001. Sa86 RNA, 
labelled by transcription with α [32P] UTP (24.1015 Bq/mmol) was used as tracer. To set up 
the conditions of the competition experiments, 200 nM cold Sa86 RNA (containing 20 000 
Cpm of labelled SA86 RNA as tracer) was titrate against SRP9/14 protein with concentration 
ranging from 25 nM to 600 nM. Conditions allowing 100% of protein-RNA binding were 
achieved with final concentration of 200 nM RNA and 190 nM SRP9/14. 
Individual reconstitution assays were done in 20 mM Hepes pH 7.5, 300 mM potassium 
acetate, 10 mM magnesium acetate, 5 mM DTT, 0.015% (v/v) Nikkol. For reconstitution, 5 µl 
of RNA pSA86H (containing 20 000 Cpm of labelled RNA) were recombined with 5 µl of 
competitor RNA and 10 µl of human SRP9/14 heterodimer. The binding reaction was allowed 
to proceed for 10 minutes on ice, then for 10 minutes at 37°C. Labelled and unlabelled RNAs 
were annealed in assay buffer without DTT and Nikkol, immediately before use at 4x of final 
concentration. Competitor RNA final concentrations ranged from 50 to 800 nM. As negative 
control, samples consisting of Sa86 in absence of protein, and Sa86 in presence of bovine 
serum albumin were loaded on the gel.  
 
1.11.1 Native gels 
 
Native 8% polyacrylamide gels (acrylamide/bisacrylamide 40:1) containing 10 mM 
magnesium acetate and 50 mM Tris acetate pH 7.5 were prerunned at 0.22 W/cm3 for two 
hours in the cold room. Reconstitution samples in buffers without dye were mixed with 4 µl 
80% (v/v) glycerol prior to loading and were runned for 120 minutes at 0.22 W/cm3 in the 
cold room. Gels were then fixed with 20% (v/v) methanol, 10% (v/v) acetic acid for 30 
minutes and dried before autoradiography or exposure to phosphoimager screen. 
 
1.11.2 Kd measure 
 
Measurement of the mutated RNAs dissociation constant from competition in electromobility 
shift assay, were made according to Bovia et al., 1997. 
The equilibrium dissociation constant (Kd) of RNA-protein interaction is described by the law 
of mass action as follows: [ ] [ ]
[ ]RP
PRKd *=  
were [R] represents the concentration of free RNA, [P] the concentration of free protein and 
[RP] the concentration of complex. Hence the dissociation constants of wild type RNA 
(Kdwt) and of competitor RNA (Kdcomp) are defined by: 
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[ ] [
[ ]
]
RwtP
PRwtKdwt *=   and  [ ] [ ][ ]RcompP
PRcompKdcomp *=  
 
Since the protein concentration is identical for both RNA in the competition experiments, this 
leads to the equation (1): [ ] [ ]
[ ] [ ]RcompRwtP
RcompPRwt
Kdcomp
Kdwt
*
*=  (1) 
 
Taking into consideration that: [ ] ( ) [ ]RowtvvoRcompP *−= ; ; [ ] [RowtvRwtP *= ]
[ ] [ ] ( ) [ ][ ]RowtvvoRocompRcomp *−−=  and [ ] [ ] [ ]RowtvRowtRwt −= , equation (1) can be 
transformed in : [ ]
( ) [ ] ⎟⎠
⎞⎜⎝
⎛ −=−− 1
1*1
* vKdwt
Kdcomp
Rowtvvo
Rocomp  (2) 
 
were  represents the fraction of complexed wild type RNA in absence of competitor and  
the fraction of complexed wild type RNA at the different competitor concentrations.  
vo v
[Rowt] ] and [  are the input concentrations of wild type RNA and of competitor RNA, 
respectively. The competitor RNAs dissociation constants were derived from equation (2), 
were the slope represents the 
Rocomp
Kdwt
Kdcomp  ratio. 
 
 
1.12 Computer programs 
 
 
The figures of proteins or RNA structure were realised by the generation of povscript file with 
SwissPDB viewer or Ribbons. The povscript files were then rendered with Povray. 
Pdb files that contain only alpha carbon cannot be opened with Swisspdb or Ribbons, figures 
derived from such files were realised with Rasmol. 
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 ABSTRACT 
 
The eukaryotic signal recognition particle (SRP) tightly links protein synthesis to 
translocation into the endoplasmic reticulum (ER) by delaying elongation of the nascent chain 
during co-translational targeting. The results presented here provide evidence that a specific 
RNA structure in the Alu domain of SRP plays an important role in the elongation arrest 
activity of SRP. Three base pairs between two distant loops, L2 and L1.2, form an extended 
stack together with an additional base from each loop. Mutations in L2 that disrupt base 
pairing diminished the elongation arrest activities of reconstituted SRPs. Complementary 
mutations in L1.2 fully restored elongation arrest activities despite the differences in the 
primary sequences of the loops. Mutations in L1.2 had less dramatic effects on the function of 
SRP. Hence, the well-defined, rigid structure of loop L2 appears to play a fundamental role in 
the formation and the stability of the tertiary structure. The loss in elongation arrest activity is 
not explained by the absence of h9/14 in the particles or by another assembly defect. Instead, 
it is an intrinsic property of SRPs containing RNAs with mutations that impair formation of 
the tertiary structure. A structure-based alignment reveals a significant conservation of the 
structural elements that may allow formation of the tertiary structure, a result that underlines 
the importance of the tertiary structure in SRP function. 
 
 INTRODUCTION 
 
The signal recognition particle (SRP) plays an essential role in targeting proteins to the 
endoplasmic reticulum (ER, review see (1)), which is the first step in routing proteins into the 
secretory pathway. SRP samples translating ribosomes for nascent chains bearing signal 
sequences, a common hallmark of ER-targeted proteins. Signal sequence recognition results 
in an arrest or a delay in polypeptide elongation. An interaction of SRP with its receptor (SR) 
in the ER membrane targets the SRP-ribosome-nascent chain complex to the translocon, a 
specific structure in the membrane that promotes translocation into the ER (for review see 
(2,3)). At the translocon, translation resumes at its normal speed and the nascent chain is 
transferred across or into the ER membrane while the released SRP enters a new targeting 
cycle. Three GTPases control the targeting process: The signal sequence binding protein 
SRP54 and the two subunits of SR, SRα and SRβ (for review see (4)). In this model, SRP 
serves as an adaptor between protein synthesis and the translocation process into the ER. 
SRP can bind to all ribosomes and its affinity increases in the presence of an exposed 
signal sequence (5,6). Notably, SRP can distinguish between actively translating and inactive 
ribosomes and therefore appears to recognise conformational changes in the ribosome (7). 
This notion is also supported by the observation that SRP interacts with the ribosome at a 
specific stage in the elongation cycle, just before peptidyl-tRNA undergoes translocation from 
the A site to the P site (8). Furthermore, SRP interacts with the ribosome to delay elongation 
of the nascent chain upon signal sequence recognition, which is referred to as the elongation 
arrest activity (9,10). It is thought to prevent premature folding of the nascent chain, which 
may interfere with efficient translocation. In yeast, abrogating elongation arrest activity 
impairs the tight coupling of translation and translocation, although a significant translocation 
defect could not be observed for several proteins (11). 
The signal recognition and targeting functions of mammalian SRP are contained within 
the S domain, which comprises the central part of SRP RNA and the proteins SRP19, SPR54 
and SRP68/72 (6,12). The signal sequence binding protein SRP54 could be cross-linked to 
two ribosomal proteins in the vicinity of the nascent chain exit site (13). Similarly, cross-links 
between bacterial SRP and ribosomes are also consistent with its location close the nascent 
chain exit site (14,15). The Alu domain, which comprises the 3’ and 5’ ends of SRP RNA and 
the SRP9/14 heterodimer, is required for the elongation arrest activity of SRP as deduced 
from the observation that the S domain alone lacked this activity (16). However, the S domain 
 
 alone also lacks signal sequence-independent ribosome binding activity (17). A small C-
terminal truncation of SRP14 specifically abrogated the elongation arrest of the particle 
without interfering with signal sequence recognition or ribosome-binding (18) indicating that 
direct interactions between the Alu domain and the ribosome may indeed mediate the arrest or 
delay in nascent chain elongation.  
In recent years, significant progress has been made in determining the structure of SRP 
(for review see (19)). The Alu portion of SRP RNA includes a 5’ domain comprising two 
hairpin structures linked by a conserved single-stranded region and a short stem as well as a 
3’ domain including a portion of the central stem connecting the Alu and the S domains 
(Fig. 1). The crystal structure of the Alu RNA 5’ domain bound to SRP9/14 revealed that it is 
compactly folded into two helical stacks, which are connected by the single-stranded region 
forming a U-turn (20). In agreement with previous footprinting studies (21), the U-turn and 
adjacent nucleotides represent the primary binding site of the SRP9/14 heterodimer. Opposite 
the protein-binding site, the two loops of the 5’ domain form three base pairs (20). Formation 
of this tertiary structure is most likely induced and/or stabilised upon protein binding (22). 
The potential to form base pairs between the two distant loops is conserved in SRP RNAs of 
Metazoa and of Archaea as well as of the bacterial species Bacillus and Clostridium (23,24). 
Further biochemical and structural data support a model in which the complete Alu 
domain may exist in two conformations (25). In the open conformation, the central stem 
would not participate in complex formation with SRP9/14 whereas in the closed 
conformation, the central stem would fold back by up to 180° to align beside the 5’ domain 
allowing contacts to the SRP9 moiety of the protein. The model for the closed conformation is 
consistent with the observed footprints on the central stem (21) and with the requirement that 
the 3’ and the 5’ domains have to be flexibly linked for fully efficient binding of SRP9/14 
(26). 
The RNA moieties of ribonucleoprotein complexes are known to play essential roles in 
many diverse cellular processes. By analogy, SRP RNA may play an active role in the 
specific targeting process rather than just serving as a scaffold for the proteins. In particular, 
the conservation of the RNA moiety in the E. coli SRP, which contains just one protein 
subunit, argues strongly against a scaffold role of SRP RNA. So far, a specific role of the 
RNA has been characterized in the interaction between SRP and its receptor. It accelerates 
complex formation between the two, which leads to an increase in the observed GTP 
hydrolysis rate (27-29). Additional observations also support a functional role of the RNA. In 
the E. coli particle, the RNA stabilises the structure of the signal sequence recognition protein 
 
 (Ffh, (30)). Conformational changes in the RNA upon binding of SRP to polysomes (22), 
suggest a role for SRP RNA in the interaction with the ribosome and conformational changes 
in one of the loops of the 5’ Alu domain were associated with a loss of elongation arrest 
function of the particle (18). Particularly interesting is the finding that trypanosome SRP 
comprises two RNA species: SRP RNA, which has a truncated 5’ domain structure, and a 
tRNA-like RNA (sRNA-85) linked to the 5’ domain of SRP RNA (31,32). It is hard to 
explain the acquisition of sRNA-85 without evoking a significant role of the RNA. 
The tertiary RNA structure formed between the two loops in the Alu domain of SRP 
RNA is not bound by the protein and is therefore presumably free to interact with other 
cellular components such as the ribosome. This structure was therefore an interesting putative 
candidate for a functional role of SRP RNA in elongation arrest activity. To examine this 
hypothesis, we produced synthetic SRP RNAs with individual mutations in both loops that 
would disrupt base pairing, and with simultaneous mutations in both loops that would restore 
base pairing with a different primary sequence. The mutated RNAs were reconstituted into 
SRP and assayed for their elongation and translocation activities. We report here that the 
tertiary structure formed between the two distant loops is required for elongation arrest 
activity. Mutations disrupting the tertiary structure reduced the elongation arrest activity of 
reconstituted SRP. The loss of elongation arrest activity was the direct result of changing the 
RNA structure and was not due to the absence of h9/14 or another assembly defect. The 
functional importance of the structure is emphasised by its significant conservation. 
 
 MATERIALS AND METHODS 
 
Mutated SRP RNA and Alu RNA genes 
Mutations at specific sites in the SRP RNA gene were introduced by polymerase chain 
reaction (PCR) using the QuickchangeTM method (Stratagene). The primer oligonucleotides 
contained the desired mutations flanked by 15 nucleotides (Interactiva, Germany). As 
template for the polymerase chain reaction, we used either the plasmids p7Sswt (21) or 
pSA86H (26). Clones with complementary mutations in two different regions were obtained 
in two steps. All clones were verified by automatic sequencing. Nomenclature for the mutated 
SRP RNAs: The first number indicates the mutated nucleotides followed by the name of the 
loop. For example 2L2 represents the mutation of two nucleotides in L2. 
 
1.12.1.1 RNA synthesis 
Plasmids were linearized with Xba I (Gibco BRL) before synthesis of the RNA with T7 
RNA polymerase in 100 µl reactions (40 mM Tris-HCl pH 8.1, 20 mM MgCl2, 1 mM 
spermidine, 5 mM dithiothreitol (DTT), 4 mM of each rNTPs, 1 µg/µl BSA, 100 ng/µl DNA 
template and 22 U/µl T7 RNA polymerase. The plasmid for expression of T7 RNA 
polymerase was the kind gift of (33). Nucleotides were obtained from Sigma and stored as 
50 mM solutions at -80°C. After transcription, the DNA was digested with RQ1 RNAse-free 
DNAse (Promega), the samples extracted with phenol and purified on a 1 ml Sephadex G50 
(fine, Pharmacia) column. The RNAs were precipitated and dissolved in sterile water. The 
qualities and the quantities of the RNAs were verified on denaturing polyacrylamide gels and 
by measuring the optical density at 260 nm. For the synthesis of radiolabelled RNA, we used 
α [32P] UTP (24.105 Bq/mmol, Amersham Biosciences). 
 
1.12.1.2 SRP proteins 
The proteins h9, h14 and hφ19 were expressed in E. coli from the plasmid pEh9, pEh14 
and pEφ19 (18,34) using the T7 RNA polymerase expression system (35). Cells were lysed in 
a French Press™ and the extracts of h9 and h14 were combined for purification. The h9/14 
heterodimer was purified by Hi-Trap Heparin (Amersham Biosciences), by hydroxylapatite 
(BioRad) and by Superdex-200 (Amersham Biosciences) chromatography. The protein hφ19 
 
 was purified by Hi-Trap Heparin, CM and Superdex-200 (Amersham Biosciences) 
chromatography. Canine SRP54 was expressed in the baculovirus system (6). SF21 cells were 
used to amplify the virus encoding for SRP54, whereas the protein was produced in Tn5 cells. 
Following lysis of the cells in a homogenizer, the protein was purified on a CM and on Hi-
Trap Heparin column (Amersham, Pharmacia, Biotech). The purified proteins were quantified 
by spectrophotometry at 280 nm. Molar extinction coefficient εh9/14: 15 130 M-1 cm-1, 
εhφ19: 12 570 M-1 cm-1 and ε54: 22 220 M-1 cm-1. Canine SRP68/72 was purified from canine 
SRP as described in (12). 
 
1.12.1.3 Elongation arrest and translocation assays 
SRP was reconstituted with SRP RNA, canine SRP68/72 and recombinant SRP9/14, 
SRP19 and SRP54 proteins. Reconstitutions were done in 8 µl at 0.5 µM and 1 µM final 
concentrations of all the proteins and in vitro transcribed SRP RNA, respectively, in 20 mM 
HEPES-KOH, pH 7.5, 500 mM potassium acetate (KOAc), pH 7.5, 5 mM magnesium acetate 
(MgOAc), 0.01% (v/v) Nikkol, 1 mM DTT. Samples were incubated for 10 minutes on ice 
and for 10 minutes at 37°C. Reconstituted SRP was then added at the desired concentrations 
to 10 µl wheat germ translation reactions, programmed with synthetic preprolactin and sea 
urchin cyclin D transcripts as described in (36). Translation reactions were stopped after 30 
minutes at 26°C, proteins precipitated with 10% (w/v) trichloroacetic acid and analysed by 
12% SDS-PAGE. Preprolactin, prolactin and cyclin D were quantified by the use of a 
phosphorescence imaging system (BioRad). To monitor translocation, the 10 µl wheat germ 
translation reactions were complemented with SRP-depleted canine microsomes (0.15 eq./µl) 
prepared as described in (37). Elongation arrest and translocation efficiencies were evaluated 
as follows: 100]
/
/1[ ×−=
CoPo
CsPsEA  where EA is percent elongation arrest activity, Ps and Cs 
are the amounts of preprolactin and cyclin quantified in the sample and Po and Co the 
amounts of preprolactin and cyclin present in the negative control (SRP buffer or SRP 
reconstituted without h9/14). T =100 × [P /(pP + P)] where T is percent translocation, P is the 
amount of prolactin and pP the amount of preprolactin quantified in each sample. T is about 
20% without the addition of purified canine SRP or reconstituted particles. All SRPs were 
tested in at least two independent experiments. For purification by ion exchange 
chromatography, SRP was reconstituted in 50 µl reactions at final concentrations of 2 µM of 
 
 each protein and 12 µM of synthetic SRP RNA in 50 mM HEPES-KOH, pH 7.5, 500 mM 
KOAc, pH 7.5, 5.5 mM MgOAc, 0.01% (v/v) Nikkol, 1 mM DTT, 0.5 mM EDTA, pH 7.5, 
10% (v/v) glycerol. Fully reconstituted particles were purified away from incomplete particles 
through a 50 µl DE53 column essentially as described in (38). Samples were eluted twice with 
50 µl 50 mM HEPES-KOH, pH 7.5, 600 mM KOAc, pH 7.5, 6.5 mM MgOAc, 
0.01% (v/v) Nikkol, 1 mM DTT, 0.5 mM EDTA, pH 7.5, 10% (v/v) glycerol and twice with 
50 µl of the same buffer containing 1000 mM KOAc and 10 mM MgOAc. Aliquots of all 
fractions were precipitated with 10% (w/v) trichloroacetic acid and analysed by 5-20% SDS-
PAGE followed by silver staining. Complete particles eluted at 600 mM KOAc, whereas 
incompletely reconstituted particles eluted at 1000 mM KOAc. The concentrations of the 
purified particles were first evaluated by silver staining. However, for greater accuracy we 
quantified the SRP samples by Western blot analysis using affinity-purified antibodies against 
SRP14 and SRP54. 
 
RNA binding assays 
The protein h14 was synthesised in 10 µl wheat germ translation reactions in the presence of 
1 pmole of recombinant h9 (34). The heterodimer h9/14 was bound to 2 pmole of biotinylated 
SRP RNAs in 50 mM HEPES-KOH, pH 7.5, 350 mM KOAc, pH 7.5, 3.5 mM MgOAc and 
0.01% (v/v) Nikkol. The bound protein was purified away from unbound protein by the use of 
magnetic Streptavidin beads (Dynal) as described in (39). Bound proteins were analysed by 
15% SDS-PAGE, visualised by autoradiography and quantified with the phosphoimager 
(BioRad). 
 
1.12.1.4 Electromobility shift assays 
To set up the conditions for the competition experiments, 200 nM cold SA86 RNA 
(containing 20 000 cpm of labelled SA86 RNA as a tracer) was titrated against h9/14 at 
concentrations ranging from 25-600 nM. Conditions allowing optimal complex formation in 
the absence of an excess of protein were achieved at 190 nM h9/14. Individual reconstitution 
assays were done in 20 mM Hepes pH 7.5, 300 mM KOAc, 10 mM MgOAc, 5 mM DTT, 
0.015% (v/v) Nikkol. For reconstitution, 5 µl of RNA pSA86 (containing 20 000 cpm of 
labelled RNA) were recombined with 5 µl of competitor RNA and 10 µl of h9/14. The 
binding reactions were allowed to proceed for 10 minutes on ice, then for 10 minutes at 37°C. 
 
 Labelled and unlabelled RNAs were annealed in assay buffer without DTT and Nikkol 
immediately before use. The final concentrations of competitor RNAs ranged from 50 to 
800 nM. Negative control samples consisted of SA86 RNA alone and in the presence of 
equivalent amounts of bovine serum albumin. Native 8% polyacrylamide gels 
(acrylamide/bisacrylamide 40:1) containing 10 mM MgOAc and 50 mM Tris acetate pH 7.5 
were prerun at 0.22 W/cm3 for two hours in the cold room. Reconstitution samples in buffers 
without dye were mixed with 4 µl 80% (v/v) glycerol prior to loading and were run for 120 
minutes at 0.22 W/cm3 in the cold room. Gels were then fixed with 20% (v/v) methanol, 
10% (v/v) acetic acid for 30 minutes and dried before autoradiography or exposure to 
phosphoimager screen. Relative dissociation constants were calculated as described (34) using 
the following equation: 
Kdwt
Kdcomp
= [Rwt]
RwtP[ ] ×
[RcompP]
[Rcomp]
 (1) where [R] represents free RNA, 
[P] free protein and [RP] the complex. Taking into consideration that 
[RcompP] = (vo − v) × [Rowt]; [RwtP] = v × [Rowt]; ][)(][][ RowtvvoRocompRcomp ×−−=  
and [Rwt] = [Rowt] −v × [Rowt], equation 1 can be transformed into 
[Rocomp]
(vo − v) × [Rowt] −1=
Kdcomp
Kdwt
× (1
v
−1) (2) where νo and v represent fractions of the wt RNA 
bound to the protein in the absence and in the presence of different competitor concentrations, 
respectively. [Rowt] and [Rocomp] are the concentrations of wild type and competitor RNA, 
respectively, used in the experiments. The slope represents the ratio between the dissociation 
constants of the competitor and SA86 RNA.  
 
1.12.1.5 Computer programs and data bases 
For the sequence comparison of SRP RNAs we used the SRP database by (23) 
(http://www.psyche.uthct.edu/dbs/SRPDB/SRPDB.html). The image of the Alu RNP structure 
were generated as povscript file with the Swiss PDB viewer and rendered by Pov-Ray™.
 
 RESULTS 
 
1.12.1.6 SRP RNA mutagenesis and SRP9/14 binding 
 
The 5’ domain of Alu RNA is folded into a compact structure consisting of two helical 
stacks connected by a U-turn, which determines the relative orientation of the stacks (Fig. 1A 
and B, H1.1, H1.2 and H2; (20)). The single-stranded U-turn motif is highly conserved in 
primary sequence and represents the major protein-binding site. However, the protein makes 
additional contacts to the central stem (3’ domain), which is thought to flip back by almost 
180° to align alongside the compactly folded 5’ domain (Fig. 1B). The RNA-protein complex 
is further stabilised by tertiary RNA contacts between helix H2 and the central stem and a 
tertiary structure consisting of three G-C base pairs, which are formed between the two distant 
loops L1.2 and L2 (Fig. 1, G13-C37, G14-C34 and C15-G33). Whereas loop L2 is very rigid 
as it is constrained by a U-turn at position U12 and by a sheared G11-G16 base pair (Fig. 1), 
loop L1.2 is rather flexible lacking internal stabilizing structures. Another striking feature of 
the tertiary structure is the stack formed by the three base pairs and which is extended on both 
sides with purines from either loop L2 or loop L1.2 (Fig. 1, G16 and A36). 
To assess the role of the tertiary base pairs in elongation arrest activity of SRP, we 
specifically mutated two and three positions in each loop individually or in both loops 
simultaneously (Fig. 2A). Guanidine was replaced by cytidine and vice versa. Hence, the 
complementary mutations restored either two or three G-C base pairs. First, we studied 
whether the mutated SRP RNAs were still able to bind SRP9/14, since its presence is a 
prerequisite for elongation arrest activity of SRP (16). Binding of SRP9/14 was examined 
using biotinylated SRP RNAs and in vitro synthesised human SRP14 (h14) complemented 
with recombinant human SRP9 (h9). As previously observed (39), wild type SRP RNA bound 
30% of the protein h9/14 used in the assay (Fig. 2B and C, compare Input and WT). Although 
some differences could be seen, all of the mutated SRP RNAs were able to bind h9/14 as 
compared to the negative control (lane 3). Mutations in loop L1.2 and two compensatory 
mutations in both loops had no effect on the binding efficiency, whereas three compensatory 
mutations in both loops increased the binding efficiency. Both SRP RNAs with mutations in 
loop L2 showed a two-fold decrease in the binding efficiency. Hence, changes in the primary 
sequences of the loops did not abolish protein binding, but moderately changed the binding 
efficiencies of h9/14. To examine whether the observed effects were the fortuitous results of 
 
 the specific changes we made, we tested six other mutated RNAs in which G14,C15 and 
G33,C34 were changed into uridines and adenines (Fig. 2D). We observed similar results as 
with the previous mutations. RNAs with complementary mutations and the RNA with the 
mutation A33A34 in loop L1.2 bound h9/14 like wild type. The two RNAs with mutations in 
loop L2 were reduced to 41 and 44%, respectively. Notably, the double mutation in loop L1.2, 
U33U34, also had a slightly reduced binding efficiency (77%). 
It has previously been observed that G13 and G14 can be modified in naked SRP RNA 
but not in SRP (22) suggesting that tertiary base pairing occurs upon protein binding. Hence, 
the three base pairs are likely to contribute to stabilising the RNA-protein complex and their 
disruption might therefore be expected to have a moderate impact on the efficiency of 
complex formation. Most importantly, the effects of the mutations in one loop were always 
rescued by complementary mutations in the other loop consistent with the interpretation that 
they were due to the disruption of base pairing and not due to the changes in the primary 
sequences per se. However, it remained puzzling that only mutations in L2 and not in L1.2 
had noticeable effects on binding. It suggested that as long as the primary structure was 
conserved in L2, base pairing had only an auxiliary function for protein binding. However, 
when loop L2 is mutated, base pairing becomes essential to compensate the negative effects. 
In order to determine whether the observed decrease in the efficiencies reflected a 
significant change in the dissociation constants of the complexes, we used a quantitative 
approach to study the effects of the mutations. We have previously compared dissociation 
constants of Alu RNA variants in competition experiments with an electrophoretic mobility 
shift assay (EMSA, (25)). Complete SRP RNA could not be used in these experiments, 
because free RNA and the RNA-protein complex were not separated sufficiently. We 
therefore made the 2L2, 2L1.2 and 2 Comp mutations in SA86 RNA, which comprises all 
elements required for h9/14 binding (26). The relative dissociation constants were then 
determined with competition experiments (Materials and Methods) In addition, we also made 
a variation of the triple mutations made in complete SRP RNA. Instead of changing all three 
nucleotides in one loop, we mutated the three guanidines (G13G14G33) simultaneously into 
cytidines and the three cytidines (C15C34C37) into guanidines. Notably, the complementary 
mutation 3 Comp was identical in Alu SA86 RNA and complete SRP RNA. In these 
experiments, we used the same experimental conditions as described in (25) (see also Material 
and Methods). The results (Fig. 3 A and B) demonstrated that the dissociation constants of the 
various mutated SA86 RNAs differed very little from the dissociation constant of wild type 
Alu SA86 RNA. Consistent with the previous results, the biggest difference was seen with the 
 
 2L2A RNA with an apparent dissociation constant three-fold lower than wild type SA86 
RNA. If this difference reflected a decreased kinetic stability of the complex, it might account 
for the lower binding efficiency in the RNA binding experiments. Although SA86 RNA 
comprises all elements required for high efficient binding of h9/14, we cannot entirely 
exclude the possibility that mutations in the complete SRP RNA have a stronger effect on 
h9/14-binding than the same mutations in Alu SA86 RNA. 
In summary, we concluded from these results that certain nucleotide changes in the 
loops designed to interfere with base pairing moderately influenced the binding efficiency of 
h9/14. The effects were suppressed, if base pairing was restored. Importantly, taking into 
consideration that the Alu RNA-h9/14 complex is very stable (dissociation constant in the 
subnanomolar range (34,40), it was unlikely that the small changes observed would interfere 
with reconstituting SRP for functional assays. 
 
1.12.1.7 Functional analysis of SRPs comprising mutated RNAs 
 
SRP was reconstituted (41) from canine and recombinant SRP proteins together with 
synthetic SRP RNAs. The RNAs were produced in large-scale transcriptions and purified 
away from DNA and nucleotides under non-denaturing conditions. Human SRP19 (h19) and 
canine SRP54 were expressed in E. coli and insect cells, respectively. SRP68/72 was purified 
from canine SRP. The conditions for reconstituting SRP were optimised by testing different 
protein and RNA concentrations (results not shown). A slight excess of RNA over protein 
gave the highest yield in active particles (see below). Translocation and elongation arrest 
activities of the reconstituted particles were assayed in a wheat germ translation system. To 
examine their elongation arrest activities, we monitored the relative inhibition of preprolactin 
synthesis (a secreted protein) as compared to cyclin D synthesis (a cytoplasmic protein). To 
examine the signal recognition and targeting activities of the particles, we assayed their 
capacities to promote translocation into salt-washed canine microsomes as revealed by 
processing of preprolactin to prolactin (Material and Methods). Particles with intact signal 
recognition and targeting functions, but lacking elongation arrest activity, have their 
translocation capacities reduced by about 50% (12,18).  
The positive controls, canine SRP and SRP reconstituted with canine RNA efficiently 
and specifically inhibited preprolactin synthesis as compared to cyclin synthesis at a final 
concentration of 100 nM (Fig. 4A, upper panel, lanes 2 and 3, 94% and 91% inhibition, 
 
 respectively). The signal recognition and targeting activities of the same particles resulted in 
the processing of 85 and 81% of preprolactin to prolactin (lower panel, lanes 2 and 3). At the 
same concentration, the elongation arrest and processing activities of particles reconstituted 
with synthetic wild type RNA (WT RNA) were 78 and 43%, respectively (lane 4 upper and 
lower panel, respectively). No activities were detected at particle concentrations below 25 nM 
(results not shown). Hence, synthetic SRP RNA was less active in reconstituting functional 
particles. Re-annealing the RNA under different conditions as well as increasing the amount 
of RNA in the reconstitution reactions (see below) failed to improve the reconstitution 
efficiency. 
In the following, we compared the elongation arrest and translocation activities of 
particles reconstituted with mutated SRP RNAs to the activities of particles reconstituted with 
synthetic WT RNA. Disrupting base pairing through mutations in loop L2, 2L2 and 3L2 
RNAs, resulted in a significant loss of elongation arrest activity (Fig. 4A and B) whereas a 
moderate loss was observed with three mutations in loop L1.2 (3L1.2 RNA). Two mutations 
in loop L1.2 had no significant effect on the elongation arrest activity of the particle. Most 
importantly, mutations in the complementary loop always rescued the negative effects of the 
first mutations confirming that the RNA tertiary structure and not the changes in the primary 
sequence caused the loss in elongation arrest activity. Interestingly, not all mutations appeared 
to affect elongation arrest activity to the same extent suggesting that they interfered to 
variable degrees with the formation of the tertiary structure. Mutations in loop L2 appeared to 
be more detrimental to elongation arrest activity than mutations in loop L1.2. 
All SRPs containing mutated synthetic RNAs promoted translocation into salt-washed 
membranes and were therefore active in signal recognition and targeting (Fig. 4A and C). 
Hence, disrupting base pairing interfered predominantly with the elongation arrest function of 
SRP. In addition, the processing efficiencies were in agreement with the observed elongation 
arrest activities. All SRPs with defective elongation arrest functions had reduced translocation 
efficiencies as compared to WT SRP (Fig. 4, lanes 2L2, 3L2 and 3L1.2). 
 
Defective elongation arrest activity is the intrinsic property of fully assembled mutated SRPs and not the result of an assembly defect. 
 
We made several experiments to confirm that the observed decrease in elongation arrest 
activity was indeed an intrinsic property of SRPs comprising certain mutated SRP RNAs and 
was not due to incomplete assembly. 
 
 First, we examined whether increasing the amount of RNA in the reconstitution reaction 
improved elongation arrest activity. The reconstitution conditions have been elaborated with 
WT RNA and it was feasible that the mutated RNAs had a different activity in reconstituting 
active particles. SRP was reconstituted in the presence of a constant amount of all proteins 
and increasing concentrations of SRP RNAs. Binding of SRP proteins has previously been 
observed to be cooperative (41). An excess of RNA within certain concentration limits was 
therefore not expected to interfere with the assembly of fully reconstituted particles. In these 
experiments, we compared WT RNA to 3L2 RNA (Fig. 5A and B). Elongation arrest and 
translocation assays were performed as before. For WT RNA, reconstitutions worked best 
with an excess of 1.5-fold of RNA over protein (white bars). For 3L2 RNA maximal 
elongation arrest activity was observed at a four-fold excess of 3L2 RNA. Notably, the 
elongation arrest activity remained within the error bars around 35-45% inhibition as 
compared to WT SRP between a two-fold to eight-fold excess of RNA. All particles were still 
active in signal recognition and targeting as indicated by their processing activities. In 
addition, the observed processing efficiencies confirmed the results of the elongation arrest 
assays. The processing efficiencies were decreased for particles that had a partially defective 
elongation arrest function. 
Second, we titrated h9/14 into reconstitution reactions with 3L2 and WT RNAs. The 
excess of protein was thought to ensure that h9/14 was driven into the RNA-bound state even 
after dilution into the translation reactions. In these experiments, the amounts of SRP RNA 
and of all proteins except h9/14 were kept constant in the reconstitution reactions whereas the 
amounts of h9/14 were increased to the extent indicated (Fig. 5C and D). As before, the 3L2 
SRP had reduced elongation arrest and translocation activities as compared to WT SRP. 
Notably, both activities remained unchanged upon addition of up to an eight-fold excess of 
h9/14 indicating that the defect in the elongation arrest function was most likely not caused by 
the absence of h9/14 in the particle. 
Third, we decided to purify the particles after reconstitution. This approach requires 
large amounts of native canine proteins. To complement the previous experiments, we 
therefore limited our analysis to the mutated particles 2L2, 2 Comp and, as a positive control, 
WT particles. The reconstitution reactions were purified by anion exchange chromatography 
to remove non-bound proteins and partially reconstituted particles (Materials and Methods). 
Fully assembled SRP is expected to elute at 600 mM potassium acetate (38,42). As predicted 
from the RNA-binding experiments 2L2 RNA bound all SRP proteins including h9/14 as 
visualised by silver staining (Fig. 6B, lane 2). WT and 2 Comp particles gave similar results 
 
 (Fig. 6A, result not shown). Notably, SRP54 was the protein which bound with the lowest 
efficiency in all reconstitution reactions. The concentrations of the particles were determined 
by immunoblotting with anti-SRP14 and anti-SRP54 antibodies and by comparing to dilution 
series of recombinant h14 and canine SRP54 proteins (results not shown). The yield in 
purified SRP was about 30% of the protein input. 
The purified particles were added at different concentrations into translation and 
translocation assays. At concentrations below 20 nM of purified SRP, none of the 
reconstituted particles exhibited a significant elongation arrest activity (Fig. 6C). As 
compared to the negative control, which contained buffer instead of SRP, we observed an 
apparently non specific inhibition of about 20% for all samples. We have previously observed 
the same level of non specific inhibition with a particle lacking the SRP9/14 protein (18). In 
addition, there were significant fluctuations in the ratio of preprolactin to cyclin in the absence 
of a specific effect on preprolactin synthesis as indicated by the large error bars. The error 
bars decreased noticeably as soon as elongation arrest activity could be detected. We can as 
yet not explain this observation. Corroborating our previous results, elongation arrest activity 
increased in a concentration-dependent manner upon addition of WT and 2 Comp SRPs. 
Particles with 2 Comp RNA were even more active than WT SRP, although the shift in the 
two curves might be enhanced by a slight error in the concentrations of the particles. In 
contrast, 2L2 particles had again a reduced elongation arrest activity. The apparently 
increased elongation arrest activity of 2L2 particles at a concentration of 40 nM was most 
likely the fortuitous result of the significant errors rates in the absence of elongation arrest 
activity. In contrast, preprolactin processing could be monitored more accurately for all 
samples and at low SRP concentrations. The results of the translocation assays supported the 
previous interpretation. The processing activity of 2L2 SRP increased more slowly than the 
ones of WT and 2 Comp SRPs as would be expected for an elongation arrest-defective 
particle (Fig. 6D). Notably, at concentrations around 40 nM both 2 Comp and WT SRPs 
reached maximal translocation activities. As previously observed, the translocation efficiency 
of 2L2 SRP was only half maximal at the same concentration. Interestingly, the translocation 
efficiency continued to increase at 80 nM 2L2 SRP and might ultimately reach the same level 
as WT SRP at sufficiently high concentrations of 2L2 SRP. Hence, the decrease in the 
translocation efficiency of an elongation arrest-defective SRP could be compensated with 
higher particle concentrations. 
 
 
 DISCUSSION 
 
In these studies, we unravelled a function for a specific RNA structure in the Alu domain 
of SRP. It is directly required for elongation arrest activity and includes three tertiary base 
pairs between loop L2 and loop L1.2 that form an extended stack with one base from each 
loop. Mutations disrupting base pairing diminished elongation arrest activities of reconstituted 
SRPs, whereas complementary mutations in both loops fully restored elongation arrest 
activities to wild type levels despite the differences in the primary sequences of the loops. 
Mutations also had a moderate effect on protein binding. However, the loss in elongation 
arrest activity is not explained by the absence of h9/14 in the particles or by another assembly 
defect. It is an intrinsic property of SRPs comprising RNAs with mutations that impair 
formation of the tertiary structure. 
The experimental strategy employed in these studies has previously been successfully 
exploited to prove functional roles of base pairing structures in many processes such as pre-
mRNA splicing (43) and translation (44,45). In our experiments, we made the puzzling 
observation that individual mutations in loop L2 had stronger effects on elongation arrest 
activity of SRP and, to a much lesser extent, also on h9/14 binding, than mutations in loop 
L1.2. Or both mutations are expected to abolish base pairing between the loops. However, the 
negative effects of mutations in loop L2 were always completely rescued by complementary 
mutations in loop L1.2. Hence, if loop L2 remains unchanged, loop L1.2 mutations appear to 
have minor effects on Alu domain functions (see Fig. 4, lanes 2L1.2 and 3L1.2) whereas after 
mutation of loop L2, base pairing with loop L1.2 becomes essential for full elongation arrest 
activity (lanes 2L2 and 3L2). In structural terms, these results are consistent with the 
hypothesis that in addition to Watson-Crick base pairing per se an additional L2-specific 
factor may influence the formation and the stability of the tertiary structure. 
As mentioned before, loop L2 has a highly ordered structure in the h9/14-Alu RNA 
complex as it is constrained by a U-turn at position U12 and by a sheared G11-G16 base pair. 
A similar structural motif is also found in the ribosomal RNA-protein complex of L11 
(46,47). When base paired with loop L1.2, the three base pairs form a stack which is extended 
on both sides by a purine base from L2 and L1.2 (Fig. 1). The highly ordered structure of loop 
L2 may facilitate base pairing as well as the formation of the stack as four of the bases that 
participate belong to it. It is therefore feasible that in 2L1.2 and 3L1.2 SRPs, where loop L2 is 
unchanged, the constrained conformation of loop L2 facilitates formation of non-canonical 
 
 base pairs with loop L1.2 by keeping its four bases in a stacked conformation. In contrast, 
mutations in loop L2 may change its conformation or simply disfavour stacking because 
purines have been replaced by pyrimidines. Loop L1.2 lacks internal stabilizing structures and 
its flexibility is consistent with non-canonical base pairing with loop L2. The finding that G13 
was found to base pair with either C37 or U35 in the two Alu RNP structures illustrates its 
potential for alternative base pairing, although the G13-U35 base pair most likely represents 
an artefact caused by crystal contacts (20). Notably, the observation that 3L1.2 SRP has a 
slight defect in elongation arrest (Fig. 4) suggests that with an unchanged loop L2 structure, at 
least one Watson-Crick base pair is required for full activity of the tertiary structure. Another 
factor which might fortuitously influence the capacity to form alternative base pairs is that 
2L1.2 and 3L1.2 RNAs have a majority of purine bases and 2L2 and 3L2 RNAs a majority of 
pyrimidine bases in their loops. The pyrimidines might be too distant to form hydrogen bonds 
whereas the purines may form non Watson-Crick base pairs. 
The Alu domain of SRP RNAs of Metazoa, Plantae and Archaea as well as of the 
eubacterial species Bacillus and Clostridium (not shown) most likely all have the same overall 
fold as human Alu RNA, since the two helical stacks as well as the highly conserved U-turn 
motif linking the two stacks are preserved (Fig. 1 and 7). We have revised the previously 
published alignments (24) taking into consideration the conservation of essential structural 
nucleotides in the two hairpin structures of human Alu RNA (Fig. 7, (20)). As mentioned 
before, they include the base paired nucleotides (Fig. 7, red), the U-turn residue (star) and the 
sheared G-G base pair in loop L2 (green). The new alignment confirmed that all SRP RNAs 
of Metazoa, Plantae and Archaea can form tertiary base pairs between the two loops. In 
addition, the alignment reveals certain specific features for each group. 
Metazoan SRP RNAs contain all the specific structural features of human Alu RNA, 
although some minor differences are observed. They include differences in the loop sizes of 
D. melanogaster SRP RNA and an unusual U-U base pair preceding the sheared G-G pair in 
X. laevis SRP RNA. In plant SRP RNAs, loop L2 is highly conserved except that the U-turn 
residue is sometimes replaced by cytidine. This replacement may not have an important effect 
on the structure, since a C residue may introduce a U-turn-like bent as revealed by the 
pseudoknot structure of beet western yellow virus RNA (48). In certain cases, a non Watson-
Crick base pair precedes the sheared G-G base pair. The most important difference is that the 
loop L1.2 is always smaller and helix 1.2 shorter by one base pair. However, sequence 
conservation and complementary nucleotide changes support formation of two base pairs 
between the loops. Furthermore, the two base pairs are adjacent to the G of the sheared base 
 
 pair in loop L2 and the two base pairs and the adjacent G may therefore form a continuous 
stack as in human Alu RNA. 
In SRP RNAs of Archaea, the U-turn residue is still conserved whereas the sheared G-G 
base pair is absent. Instead, there is often a G-U or A-U base pair lengthening helix H2. The 
base complementarities between the loops are clearly expanded to four nucleotides. The 
biggest changes are in helix 1.2 and loop L1.2. Only the first four base pairs are confirmed by 
sequence complementarities. They are followed by a highly conserved apparently single-
stranded G residue. Its presence in all archaeal RNAs may highlight an important structural or 
functional role. The remaining nucleotides may either form a very large loop L1.2 (up to 
fifteen nucleotides) or extend helix H1.2 by non-canonical base pairing. As indicated in 
Fig. 7, an extension of H1.2 might be favoured, since large loops are thermodynamically 
unstable (49). The conserved G residue may allow bending of the longer helix thereby 
enabling loop L1.2 to base pair with L2 despite the presumably longer helix. 
In summary, the conservation of the key structural features such as the constrained 
structure of loop L2 and the potential to form base pairs which may form an extended stack 
with bases from the loops L2 and L1.2 emphasises the importance of this tertiary structure for 
SRP functions. Notably, the tertiary structure is not conserved in SRP RNAs of Protozoa and 
Fungi (50-53), which have truncated Alu-like domains lacking one or both hairpin structures. 
In trypanosomes, the absence of the specific tertiary structure in the Alu domain might have 
been compensated for by the acquisition of an additional tRNA-like RNA in the SRP particle 
(31,32). 
What is the function of the conserved tertiary structure in elongation arrest activity? The 
minor effects of the mutations on the dissociation constants of the complex are in agreement 
with binding of SRP9/14 to Alu RNA on the opposite side of the tertiary structure. In addition, 
the formation of the RNA binding surface of SRP9/14 (20) requires a largely intact protein 
complex and only very small changes in the C-terminal regions of SRP14 and SRP9 are 
tolerated without interfering with RNA binding (54). It is therefore unlikely that the structure 
of the SRP9/14 protein in the complex was changed significantly by the mutations in the 
RNA. As mentioned before, tertiary structure is most likely induced by protein binding (22) 
and it therefore contributes to the stability of the complex. The small changes in the 
dissociation constants and in the RNA binding efficiency are therefore plausibly explained by 
a slight diminished stability of the complex. It is also unlikely that the mutations in the two 
loops interfered with the formation of the closed complex. Alu RNA variants with mutations 
that interfere with the formation of the closed conformation have their dissociation constants 
 
 reduced by 50-100-fold (25). In addition, the particles containing the mutated RNAs have 
intact signal recognition and targeting functions, arguing against a significant influence of the 
mutations on the overall structure of SRP. Although it cannot be excluded entirely, it is 
therefore rather unlikely that conformational changes in SRP9/14 or in the overall structure of 
SRP account for the observed effects of the mutations on elongation arrest activity. 
A more attractive hypothesis is that the structure might be recognised by a ribosomal 
component. Indeed, the Alu domain is expected to make direct contacts with the ribosome to 
effect elongation arrest as deduced from the analysis of a truncated SRP14 protein. 
Interestingly, truncation of SRP14 has a more dramatic effect on elongation arrest activity of 
the particle than the disruption of the tertiary structure. Removal of only five amino acid 
residues (residues 96-100 in h14) at the C-terminus of SRP14 completely abrogates 
elongation arrest activity ((18,39), L.H. and K.S., unpublished results). Mutations in the two-
loop structure do not completely abolish elongation arrest activity consistent with an auxiliary 
role of the tertiary structure, which may optimise the essential function of the C-terminal 
region in SRP14. This interpretation is supported by the result that increasing the 
concentration of the mutated particle 2L2 could compensate its defect in translocation 
efficiency. In addition, it may explain why certain organisms like S. cerevisiae, which contain 
SRP14 but apparently lack the tertiary structure, have an elongation arrest function (11). The 
interacting partner for the tertiary structure may be ribosomal RNA or protein. Ribosomal 
RNA may recognise the geometry of the base pairs as it has recently been observed in codon-
anticodon recognition during translation (55) whereas a ribosomal protein may recognise the 
critical structure by shape. The results presented here clearly established an important role for 
the conserved tertiary structure in elongation arrest activity of SRP; future experiments will 
have to clarify its exact role in the mechanism of the elongation arrest function.  
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 FIGURE LEGEND 
 
Figure 1: Structure of the SRP Alu domain. (A) Secondary structure of the synthetic 
SRP RNA Alu domain. Stems and loops are named according to the topological 
nomenclature. Bases in the loops, which form tertiary base pairs are highlighted in red. 
Protein and RNA footprints are shown in bold. Stretches of ten nucleotides are marked in 
blue. (B) Structure model of the SRP Alu domain as derived from two crystal structures. SRP9 
and SRP14 are displayed as red and green ribbons respectively. Nucleotides from loops L2 
and L1.2 that are involved in tertiary interactions between the loops are shown as wireframe. 
The protein makes contacts to the U-turn as well as to the central stem. (C) Detailed view of 
the tertiary base pairing between loops L2 and L1.2. Bases G13, G14 and C15 form hydrogen 
bonds with C37, C34 and G33, respectively (dotted green lines). One base from each loop, 
G16 and A36, are positioned to extend the stack formed by the three base pairs. 
 
Figure 2: Binding of human SRP9/14 to mutated SRP RNAs. (A) Description and 
names of the mutated SRP RNAs. L2 and L1.2 mutations disrupt base pairing whereas Comp 
mutations restore base pairing with a different sequence. (B) In vitro synthesized 
[35S]-labelled h14 combined with recombinant h9 were bound to biotinylated mutated SRP 
RNAs as indicated on top of each lane. The RNA-bound proteins were submitted to SDS-
PAGE followed by autoradiography. The input represents 1/3 of the total [35S]-labelled h14 
protein used in the experiments. Neg: as a negative control we used rat 4.5S RNA. Lower 
panel h9/14 binding was quantified by phosphorescence imaging. (C) Protein binding 
efficiencies of mutated SRP RNAs in which guanidines and cytidines were replaced by 
adenines and uridines. The binding efficiencies of the mutated RNAs were normalised to wild 
type RNA (WT), which was set to 100%. 
 
Figure 3: Apparent dissociation constants of mutated SA86 Alu RNAs. (A) The h9/14-
SA86 complex and free SA86 were separated on 8% native RNA gel. Increasing amounts of 
3 Comp Alu RNA was added as a competitor. WT alone: SA86 Alu RNA. WT+BSA: h9/14 
was replaced with the same amount of bovine serum albumin. WT+h9/14: Complex 
formation in the absence of competitor RNA. (B) Complex formation was quantified by 
phosphorescence imaging and the apparent ratio of the dissociation constants calculated as 
 
 described in Material and Methods. WT: SA86 Alu RNA. 2L2, 2L1.2, 2 Comp and 3 Comp: 
The same mutations as described in Fig. 2A in the SA86 Alu RNA. Kdc and Kdwt: Dissociation 
constants of the mutated and of SA86 Alu RNAs, respectively. 
 
Figure 4: Elongation arrest and translocation activities of particles reconstituted with 
mutated SRP RNAs. (A) An example of elongation arrest and translocation assays. SRPs were 
reconstituted with canine and recombinant proteins and with canine, synthetic and mutated 
synthetic SRP RNAs. Reconstituted SRPs were added at a final concentration of 100 nM to 
10 µl wheat germ translation reactions programmed with sea urchin cyclin and bovine 
preprolactin mRNAs. SRP-depleted microsomes were added to assay translocation activities. 
After 30 min the reaction was stopped and the samples analysed by SDS-PAGE. Upper panel: 
Elongation arrest assays; lower panel: Translocation assays. Neg. : Negative control, 
reconstitution in the absence of h9/14; lanes 3-7: Particles reconstituted with SRP RNAs: 
cSRP: Canine SRP RNA; WT : Synthetic SRP RNA. (B) Quantification of the elongation 
arrest activities of mutated SRPs. The relative inhibition in the accumulation of preprolactin 
as compared to cyclin was calculated for each sample. The ratio of preprolactin to cyclin in 
the negative control was taken as 0% inhibition. (C) Quantification of the translocation 
activities of SRP. Values represent the ratio between prolactin and the total amount of 
preprolactin synthesised (preprolactin and prolactin). WT: Particles reconstituted with WT 
SRP RNA. Values represent the average of two or more independent experiments. 
 
Figure 5: Effects of increasing RNA and h9/14 concentrations on the activities of 3L2 
SRP. (A) Elongation arrest assays of particles reconstituted with increasing amounts of 3L2 
and, as a positive control, with WT SRP RNAs. 0.5x, 1X, 1.5x, 2x, 4x, 8x indicates the ratio 
between RNA and proteins. White bars: WT RNA; grey bars: 3L2 RNA. (B) Translocation 
assays with 3L2 SRP. S: standard reconstitution with WT SRP RNA standardised to 100 %. 
(C) Elongation arrest assays of 3L2 particles reconstituted with increasing amounts of h9/14. 
WT: Reconstitution with WT SRP RNA; 1x: Standard reconstitution of 3L2 particles; 2x, 4x, 
8x: Excess of h9/14 as compared to 1x. (D) Translocation assays with the same particles as 
in C. Values represent the average of two or more independent experiments. 
 
Figure 6: Elongation arrest and translocation activities of purified SRPs. 
(A) Purification of WT SRP by DE53 chromatography. Column fractions analysed by 5-20% 
SDS-PAGE and silver nitrate staining. FT: flow through, W: wash, lanes 1 and 2: elutions at 
 
 600 mM KOAc, lanes 3 and 4: elutions at 1M KOAc. Fully reconstituted SRP is in lane 1. 
(B) Comparison of the different reconstituted particles after purification. Lane 1: WT; lane 2: 
2L2; Lane 3: 2 Comp. The concentrations of the different SRPs were subsequently 
determined by Western blotting. (C and D) Elongation arrest and translocation activities are 
plotted against the concentration of purified SRP used in the assay. WT: black line, 2L2: 
dotted line, 2 Comp: dashed line. Values represent the average of at least four independent 
experiments. At low elongation arrest activities, the error bars were reproducibly more 
elevated. 
 
Figure 7: Evolutionary conservation of the tertiary structure. (A) Loop L1.2 and loop L2 
sequence alignments of a representative sample of metazoan, plant and archaeal species. Loop 
sequences are labelled with a black bar and the adjacent helix sequences are outlined in bold 
italic, dotted line: borders of loop sequences not unambiguously identified. (B) Secondary 
structure models of the 5’ Alu domain. Green: sheared G-G base pair, red: base paired 
nucleotides in the loops, blue: conserved nucleotide in Archaea. 
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